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ABSTRACT 
Behavioural activation (BA) therapy (Lejuez, Hopko, & Hopko, 2001; Martell, Addis, 
& Jacobson, 2001) is based on operant behavioural principles and involves efforts to 
increase the amount of ‘meaningful’ activity in the client’s everyday life, so that he or 
she increases contact with positive reinforcement for clinically-healthy behaviours 
while also decreasing contact with negative reinforcement for ‘depressed’ or ‘anxious’ 
behaviours. BA is an effective treatment for depression, yet rarely has been applied to 
anxiety despite functional similarities including the habitual avoidance that is a feature 
of both disorders. In this study Behavioural Activation Treatment of Anxiety (BATA) 
was evaluated across a series of single-case replications involving seven adults, each of 
whom met criteria for clinical anxiety. In each case, following a baseline period, BATA 
was delivered in twelve weekly 60-minute individual sessions. The effects of the 
treatment were evaluated using an A-B-C phase change with repeated measurement 
design. Dependent variables were self-monitored daily anxiety and activity levels, self-
reported anxiety, and the participants’ ratings of the ‘therapeutic relationship’ between 
themselves and the BATA therapist. A measure of treatment integrity was used.  
In six of the seven cases significant changes in daily activity levels and 
clinically significant decreases in anxiety were reported during the treatment phase. In 
five of those six cases, decreases in anxiety matched decreases in self-monitored daily 
anxiety. Reductions in anxiety were maintained up to a 3-month follow-up. Overall, 
participants rated the therapeutic relationship as just approaching ‘adequate’ and these 
ratings appeared not to be associated with the changes in anxiety and activity levels 
across the course of treatment. The treatment integrity data showed that the therapist’s 
behaviour followed the treatment protocol. 
Overall, the results of the study were promising and showed that BATA can 
provide effective treatment for chronic anxiety problems in adults. v      
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CHAPTER 1 
 GENERAL INTRODUCTION 
 
Anxiety has been defined as “the apprehensive anticipation of future danger or 
misfortune accompanied by a feeling of dysphoria or somatic symptoms of tension” 
(American Psychiatric Association (APA), 2000, p. 820) and is the most common 
mental health problem in contemporary society. In the United States, the lifetime 
prevalence rate for any anxiety-related disorder is 28.8% (Kessler, Berglund, Demler, 
Jin, Merikangas, et al., 2005) and the twelve-month prevalence rate is estimated at 
18.1% or approximately 40 million adults (Kessler, Chiu, Demler, & Walters, 2005). In 
Australia, the twelve-month prevalence rate for any anxiety-related disorder is lower at 
14.4% yet this rate still equates to approximately 2.3 million adults experiencing some 
form of clinical anxiety every year (Australian Bureau of Statistics, 2007). In primary 
care settings, it is estimated that 1 out of every 5 patients fulfill the diagnostic criteria 
for an anxiety-related disorder (Spitzer, Kroenke, Linzer, Hahn, Williams, et al., 1995).  
In the United States alone it is estimated that anxiety disorders represent an 
economic burden of over US $40 billion annually, 85% of which is the cost of 
psychiatric and non-psychiatric medical treatment (Greenberg, Sistsky, Kessler, 
Finkelstein, Berndt, et al., 1999). Sufferers of anxiety disorders experience more 
physical health problems, use more health services, take more days off work, and access 
more workers’ compensation compared to those never having been diagnosed with any 
anxiety disorder (Marciniak, Lage, Landbloom, Dunayevich, & Bowman, 2004). 
Anxiety is also associated with an increased likelihood of alcohol and/or other drug use 
(Chambless, Cherney, Caputo, & Rheinstein, 1987), depression (Greer & Trivedi, 
2005), and cardiovascular disease (Kawachi, Colditz, Ascherio, Rimm, Givannucci, et 
al., 1994). Thus, along with the personal cost to the sufferer, anxiety stands as a 2      
 
 
 
significant concern within contemporary society and represents a major challenge to the 
practicing clinician.  
Cognitive behavioural therapy (CBT) holds an almost unequivocal primacy as 
the empirically supported front-line psychological treatment for anxiety-related 
disorders (Barlow, 2002). Typical components of CBT include psycho-education, 
breathing retraining, cognitive restructuring, imaginal exposure, and in vivo exposure. 
Exposure, which essentially requires the anxiety-sufferer to deliberately and repeatedly 
contact fear-evoking stimuli, is perhaps the most scientifically valid and reliable 
component of CBT for anxiety-related disorders (Barlow, 2002). CBT has been shown 
to be the most effective psychological approach to the treatment of anxiety and has been 
found to be at least as effective as medication alone and often more so (White & 
Barlow, 2002). 
Nonetheless, contemporary psychological treatments for anxiety require further 
development because clinically significant outcomes often are not achieved by a 
proportion of the clinical population who receive CBT and other empirically supported, 
established treatments. For example, subsequent to psychological treatment, recovery 
rates range from 58% to 76% among obsessive-compulsive disorder (OCD) sufferers 
(Whittal, Thordarson, & McLean, 2005); approximately 75% among panic disorder 
with agoraphobia (PDA) sufferers (Ost, Thulin, & Ramnero, 2004); and 58% for people 
suffering generalised anxiety (Ladouceur, Dugus, Freeston, Leger, Gagnon, et al., 
2000). However, more generally between 20% and 80% of the clinical population will 
not benefit from contemporary treatments (Barlow, Allen, & Choate, 2004) and, 
although 20% to 80% may achieve desired outcomes, the shortcomings of present day 
clinical practices require continued efforts to develop more effective treatments.  
Applied behaviour analysis (ABA), an analytical approach founded on 
fundamental principles of operant psychology, emerged in the 1960’s and has been 3      
 
 
 
shown to be highly effective in changing behaviour within clinical and community 
settings. Mostly, however, ABA has been utilised with severely impaired populations; 
such as those with autism, acquired brain injury, and developmental disabilities - with 
relatively few published accounts describing the use of traditional ABA with non-
disabled populations with clinical problems such as adults experiencing anxiety 
(Friman, Hayes, & Wilson, 1998; Friman, 2010). However, some recent accounts 
describing the broad application of behaviour analysis to ‘traditional clinical issues’ 
(clinical behaviour analysis; Dougher & Hayes, 2000) have included increased 
discussion of the applications of ABA principles transferred to more common clinical 
populations. Functional Analytic Psychotherapy (FAP; Kohlenberg & Tsai, 1991), 
Dialectical Behavior Therapy (DBT; Linehan, 1993), Acceptance and Commitment 
Therapy (ACT; Hayes, Strosahl, & Wilson, 1999), and Behavioral Activation (BA; 
Martell, Addis, & Jacobson, 2001) are among the most notable. They have been 
categorised as third-wave therapies (Hayes, 2004) with a growing body of empirical 
support (Hayes, Luoma, Bond, Masuda, & Lillis, 2006; Mazzucchelli, Kane, & Rees, 
2009). Generally, in therapies such as ACT and BA, clinically relevant behaviour is 
organised into broad functional classes (e.g., avoidance) and is analysed with reference 
to environmental events and conditions (e.g., loss of job, death of spouse). The causes 
of the behaviour are “the external conditions of which behaviour is a function” (Skinner, 
1953, p.35).  
A behaviour-analytic approach to clinical issues has achieved growing attention 
from clinicians because private events, such as feeling anxious or depressed, have been 
included and examined from a functional perspective (Ferster, 1973; Friman et al., 
1998).  Also, the function of escape and avoidance behaviour has been emphasised 
particularly in recent behavioural models of depression (Kanter, Cautilli, Busch, & 
Baruch, 2005). In this model, depressed individuals show a class of responses defined 4      
 
 
 
by common functions of escape and avoidance. Thus, for example, avoiding contact 
with the social community or staying in bed all day can function to avoid exposure to 
environmental stimuli that elicit aversive thoughts and feelings in the individual 
(Martell et al., 2001). Lejuez, Hopko, and Hopko (2001) have argued that depressed 
behaviour can be explained by application of the matching law (Hernstein, 1961, 1970) 
suggesting that response allocation (i.e. either avoidant or approach behaviour) is a 
function of the relative reinforcement associated with each class of responses. They 
argue that concurrent reinforcement schedules of negative reinforcement of avoidant 
behaviour and decreased response-contingent positive reinforcement of approach 
behaviour maintain depression. Likewise, recent accounts of behavioural activation 
(BA) therapy have involved strategies, such as activity scheduling, that decrease 
avoidance behaviour as well as increase approach behaviour leading to a greater 
likelihood of expanding behavioural repertoires maintained by response-contingent 
positive reinforcement (Dimidjian, Martell, Addis, & Herman-Dunn, 2008). Some 
research has suggested that BA alone is as effective as cognitive-behavioural therapy in 
the treatment of depression (Jacobson, Dobson, Truax, Addis, Koerner, et al., 1996) and 
BA has received strong empirical support as a stand-alone treatment for depression 
(Cuijpers, van Straten, & Warmerdam, 2007; Mazzucchelli et al., 2009; Spates, Pagoto, 
& Kalata, 2006).  
BA is designed to assist the depressed individual to systematically increase the 
range of activity in his or her life contexts where contacting sources of reinforcement 
for activity potentially fulfils an anti-depressant function (Martell, et al., 2001). Anxiety 
shares functional similarities with depression because individuals reporting behaviours 
typically classed as anxious respond in contexts in which relatively high frequencies of 
negative reinforcement and avoidance behaviour is commonplace (Hayes, Wilson, 
Gifford, Follette, & Strosahl, 1996). In behavioural terms, avoidance has been defined 5      
 
 
 
as “the substitution of behaviors that bring immediate relief from distress for behaviors 
that may cause immediate discomfort or anxiety but can be very helpful over the long 
run” (Addis & Martell, 2004, p.49). Techniques that function to block avoidance are 
major aspects of BA and they may be as effective in the treatment of anxiety as in the 
treatment of depression. For example, the range of alternative approach responses 
emitted by an anxious individual could potentially widen proportionate to increased 
contact with potential positive reinforcers leading to a concurrent decrease in negatively 
reinforced behaviour, such as avoidance of pain, fear of task difficulty or threat. 
Increased approach behaviour may result in approach behaviours that include 
behavioural cusps, which are defined by Rosales-Ruiz and Baer (1997) as “behaviour 
change that has consequences for the organism beyond the change itself, some of which 
may be considered important” (p.534). To date, BA therapy has rarely been applied and 
evaluated with clients reporting mainly anxiety problems (e.g., Jakupcak, Roberts, 
Martell, Mulick, Michael, et al., 2006). However, it was the success of BA treatment for 
depression that led to the study reported in this thesis. This study describes one of the 
first clinical applications of a BA approach to reducing chronic anxiety in adults and its 
subsequent experimental evaluation. 
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CHAPTER 2 
 BEHAVIOURAL ACTIVATION 
 
2.1 Chapter Overview 
One of the principles of behaviour analysis is the use of objective definitions and 
descriptions of behaviour and the environment (Skinner, 1966). Being the treatment 
investigated within this study, it is important that behavioural activation (BA) and its 
scientific context are properly described. Essentially, BA is a structured therapy that 
focuses on increasing behaviour in socially important areas such that opportunities for 
contact with naturally occurring positive reinforcement are increased, along with 
increases in the likelihood of concurrent changes to mood, thought, and even overall 
quality of life. The most important distinction between BA and frontline psychological 
treatments such as cognitive behavioural therapy (CBT; Beck, Rush, Shaw, & Emery, 
1979) is that within BA there is no focus on directly modifying covert private behaviour 
such as thinking and feeling.    
Contemporary BA (e.g., Martell et al., 2001) has been practiced since the mid 
1990s (Jacobson et al., 1996) yet BA-type interventions (although not referred to as 
such) have been in use at least since the early 1970s (e.g., Lewinsohn & Graf, 1973). 
There are two current accounts of BA (Brief Behavioural Activation Treatment for 
Depression (BATD); Lejuez et al., 2001; Behavioural Activation (BA); Martell et al., 
2001) that are commonly applied in clinical settings. In this chapter contemporary BA 
will be discussed in terms of its essential philosophical, conceptual, and technical 
characteristics. Also, differences between BA and other popular contemporary 
behaviour-analytic treatments are discussed along with the differences between the two 
predominant BA treatment models. 
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2.2 Philosophical Roots 
Contemporary behavioural activation therapy (BA) developed from a radical 
behaviour-analytic viewpoint (Ferster, 1973; Skinner, 1953; 1966). Behaviour analysis 
places emphasis on identifying behaviour, the context in which it occurs, and the 
functional relations between behaviour and context. The causes of behaviour are to be 
discovered by analysing the events that precede behaviour (antecedents) and the events 
that follow the behaviour (consequences). A cause is a change in the independent 
variable that effects a change in the dependent variable. Thus, the “old cause-and-effect 
connection becomes a functional relation” (Skinner, 1953, p. 23). The underlying 
philosophy is contextualism or functional contextualism, which views human behaviour 
as the “act in context” (Hayes & Brownstein, 1986, p. 177) and focuses on the 
environmental context of behaviour and the functional utility of the behaviour itself 
(Biglan & Hayes, 1996). As a scientific philosophy functional contextualism can be 
practically synonymous with radical behaviourism. However, radical behaviourism 
historically has been misunderstood (Chiesa, 1994) and the term, ‘functional 
contextualism’, may be more contemporarily relevant, especially with regards to clinical 
behaviour analysis (Hayes & Hayes, 1992).  
The ‘functional contextualist’ views any overt or covert behavioural event as an 
interaction between the person and a context that is defined by historical and current 
antecedents and consequences of behaviour. Functional contextualism has been referred 
to as a “practical” and “pragmatic” approach to changing behaviour (Hayes, 1993). 
Essentially, all behaviour whether covert (e.g., private thoughts, feelings, recollections) 
or overt (e.g., shouting, complaining) occurs due to its “successful working” (Hayes and 
Brownstein, 1986) within context. Thus, in applied settings, the analysis in behaviour 
analysis is a means to an end – not the end itself. The analysis of clinically-relevant 
behaviour orientates the therapist towards actions that are likely to be therapeutic. 8      
 
 
 
Simply stated, if the desired change (e.g., a reduction in anxiety) occurs as a 
consequence of the planned actions taken or arranged then the analysis is complete. If 
change is not forthcoming or is unpredictable (i.e., variable) then the analysis ought to 
continue. Although the underlying principles are considered lawful and immutable 
(Skinner, 1953), behaviour-analysis is inherently idiosyncratic and views the person as 
unique, singular and belonging to heterogeneous groups.  
Behaviour analysis stands in obvious contrast to those approaches described as 
“mentalistic” (e.g., cognitive psychology; Hayes & Brownstein, 1986). In these types of 
approaches, the private behaviour of the individual (thinking, feeling, remembering) is 
given causal status and assumed to lead to and maintain other behaviour (e.g., declining 
social invitations), or mediate the relationship between an environmental event (e.g., 
receiving social invitations) and behaviour (e.g., declining invitations). Cognitive 
processes are often purported to hold central agency in producing, predicting and 
understanding others’ behaviour. For example, “Automatic thoughts are those thoughts 
that intervene between outside events and the individual’s emotional responses to 
them”…….“the patient in cognitive therapy must learn to recognise these automatic 
thoughts for therapy to proceed effectively” (Young, Weinberger, & Beck, 2001, 
p.278). And, “It is important to remember that anxiety results from overestimating the 
cost of feared events….” (Clark, 1999, p. 27). Conversely, an example of a behaviour-
analytic view is: “The behavioral activation therapist accepts her clients’ thinking, but 
encourages clients to look at the context of thinking rather than at the content of 
thoughts. So, when clients present ruminative thinking about their depression or bad life 
circumstances, the BA therapist will help them look at the antecedents and 
consequences of this kind of thinking” (Martell et al., 2001, p. 64). In this way, 
instances of private behaviour are regarded as units of behaviour caused by the same 9      
 
 
 
external conditions that occasion more public behaviour such as running and eating 
(Skinner, 1953).  
Although some behaviour analysts have objected to the study of private events 
on methodological grounds (e.g., Lamal, 1998), Skinnerian behaviour analytic 
approaches never denied the existence of private events. Skinner stated, “We need not 
suppose that events which take place within an organism’s skin have special properties 
for that reason. A private event may be distinguished by its limited accessibility but not, 
so far as we know, by any special structure or nature” (Skinner, 1953, p. 257). Any type 
of behaviour, private or public, is considered a legitimate goal of analysis (Hayes, 
1993). The behaviour analyst simply rejects the view that behaviour of one kind is best 
explained as the manifestation of some other internal process occurring within the 
individual. A description of private events is considered as exactly that – a description 
of psychological phenomena that requires explanation, and a satisfactory (i.e., 
workable) explanation, such as the description of functional relations, is unachievable 
without taking into account events external to the overt and covert behaviour of the 
individual (Hayes & Brownstein, 1986).  
 
2.3 Conceptual Characteristics  
Hayes (1978) stated, “Ways of talking about the world…. emerge which 
encompass general rules, principles, or laws. These relate not so much to specific ways 
of doing things as to a general theoretical or conceptual system” (p. 26). Within 
behaviour analysis, new findings are organised according to empirically established 
principles of behaviour (Moore & Cooper, 2003) which hold an extensive history in 
basic and applied research (see Catania, 1998 and Sulzer-Azaroff & Mayer, 1991).  
Although Skinner (1953) displayed considerable prescience in his early writings 
and discussed clinical concerns including anxiety, depression, and drug addiction, it was 10      
 
 
 
Skinner’s post-graduate student Ferster (1973) who provided a behavioural explanation 
of depression that is most often referred to within the contemporary BA literature 
(Martell et al., 2001). Ferster emphasised the usefulness of a clinical approach that 
considered “the circumstances currently present, the person’s activities, the 
consequences of the person’s acts both inside and outside of his skin, and the functional 
relation between the component events” (p. 868). Ferster placed considerable emphasis 
on the high probability of avoidance and escape behaviours by the depressed individual 
that consequently limit the opportunities for the positive reinforcement of alternative 
anti-depressant behaviour, thereby holding the individual within a context that regularly 
occasions depressed thoughts and feelings. For example, in a recently published BA-
related case study, a 46-year-old male with ‘depression’ reported regularly occurring 
aversive feelings (e.g., anger, irritability, agitation, sadness) and a large repertoire of 
avoidance behaviour, including isolating himself, yelling at his wife, ruminating, 
excessive sleeping, and long periods of television watching. Although this provided 
relief from his ‘depression’, the relief was only ever temporary, and in the long-term his 
depression-related behaviour became more frequent and intense, and critical aspects of 
his life (e.g., his relationship with his wife and children) became more negative 
(Santiago-Rivera, Kanter, Benson, Derose, Illes, et al., 2008). Thus, from a BA 
perspective, clinical symptoms such as withdrawal and avoidance are operant 
behaviours maintained according to schedules of naturally occurring reinforcement.  
Early descriptions of BA-type operant approaches to the treatment of depression, 
though not referred to as BA (Lewinsohn & Libet, 1972; Lewinsohn, Sullivan & 
Grosscup, 1980), and the more recent descriptions (Lejuez et al., 2001; Martell et al., 
2001) have emphasised the central importance of principles of reinforcement in clinical 
analysis and treatment. For example, Lewinsohn et al. (1980) explained depression as 
resulting from the loss of positive reinforcement for alternative anti-depressant 11      
 
 
 
behaviour, and found that an increase in response-contingent positive reinforcement 
(achieved by increasing activity levels in certain areas) led to improvements in mood 
(decreased Beck Depression Inventory (BDI) scores), increased engagement in pleasant 
events, and decreased engagement in unpleasant events. Thus, decreases in non-
depressed behaviour have also been attributed to a lack of positive reinforcement for 
what might be termed ‘healthier’ alternative behaviour (Lewinsohn, 1974). Also, 
approach behaviours (e.g., attending a party) may be punished due to behavioural 
deficits (e.g., poor social skills), thus adding to ‘depressed’ behaviour (e.g., withdrawal; 
Lewinsohn et al., 1980). More recently, BA techniques have focused on decreasing 
depressed behaviour by increasing opportunities for non-depressed behaviour in order to 
contact reinforcement and thereby produce corresponding improvements in mood and 
overall quality of life (Martell et al., 2001). 
 Although the distinction between negative and positive reinforcement has been 
criticised in the past as being either imprecise, inaccurate, or unnecessary (Michael, 
1975), both of these terms have been used in clinical applications of the analysis of 
behaviour including depression and anxiety (e.g., Martell et al., 2001; Ramnero & 
Torneke, 2008; Skinner, 1953). For example, depression-related behaviour, such as 
complaining, ruminating, or excessive alcohol use may function to avoid aversive 
conditions, such as silence, boredom and social embarrassment. Thus, the relationships 
between variables can be illustrated using the standard three-term (ABC) contingency:  
 
Antecedent                     Behaviour                  Consequence 
                                                         
 
 
 
At home alone, 
experiencing 
boredom and 
sadness 
Suppression of 
and escape from 
’sad’ emotional -
responses 
Engaging in 
alcohol use 12      
 
 
 
Within a different context depression-related behaviour may be maintained by positive 
reinforcement: 
Antecedent                     Behaviour                  Consequence 
                                                         
 
    
 
In any natural setting, behaviour may be reinforced in multiple ways, both 
positively and negatively (Skinner, 1953). It has been estimated that up to 15% of all 
problem behaviour is maintained by multiple reinforcement contingencies (Hanley, 
Iwata, McCord, 2003). Crucially, according to behaviour-analytic principles, if the 
examples of behaviour (i.e., alcohol use, complaining and reporting of symptoms) 
increase or re-occur in the future then the behaviour is being reinforced by its 
consequences. Accordingly, the properties of different types of behavioural classes 
(e.g., avoidance, rumination) are defined with respect to the consequences of the 
behaviours rather than their topographical features. The BA therapist accepts that “the 
form of a behavior is less informative than the function of that behavior. Two clients 
may do exactly the same thing, but the behavior has very different contexts and 
consequences” (Martell et al., 2001, p. 50). Thus, within the BA approach to therapy the 
focus is on broad classes of clinically-relevant behaviours and on the function of those 
classes of behaviours rather than on their form or topography.  
At the level of application, BA is a molar approach. This term refers to the 
analysis of broad patterns of behaviour within contexts that are to be understood 
according to an aggregate of events over time. Molecular refers to the analysis of 
discrete antecedents and behaviour occurring within momentary time intervals (Baum, 
1989). Molecular analysis is most useful and prevalent within the context of basic 
research, in which a high degree of experimental control is available and the elements of 
In presence of 
therapist, 
experiencing 
worry 
Therapist talks 
reassuringly and 
gives advice and 
support 
Complaining and 
reporting of lists 
of symptoms 13      
 
 
 
functional relations (e.g., task demands, types of prompts, presence of preferred 
reinforcers) are able to be observed within discrete time intervals. The variables are 
more easily described in concrete, measurable components and are temporally distinct 
(Carr, Carlson, Langdon, Magito-McLaughlin, & Yarbrough, 1998). Natural 
environments, however, do not hold equivalent properties, and when working with a 
client in typical clinical settings it is impractical to attempt to conduct a functional 
analysis of every contingency maintaining all clinically-relevant behaviour. Thus, molar 
relations might be more relevant to clinical behaviour analysis.  
Within BA the therapist collaborates with the client to identify patterns of 
operant behaviour and focuses on the contingencies between clinically relevant 
behaviours and their consequences. For example, the BA therapist may employ the use 
of the traditional ABC acronym or the newer TRAP acronym: Trigger, Response, 
Avoidance-Pattern (Martell et al., 2001, p. 100). The data may be informal with events 
discussed in session, or formal based on data from clients’ daily self-monitoring. 
Gaynor and Harris (2008), for example, investigated the use of BA for depression 
within an adolescent population and stated within the procedure, “The 
objectives….were to begin an ideographic functional analysis of the adolescent’s 
depression. The adolescent was asked about current activities, attempts to alleviate 
depression, and….to self-monitor activities and mood” (p. 379). Because the therapist is 
working to identify broad classes of behaviour, there is less necessity for the precision 
expected from within basic research. However, the moment by moment imprecision is 
countered by the attention given to analysing broad tracks of client behaviour. An 
individual functions under multiple schedules of reinforcement for his or her entire 
repertoires of operant behaviour (Sulzer-Azaroff & Mayer, 1991). Some behaviour may 
be reinforced immediately, and is associated with minimal effort (e.g., staying in bed), 
and some behaviour may be associated with maximum effort before reinforcement 14      
 
 
 
occurs (e.g., going to work). Reinforcement may occur frequently (e.g., alcohol-use) or 
intermittently (e.g., gambling). These schedules ultimately will determine the day to day 
behaviour of the individual and may become clear by organizing client behaviour 
according to molar functional relations (Waltz & Follette, 2009).  
 Lejuez et al. (2001) and more recently Waltz and Follette (2009) have discussed 
the principle of the Matching Law (Hernstein, 1961, 1970; McDowell, 2005) when 
discussing clinically-relevant behaviour, and the relevance of matching to approaches 
that emphasise molar functional relations.  The behavioural Matching Law describes the 
relation between overall patterns of responding and reinforcement. Thus, the amount of 
time an individual spends engaging in a particular activity (e.g., staying in bed) 
compared to the amount of time spent engaging in an alternative activity (e.g., going to 
work) is relative to the amount of reinforcement obtained for engaging in activity 1 
compared to engaging in activity 2. Engagement is further influenced by the amount of 
effort involved in contacting reinforcement, such that the individual may “choose” to 
spend his or her time engaged in activity 1 even when a larger amount of reinforcement 
is available for activity 2, because more (aversive) effort, at least initially, is involved in 
engaging in activity 2 (Fisher & Mazur, 1997). Over time, individuals typically learn to 
allocate their behaviour among alternative responses available to them proportionate to 
the amount or intensity of positive and negative reinforcement provided across those 
alternatives.  
In an example from sport, basketball players can attempt a 2-point shot or a 3-
point shot. The 3-point shot must be launched from outside of the 3-point line (23 ft 9 
in) which consequently increases the difficulty of the shot and decreases the rate of 
reinforcement (points scored) relative to the degree of difficulty and rate of 
reinforcement for 2-point shots which can be scored from within the line. For a 3-year 
period, however, between 1994-1997 the National Basketball Association in the US 15      
 
 
 
reduced the distance of the 3-point line to 22 ft thereby increasing the likelihood of 
obtaining reinforcement for 3-point shooting. During this period, NBA players 
responded by increasing their 3-point shooting by 23.9% (Ramanowich, Bourret, & 
Vollmer, 2007). In an earlier study, Conger and Killeen (1974) measured the amount of 
in-conversation attention participants allocated between two confederates, each of 
whom provided social reinforcement (e.g., “I agree with that point”) set to 
independently controlled reinforcement schedules. In a 30 min period, the researchers 
were able to demonstrate that the amount of attention allocated by participants between 
confederates matched the relative rates of social reinforcement delivered by each 
confederate. These findings were replicated by Borrero, Crisolo, Tu, Rieland, Ross, et 
al. (2007) with confederates providing independently scheduled positive social 
consequences following statements by participants during conversations about drug and 
alcohol use and the quality of schools. Overall, the duration and frequency of attention 
displayed by participants to confederates was consistent with the confederates’ varying 
independent schedules of social reinforcement.  
Consideration of the Matching Law is important within BA because the BA 
therapist and client can reliably assume that the proportional rate of engagement in, say, 
depression-related activity, such as staying in bed, using alcohol, procrastinating and 
ruminating, compared to non-depression related activity, such as working and 
socialising, matches the proportional rate of reinforcement for depression-related 
activity compared to non depression-related activity. Also, if reinforcement rates are 
increased for one class of behaviour such as going to work, and decreased or even 
eliminated for another class of behaviour such as staying in bed, then there is an 
increased likelihood that the behaviour operating under the weaker schedule of 
reinforcement will be reduced in relative proportion. In principle, increasing 
reinforcement of healthy, non-depressed behaviour, while concurrently decreasing or 16      
 
 
 
eliminating reinforcement of depressed behaviour, is an example of differential 
reinforcement of incompatible behaviour (DRI). Operant extinction also occurs when “a 
procedure in which the reinforcement of a previously reinforced behavior is 
discontinued….the process by which a previously learned behavior disappears as a 
result of nonreinforcement” (Sulzer-Azaroff & Mayer, 1991, p. 590). 
DRI strategies have been shown to be effective in treating a range of clinical 
behaviours including binge eating (Bosch, Miltenberger, Gross, Knudson, & 
Breitweiser, 2008), Tourette’s syndrome-related behaviour (e.g., tics; Verdellen, 
Hoogduin, Kato, Keijsers, Cath et al., 2008), smoking (Gifford, Kohlenberg, Hayes, 
Antonuccio, Piasecki et al., 2004), excessive alcohol use (Fournier, Ehrhart, 
Glindermann, & Geller, 2004), and aggression (Durand & Merges, 2001). With BA 
techniques, an automatic consequence of facilitating the client’s increased engagement 
in activities that are likely to be positively reinforced, such as visiting friends, is the co-
occurring equivalent decrease in negative reinforcement for depressed behaviour, such 
as staying home alone. In this case, there is an increased likelihood of extinction of 
‘staying home’ behaviour. Increased activation of a client’s behaviours automatically 
alters the density of reinforcement contingent on other behaviours and it follows that as 
some behaviours are maintained and strengthened, other behaviours will weaken and 
reduce.  
When the BA therapist is working to identify behaviour classed according to its 
consequences he or she may also identify behaviour classed according to its relation to 
the client’s psychological health. Thus, there will be examples of behaviour within a 
client’s repertoire that are likely to support ‘better psychological health’ (e.g., visiting 
friends and working) and examples of behaviour that are likely to be maintaining 
‘poorer psychological health’ (e.g., staying in bed and not answering the phone for long 
periods). At this point, consideration of Matching Law is of vital importance. It is not 17      
 
 
 
enough for the BA therapist to simply recommend a change in behaviour without at 
least initially attempting to identify potential sources of reinforcement available to the 
client that will function to maintain the alternative behaviour. The reinforcers must be 
available within the environment just as the client’s behaviour must contact them.  
Clients referred for ‘depression’ or ‘anxiety’ may demonstrate a narrow 
response class such that they are not typically behaving in ways that lead to positive 
reinforcement for more desirable behaviour. Lewinsohn (1974), for example, 
emphasised the underlying lack of response-contingent positive reinforcement within 
the depressed individual’s day to day life. Thus, when collaborating on goals to increase 
particular behaviours, the BA therapist must consider the range of potential responses 
from the client, whether the required behaviours are within the client’s behavioural 
repertoire, and whether reinforcement is reliably available in the client’s natural 
environment to support the behaviour (Kohlenberg & Tsai, 1991). The last point of 
consideration is perhaps the most important. The principle of shaping, in which 
successive approximations of the complete behaviour are reinforced, suggests there is 
the likelihood that with adequate reinforcement available within his or her environment 
the client can attain an accomplished level of healthy (i.e., non-depressive) behaviour – 
even if the initial presentation suggests considerable behavioural deficits. According to 
the principles of operant conditioning (Catania, 1998; Skinner, 1953), a single response 
is all that is needed to begin to build a comprehensive behavioural repertoire.  
Finally, within a BA-type approach to treatment there is a high probability of 
occurrence of what have been named ‘behavioural cusps’ (Rosales-Ruiz & Baer, 1997). 
In principle, a behaviour change is considered a ‘cusp’ when the change introduces the 
individual to novel or (similar-to) previously contacted environments that occasion new 
behaviours or reinvigorate old, rarely displayed behavioural repertoires, and provides 
new or (similar-to) previously contacted contingencies of reinforcement. Thereby, 18      
 
 
 
specific changes in targeted behaviours in treatment may ultimately lead to a beneficial 
expansion of the individual’s repertoire of behaviour. Examples of cusps include a 
toddler learning to walk, when he or she gains access to a range of new contexts in 
which he or she can develop new behaviours as a consequence of operating within and 
upon an expanded range of environments. A non-verbal child may be provided with an 
electronic communication device that supports the child to effectively engage with his 
or her typically developing peers and come into contact with their reinforcement of 
typical or desirable social behaviour. A young adult starting a course at university may 
find him or herself exposed to a wide range of new social, educational and political 
experiences and new contingencies related to ‘university attending’ behaviours.  
Within the published literature, behavioural cusps have rarely been discussed in 
relation to common clinical problems. Nor have behavioural cusps been discussed 
within the context of behavioural activation (BA) treatment or other behaviour-analytic 
approaches. In fact, a lack of clinical and research interest is surprising given that the 
central aim of BA specifically (and behaviour analysis generally) is overt generalised 
behavioural change. Due to its emphasis on increased behavioural activation, BA 
treatment automatically increases the likelihood of cusps. The more varied and frequent 
an individual’s daily activities become, the more likely that person will engage in some 
activity that occasions new behaviours or reinvigorates past behaviours with the 
potential for contacting multiple sources of reinforcement that leads to a ripple effect as 
even more related behaviours are generated. However, just as increased activation 
within BA therapy and its relationship to the client’s mental health and wellbeing is the 
means of analysis and not the end of analysis, only subsequent to its occurrence is the 
client’s behaviour change able to be assessed as a cusp. Furthermore, because cusps 
occur as a consequence of a treatment plan that encourages activation across a range of 
life-areas rather than specifically programmed individual activities, they do not hold the 19      
 
 
 
experimental property typically sought after within traditional behaviour analysis 
(Rosales & Baer, 1997) and an a priori identification of cusps may be time-consuming 
and (ultimately) fruitless.  
Bosch and Fuqua (2001) have expanded on Rosales and Baer’s paper to propose 
criteria for selecting potential cusps. They argue that, in order to meet the criteria, a 
‘cusp’ behaviour change should (a) provide access to new environments, reinforcers, 
and contingencies; (b) possess a general utility (i.e., generativeness); (c) compete with 
inappropriate or undesirable behaviour within the individual’s repertoire; (d) benefit 
others within the individual’s environment; and, (e) help the individual to meet the 
demands of his or her social environment. As an example, a depressed client may 
complain of feeling sad and tense in his usual social settings and having coped by either 
avoiding social occasions or excessively using alcohol, particularly before leaving home 
to attend social gatherings as well as when interacting in social settings. This may result 
in the client spending most of his non-work time at home alone, performing poorly in 
social situations due to intoxication, and regularly being absent from work due to 
‘hangovers’.  In collaboration with his BA therapist, he may consider scheduling visits 
to his local gymnasium. If he regularly visits the gym (a new environment with positive 
contingencies) there is an increased likelihood that he would decrease his alcohol use, 
meet new people, increase his work-attendance, better manage his time, improve his 
sleep, and overall improve his physical and mental health and wellbeing. As a behaviour 
change target, working-out with gym equipment simply suggests the potential outcome 
of physical improvement, yet if a range of adjunctive contingencies occur which are 
important to the individual within his social context, then the behaviour change might 
meet the criteria of a cusp. Thus, the analysis of the client’s behaviour in context ought 
to provide indications of the types of behaviours to be activated that may potentially 
function as behavioural cusps. 20      
 
 
 
Finally, the identification of behavioural cusps must take place subsequent to 
change in the targeted behaviour. This is similar to the assessment of reinforcement. 
Once a response occurs and is met with a specific stimulus event (consequence), an 
increase in the probability of the response contingent on the occurrence of that 
consequence shows that reinforcement occurred (Catania, 1998). Although reinforcers 
are often identified before procedures aimed at increasing target behaviours are 
conducted through reinforcer assessments, reinforcement is proven only with post hoc 
analysis of change in the target behaviour (Sulzer-Azaroff & Mayer, 1991). Similarly, 
behavioural cusps are established only after actual behaviour change has occurred and 
must involve the post hoc analysis of outcomes. Although Bosch and Fuqua (2001) 
have provided guidelines (only) for the a priori identification of behavioural cusps, in 
clinical settings such a system could involve assessment against the criteria proposed by 
Bosch and Fuqua of reductions in the client’s presenting problems and additional 
(unplanned) positive changes in ‘healthier’ behaviours in his or her everyday living.  
 
2.4 Technical Characteristics 
BA is a focused clinical model of therapy with a core set of techniques. At the 
technical level, BA typically includes techniques that are drawn from traditional 
behaviour therapy. The overall goals of BA therapy are to help the client to describe his 
or her behaviour and its associated eliciting, discriminating, and reinforcing stimuli, and 
to select ‘healthy’ target behaviours for activation. Two predominant models of BA 
therapy exist. One has a duration varying from 12 to 24 sessions (Behavioural 
Activation (BA); Martell et al., 2001), and the other a briefer 10 to 12 sessions protocol 
(Brief Behavioural Activation Treatment for Depression (BATD); Lejuez, et al., 2001). 
The techniques considered here are the essential elements of both BA and BATD.  
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2.4.1 Measurement 
Consistent with behaviour analytic principles, BA utilises ongoing assessment 
through repeated measurement of key outcome variables. This technique provides a 
quantification of the client’s clinical concerns (Barlow, Hayes, & Nelson, 1984) and 
provides feedback to the therapist and client of the client’s progress. If, for example, the 
measures indicate unchanging or deteriorating outcomes then the conditions of therapy 
are modified. Observations and objective measurement are necessary for the precise 
definition of behaviour within behaviour analysis, yet in clinical practice indirect and 
sometimes subjective methods are used and are justified because the naturalistic clinical 
setting is far less-controlled than a typical research environment such as a laboratory 
(Iwata & Dozier, 2008). For instance, in addition to the obvious ethical concerns within 
typical adult out-patient mental health services it is often impractical for clinicians to 
directly observe clients within their natural settings (e.g., home, workplace; Kohlenberg 
& Tsai, 1991). Within BA therapy Martell et al. (2001) recommend the use of a 
standardised self-report instrument at regular intervals, such as the Beck Depression 
Inventory (e.g., BDI-II; Beck, Steer, & Brown, 1996) which asks respondents to rate the 
level of their depression-related symptoms during the prior two weeks. Clients are also 
asked to self-monitor their daily activities by completing daily activity charts that 
require them to record what they were doing, who they were with, and how they were 
feeling in 1-hour periods throughout the day (Martell et al., 2001, p. 201). Ideally, 
practitioners will obtain sufficient information about clients’ problem behaviour from 
multiple sources in order to provide information that enables an ongoing analysis of 
functional relations between behaviour and consequences as well as identifying 
antecedent conditions and providing a comprehensive illustration of clients’ clinical 
behaviour in context.  22      
 
 
 
Self-monitoring of one’s own behaviour has been suggested as an effective 
stand-alone treatment strategy (Heidt & Marx, 2004). Past research has shown that self-
monitoring was effective in reducing smoking rates among college students (McFall, 
1970), reducing obsessive thoughts by a 25-year-old woman (Frederickson, 1975), and 
improving mood in depressed adults (Harmon, Nelson, & Hayes, 1980). Change 
subsequent to the implementation of self-monitoring is explained in terms of reactivity, 
which has been defined as “changes in the client’s behavior that are due to the 
measurement process per se” (Barlow et al., 1984, p. 93). However, other studies have 
shown that self-monitoring alone is insufficient to maintain clinically-significant change 
among marijuana users (Twohig, Shoenberger, & Hayes, 2007) and OCD-sufferers 
(Abramowitz, Franklin, Zoellner, & Dibernado, 2002). The use of self-monitoring 
within BA primarily is to measure outcomes and to provide data for ongoing functional 
analyses and is one component of the total intervention. 
 
2.4.2 Education 
Typical of the behavioural therapies, BA contains a substantial amount of 
psycho-education for the client. This includes discussing the client’s presenting 
problems, possible etiology, providing a behavioural explanation of behaviours that may 
be labelled ‘depression’ or ‘anxiety’, discussing the function of clinically-relevant 
behaviour such as avoidance of social occasions, and providing information about the 
BA treatment model itself. In relation to the reported symptoms of ‘depression’, there is 
little difference between BA and any other traditional treatment modality in terms of 
acceptance of the diagnostic criteria and the client’s problem behaviour. For example, 
low mood, sleep problems, poor concentration, and feelings of hopelessness are all 
typical symptoms reported by clients with ‘depression’ (APA, 2000) and are included 
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provide diagnostic classification of a client’s reported behaviour if required. However, it 
is important to note that the use of the terms ‘depression’ or ‘anxiety’ is only to apply a 
socially-constructed verbal term to the private and public behaviour that typically is 
reported as ‘depression’ or ‘anxiety’. Thus, in behaviour analysis the term properly 
applied should always be considered separate from the actual events that cause the 
experience of ‘depression’ or ‘anxiety’ itself (Anderson, Hawkins, Freeman, & Scotti, 
2000). These events are the subject matter of analysis in BA, not the labelling of people. 
Further, by placing depressive behaviour within its context BA treatment moves away 
from illness-based models of depression that emphasise brain function (e.g., serotonin 
deficits) and cognitive processes (e.g., negative thinking) and this is considered a part of 
efforts to ‘de -medicalise’ conditions including depression (Jacobson & Gortner, 2000).  
The BA model is formally presented to the client in the early stages of treatment 
and is regularly discussed throughout subsequent sessions (Jacobson, Martell, & 
Dimidjian, 2001). Initially, the client may hold alternative explanations for his or her 
behaviour including biology, genetics, and treatment received as a young child. The BA 
therapist acknowledges the influence that genetic, biological and more distal factors 
such as early life experiences may have on the subsequent development of a condition 
such as depression. However, often these types of explanations are unhelpful for the 
client because the proximal physical properties of the environment of which the client’s 
depressed behaviour is a function are not adequately addressed. Thus, the BA therapist 
will work carefully to orientate the client towards a functional analysis of his or her 
‘clinical’ behaviours. For example, the therapist might say, “BA is based on the idea 
that the events in your life and how you respond to such events influence how you feel” 
and, “Pulling away from the world when feeling down is natural and understandable” 
(Dimidjian et al., 2008, p. 333).  24      
 
 
 
It is an assumption of BA and other behaviour-analytic approaches such as 
Functional Analytic Psychotherapy (FAP; Kohlenberg & Tsai, 1991) that functional-
analytic interpretations of behaviour will be therapeutic. Technically, this involves the 
clients observing and describing their own behaviours along with the associated 
reinforcing, discriminative, and eliciting stimuli. In this way, a client is educated about 
functional relations and analysis. The client’s description of functional relations is 
assumed to increase the likelihood of him or her contacting reinforcement for ‘healthy’ 
behaviours (Kohlenberg & Tsai, 1991). This would work according to ‘rules’ that the 
client forms that include descriptions of the contingencies that support ‘healthy’ and 
‘non-healthy’ behaviours (see Mallot, 1989 for discussion of ‘rule-control’). This might 
lead to the depressed individual increasing alternative behaviours that could have an 
anti-depressant effect, and decreasing behaviours that have a depressant effect. If the 
natural environment provides reinforcement contingent on these alternative behaviours 
then they will be strengthened. Additionally, the client may choose to delay 
reinforcement, such as the person with social anxiety who stays at a party until his or 
her anxiety naturally decreases rather than receiving a more immediate decrease in 
anxiety by quickly leaving the party at the first signs of anxiety. Initially, the client may 
stay at the party (follow a rule) based on the knowledge of the contingencies controlling 
his or her ‘escape’ behaviours that was gained in the education process within BA, 
whereas subsequent partying behaviour is more likely under the control of naturally 
occurring contingencies.  
Therefore, an in principle characteristic of clinical behaviour analysis is the 
modification of the verbal behaviour of clients, at least in relation to how they describe 
clinically-relevant behaviour. Depending on the starting point, it is subsequent to the 
initial sessions and by degrees that descriptions of behaviour in terms of functional 
relations attains significance for the client. That verbal behaviour is shaped by its 25      
 
 
 
consequences has been well established (Catania, 1998) although the shaping of client 
verbal behaviour within specific clinical contexts awaits further empirical confirmation 
beyond the findings of the few studies conducted thus far (e.g., Busch, Kanter, 
Callaghan, Baruch, Weeks et al., 2008). 
 
2.4.3 Activation Strategies 
The core strategy of BA is focused activation which is thoroughly explained to 
the client early in treatment. Examples include, “In this treatment, we will work together 
to help you become more active and engaged in your life”; “Each session will involve 
developing practical and doable steps to engage in activities that improve mood and to 
solve specific life problems”; and “Activating and engaging in specific ways can help 
you experience more reward and effectively solve life problems” (Dimidjian et al., 
2008, p. 333). The therapist explains that the aim is not to simply engage in increased 
activation at random, or in activities that are generally assumed to have anti-depressant 
properties (e.g., going to the movies, eating ice-cream) which was a feature of early 
models (Lewinsohn & Libet, 1972). Rather, the activation targets in BA are identified 
according to the initial and ongoing functional analysis of client behaviour and, as such, 
reflect ideographic rather than nomothetic principles. In practice, activities may actually 
be considered “unpleasant” to some – yet function to improve a particular client’s 
overall health and wellbeing. 
This point is a critical difference between activity scheduling within BA and the 
type of activity scheduling used within CBT (Young et al., 2001). Within CBT, the 
therapist collaborates with the client to increase client engagement in activities chosen 
according to assumed properties of “mastery” and “pleasure”. In contrast, BA 
emphasises engagement in activities that potentially attract positive reinforcement for a 
particular client and follow a functional analysis of that individual client’s daily life. 26      
 
 
 
Engagement in these activities is simultaneously informed by the analysis and forms the 
analysis. In other words, engagement in any activity is the means of analysis, not the 
ends of analysis.  
 
2.4.3.1 Goal-Setting 
From information gained from the client’s in-session verbal reports and 
between-session monitoring the BA therapist, in collaboration with the client, is able to 
generate potential targets for activation. Typically, the obtained data will indicate the 
types of activities the client is avoiding, the types of activities that are under-activated, 
and the types of activities that are over-activated. The rate of engagement in these 
activities is assumed to correlate with reported positive mood, thought and overall 
quality of life.  
These activities initially are able to be organised according to their relationship 
to broader treatment (life) goals (goal defined as “the object or aim of an action”, Locke 
& Latham, 2002, p. 705). Goal-setting is part of contemporary BA treatment protocols 
(e.g., Lejuez et al., 2001; Martell et al., 2001) as well as other behavioural approaches 
(e.g., ACT; Hayes et al., 1999) and functions to organise activities according to their 
goal-related properties, and to orientate client behaviour according to his or her stated 
goals rather than according to often vague and ambiguous internal signals associated 
with depression and anxiety. Lejuez et al. (2001), for example, use a “Life Areas 
Assessment” (p. 269) form that requires clients to “describe activities that you would 
like to accomplish” within broad areas such as family relationships, employment, and 
hobbies. This form itself is an adaptation of the “values assessment homework” 
described by Hayes et al. (1999) which is used to identify values, goals, and actions 
within the ACT framework.  27      
 
 
 
It is well established that explicit and specific goal-setting can improve 
practically any area of human performance (Gollwitzer, 1999; Locke & Latham, 2002; 
Sulzer-Azaroff & Mayer, 1991) and is a key strategy within self-management 
approaches to mental health (Rehm & Adams, 2004). Goals may be determined by their 
temporal characteristics in that some goals are more immediately achieved than others, 
and therefore it is possible to label goals as short, medium, or long-term. Ultimately, 
though, labeling in this way is an arbitrary exercise as every goal will consist of short-
term subgoals which are quantifiable steps towards a larger goal (Sulzer-Azaroff & 
Mayer, 1991). Thus, in order to achieve “ultimate” goals there will be immediate and 
intermediate goals that need to be accomplished along the way (Malott & Garcia, 1987). 
This is important in the context of BA therapy in at least two ways. Firstly, the therapist 
and client can collaborate in generating concrete goals without strict adherence to any 
particular time-frame in relation to the accomplishment of the goals, even within the 
time-frame of a typical course of therapy (e.g., 12 weeks). Secondly, because clients 
will typically be oriented towards behaving in ways that accomplish immediate yet 
unhelpful goals such as a temporary reduction in feelings of tension or sadness, well-
specified and valued short-term goals can function to orientate behaviour in ways that 
increases the probability of contacting more immediate positive reinforcement in the 
steps towards the larger, long-term goal(s) (Malott & Garcia, 1987).  
Verbally-stated goals are assumed to function as discriminative stimuli or 
prompts (i.e., verbal antecedents to operant behaviour) such that they specify the 
antecedents and consequences of behaviour associated with accomplishing the goal 
(Sulzer-Azaroff & Mayer, 1991). Thus, statements serve to: (a) delineate the necessary 
environmental conditions for the accomplishment of the goal, (b) prompt specific 
actions by the individual to accomplish the goal, and, (c) signal the consequences for 
acting in accordance with the accomplishment of the goal. Goal setting can influence 28      
 
 
 
choice and preference within behaviour classes. This is important because all 
individuals have multiple response options available to them at any one time within the 
context of their reinforcement history (Fisher & Mazur, 1997), yet the day to day 
activities of many (most) clients are determined by the immediate consequences of 
avoidance behaviours rather than more constructive, ‘healthy’ approach behaviours. For 
example, Mullick and Naugle (2004) applied BA as treatment with a 37-year-old man 
(“Bruce”) who was experiencing co-occurring post traumatic stress disorder and 
depression. At assessment Bruce complained of having an unfulfilling and uninteresting 
job as well as being severely socially isolated. However, avoidance of effort and 
anticipated potential setbacks included no action to find alternative employment (“His 
job….was something he could handle because it required little of him”, p. 380). Also, 
avoidance of uncomfortable emotions meant he had steadily lost contact with his friends 
and didn’t plan or engage in any social activities outside of his work setting. Thus, 
Bruce’s long-term goals included re-engaging with past friends and re-starting a 
business as a magician/entertainer, something he had experienced considerable success 
with in the past.  
The goals of any individual are likely to indicate individually and socially 
important sources of reinforcement. In other words, the choice of any goal will be based 
on a past history of reinforcement provided contingent upon actions associated with 
attempts to reach a goal. Thus, the consequences of acting toward a goal are implicit 
within the goal itself. The goal may function as a rule in that the individual is stating 
that, “In the past my behaviour has been reinforced for ……and if I engage in …… my 
behaviour will be reinforced again”, or “In the past I felt happy when I …… and if I 
engage in …… I will feel happy again”. Over time goals, like rules, can form a general 
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contexts supportive of alternative ‘healthy’ behaviours compared to a possible large 
number of direct trial and error experiences (Malott, 1989).  
 
2.4.3.2 Activity Scheduling 
Subsequent to the goal-setting exercise, clients are prompted to identify specific 
activities to engage in (Lejuez et al., 2001). The activities are likely to be goal-related, 
such as enquiring about a gym membership as a step towards improving fitness levels, 
and function as alternatives to avoidance, such as attending a social event. Activities 
may be attempted according to degree of difficulty, preference and logistical order. In 
BA, clients are expected to formally schedule activities in an activity log (Lejuez et al., 
2001, p. 273) along with the preferred frequency and duration of engagement (e.g., 
walking around park, 3 occasions, 30 min per walk). Activities may be scheduled in-
session or between sessions and are varied across individuals. Examples in the literature 
include church going, driving, visiting gravesites, arranging photographs (Hopko, Bell, 
Armento, Hunt, & Lejuez, 2005), walking, attending outdoor concerts (Bottonari, 
Roberts, Thomas, & Read, 2008), and hiking, talking with partner, and visiting family 
(Armento & Hopko, 2009). However, activity scheduling in contemporary BA is not the 
same as the activity scheduling which was part of earlier approaches (Lewinsohn & 
Libet, 1972). Earlier models focused on pleasant events scheduling, which was based on 
the concept that the non-engagement in ‘pleasant events’ led to and maintained 
depression. This approach was not always successful (Hammen & Glass, 1975).  
Activity scheduling within contemporary BA (Addis & Martell, 2004; Martell et 
al., 2001) is guided by two standards: the short, medium, and long term goals of the 
client, and the initial and ongoing functional analysis of the client’s clinically-relevant 
behaviour. In terms of functional analysis, Addis and Martell (2004) use a simple 
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mood and behaviour, C = choose alternative behaviour, T = try out the alternatives, I = 
integrate the changes into your life, O = observe the results, N = now evaluate. This 
approach reflects early behaviour analytic accounts of depression (Ferster, 1973; 
Skinner, 1953) where the individual’s current mental-health status exists within 
historical and present patterns of behaviour. The aim is to help the client respond 
differently within various daily settings, and then to observe what happens and evaluate 
the outcomes. When changes in overt behaviour are associated with changes in covert 
behaviour (e.g., mood) then this is discussed with consideration of the contextual 
variables that may have influenced both changes (Jacobson et al., 2001).  
The BA therapist does not need to speculate whether an activity involves 
pleasure or mastery or any other standard categorisation such as occurs in CBT for 
depression (Beck et al., 1979). Although the briefer BA treatment (Lejuez et al., 2001) 
does state, “If you believe that completing a particular activity would bring a sense of 
pleasure and/or accomplishment, then it probably would be good to include it” (p. 268), 
this might be an unnecessary and unreliable element of treatment, especially if the client 
has experienced a chronic loss of contact with the very functional properties of events 
they are being asked to identify. In the longer version of BA (Martell et al., 2001) the 
authors state, “It (pleasure/mastery rating) is not essential” (p. 109). From a functional 
contextual perspective activities should be assessed post hoc according to workability 
(Hayes, 1993). If engagement in certain scheduled activities is shown to produce 
corresponding improvements in mood or overall quality of life, then the client is 
encouraged to continue engaging in such activity. Even without a corresponding 
improvement in mood, the exercise may demonstrate to clients that they can work 
towards personal goals regardless of mood states. If there is sufficient reinforcement 
contingent upon engaging in the activity clients may establish new patterns of 
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evidence supporting their continued use within contemporary BA, the use of mastery 
and pleasure ratings seems only to be an artifact of the full CBT protocol (Beck et al., 
1979) from which current approaches to BA were developed.   
Changes may be observed in new and therapeutic behavioural routines in the 
client’s life (Jacobson et al., 2001). Poor mental health is often characterised by 
unregulated routine activities, or a lack of opportunities, that occasion symptomatic 
responding (e.g., mood disorders; Plante & Winkelman, 2008). Regular engagement in 
alternative activities may become routine such that healthy behaviours become 
commonplace. The BA therapist works with the client to identify areas of regulation of 
routine that may have a therapeutic outcome. The provision of materials, such as self-
monitoring forms and daily activity logs, prompt and help to establish those routines.  
 
2.4.4 Addressing Barriers to Activation 
Every scheduled activity and every goal represents a ‘task’ – something that 
needs to be done. As such, every activity and goal may be part of a task assessment in 
which the activity is broken down into smaller components or steps. Any task regardless 
of complexity is able to be ordered according to its behavioural elements - the actions 
needed to meet the larger behavioural objective (Sulzer-Azaroff & Mayer, 1991). Addis 
and Martell (2004), for example, discuss strategies to help clients “break down the 
components” of activity and make changes “one step at a time” (pp. 107 – 127). This is 
different to treatment approaches such as graded exposure for anxiety (White & Barlow, 
2002) in which a hierarchy of activities is constructed relative to the degree of difficulty 
inherent in each activity due to the anticipated level of emotional responding. Within a 
task analysis, a chain of behavioural steps is created according to the most efficient, 
logical sequence of events needed to reach the overall objective; emotional responding 
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objective set by the client during BA treatment. There are a number of steps towards 
such an objective including updating a person’s resume, listing preferred employment, 
reading job advertisements, conducting online searches, calling employment agencies, 
registering with job agencies, contacting potential employers, submitting applications, 
and attending interviews. Each of these activities can also be broken down further into 
smaller components if necessary.  
The BA therapist must work with the client to be specific and detailed in the 
description of scheduled activities, including what behavioural steps are necessary to 
complete the activity (Jacobson et al., 2001). If the client fails to complete any of the 
scheduled activities necessary to reach the longer term goal the therapist and the client 
can perform a task analysis to identify possible barriers to activation. If the barriers are 
environmental, such as time demands, social intrusion or transport, ways can be 
formulated to address the barriers and plans drawn up as to how to manage them. If the 
barriers are psychological, such as avoidance, the therapist returns to discussing the BA 
model and identifies the function of the client’s behaviour.  
Thus, barriers within BA therapy are met with even more focused analysis and 
subsequent activation. Traditional behavioural techniques, including social skills 
training and time management strategies, may need to be implemented, but the overall 
aim is for component behavioural deficits to be addressed within the context of 
naturally occurring reinforcement contingencies within the client’s specific 
environment. Only a small step may be needed for the client to enter into a behavioural 
“trap” where ample or high quality reinforcement is contactable to support further 
behaviour change (Stokes & Baer, 1977). In effect, clients’ skills are to be shaped by 
their interactions with the broader environment rather than relying on interactions only 
within the therapy session. Any behaviour change that occurs in natural “community” 
settings is more likely to generalise to other settings and be maintained long-term 33      
 
 
 
(Kohler & Greenwood, 1986). The technique of focused activation in everyday contexts 
stands in contrast to behaviour-analytic approaches such as FAP (Kohlenberg & Tsai, 
1991) which relies heavily on client/therapist in-session interactions to produce 
therapeutic change.  
 
2.4.5 BA Compared to ACT 
BA differs from another behaviour-analytic approach to the treatment of 
psychopathology, Acceptance and Commitment Therapy (ACT; Hayes et al., 1999). 
The main difference is that the ACT model emphasises the verbal context of clinical 
behaviour, assuming that the client’s responses are predominately under the control of 
his or her own verbal processes, and that they have become insensitive to direct 
environmental contingencies (for a more comprehensive comparison see Kanter, 
Baruch, & Gaynor, 2006). In the BA model, the emphasis is on behaviour/environment 
relations, and ‘depressed’ behaviour is assumed to be predominately controlled by 
external stimuli. Thus, ‘avoidance’ is due to contingencies involving the negative 
reinforcement of avoidance behaviour, whereas in the ACT model ‘experiential 
avoidance’ (Hayes et al., 1996) is due to verbal processes that function to maintain 
avoidance repertoires, as well as the external contingencies of reinforcement. ACT 
includes techniques such as ‘defusion’, ‘acceptance’, and ‘mindfulness’ which are 
aimed at altering the verbally derived support for avoidance behaviours whereas BA 
does not. For example, the ACT therapist might conduct the ‘Milk, Milk, Milk’ exercise 
(Hayes et al., 1999) in which the client is asked to quickly repeat a ‘negative’ word or 
words (e.g., “I’m bad”) to alter the symbolic function of the words and demonstrate to 
the client that the stimulus functions of words are largely derived. Or the ACT therapist 
might strategically employ the use of ‘metaphors’ in order to ‘deliteralise’ the 
provocative content of the clients’ verbal behaviour.  34      
 
 
 
Both BA and ACT treatments include ‘activation’ strategies. The difference is 
that in BA treatment activation is the first and foremost strategy, designed to reduce 
avoidance and to assist the client in establishing contexts that provide positive 
reinforcement for ‘healthy’ behaviours based solely on a collaborative functional 
analysis. In ACT, activation occurs in the context of ‘valuing’ where the aim is for 
clients’ overt behaviours to come under the verbal control of their ‘values’, defined as 
“verbally construed global desired life consequences” (Hayes et al., 1999, p. 206). 
Activities are called ‘actions’ in ACT and are  chosen according to their correspondence 
with the client’s goals. A difference is that the scheduling of and engagement in 
activities is preceded by ‘values’ exercises where a client might be asked to describe an 
ideal friendship, or the type of person he or she would like to be in an intimate 
relationship. Furthermore, activation itself is preceded by strategies aimed at directly 
modifying verbal processes through defusion and mindfulness and ‘valuing’ occurs in 
the latter stages of treatment (e.g., Chapter 11; Hayes, 2005).  In BA, a focus on 
activation appears early in the treatment manual (e.g., Chapter 2; Addis & Martell, 
2004). Both BA and ACT acknowledge that clients’ clinical behaviours are operant 
behaviours supported by contingencies of reinforcement. The central difference is that 
ACT focuses on verbally ‘derived’ consequences of client behaviour whereas BA is 
more concerned with ‘direct’ consequences. Whether there are any differences in terms 
of traditional psychotherapy outcomes between ‘valuing’ alone, ACT, and BA awaits 
empirical evaluation (see Ruiz, 2010 for a comprehensive review of the ACT research).  
 
2.4.6 BA (Martell et al., 2001) Compared to BATD (Lejuez et al., 2001) 
The BA model of treatment as discussed in this chapter has been shown to be 
comprised of the essential elements of the two predominant contemporary BA 
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to present BA in its most parsimonious and principled form. Both BA and BATD are 
treatments based on operant principles and both assume depression is maintained by 
contingencies of positive and negative reinforcement. BATD is briefer than BA (10 – 12 
sessions compared to 20 – 24) and has fewer procedures. Both treatment models include 
self-monitoring of activities and mood, specific and concrete goal setting, and activity 
scheduling. Both models recommend active ‘problem solving’ to address barriers to 
activation, hierarchical ordering of activities according to difficulty or effort, and the 
involvement of ‘significant others’ for practical support. BATD includes a ‘Life 
Activities Checklist’ which lists potential activities a client may choose to engage in. 
This is similar to the ‘pleasant events scheduling’ within earlier BA-type approaches to 
the treatment of depression (e.g., Lewinsohn, Munoz, Youngren, & Zeiss, 1986). In 
fact, BATD is closer in practice to earlier models of BA-type interventions. BATD 
encourages clients to “engage in activities that bring you a sense of pleasure and/or 
accomplishment” (Lejuez et al., 2001, p. 261).  In comparison, BA clearly states that 
simply increasing pleasant activities is insufficient treatment and emphasises a 
collaborative functional analysis of the client’s day to day behaviours with activities 
scheduled in order to match the client’s goals and provide alternatives to avoidance 
behaviours. Altering avoidance patterns is the focal point for intervention in BA rather 
than simple engagement in ‘pleasant’ activities.   
BA has a larger set of procedures than BATD. BA also includes teaching 
functional analysis to clients and uses the analysis to orientate behavioural activation. 
BA includes verbal (imaginal) rehearsal of scheduled activities (e.g., phoning a friend), 
in-session role-playing, therapist modeling, relief techniques (e.g., distraction), 
‘behavioural stopping’ (in which the client is advised to do something to stop his or her 
own undesirable behaviour at the time it occurs), mindfulness exercises, and skills 
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these techniques in BA from other treatment approaches (e.g., ACT; Hayes et al., 1999) 
by suggesting that any technique in BA is used only to increase activation rather than to 
target verbal processes or directly alter cognitions.  
BA was used in the two largest randomised controlled trials comparing BA to 
the full CBT package (Jacobson et al., 1996; Dimidjian, Hollon, Dobson, Schmaling, 
Kohlenberg, et al., 2006), the results of which largely provide the empirical support for 
using BA treatment for depression (see Chapter 3 for a comprehensive review). 
However, neither of these studies provided information regarding the frequency, degree, 
or intensity of which any or all of these recommended techniques were used. A direct 
comparison of the effectiveness of the two treatments is yet to be conducted.  
 
2.5 Summary 
This chapter discussed the philosophical, conceptual, and technical 
characteristics of behavioural activation therapy (BA). BA is a contemporary behaviour-
analytic approach to the treatment of depression, and the two predominant models are 
the brief 10 – 12 session format (BATD; Lejuez et al., 2001) and the longer and more 
comprehensive 20 – 24 session protocol (BA; Martell et al., 2001). There is also a self-
help manual (Addis & Martell, 2004) and a recent book chapter describing BA for 
depression (Dimidjian et al., 2008). BA has its philosophical roots in radical Skinnerian 
behaviourism – also referred to as functional contextualism. Within the BA model, a 
person’s mental health and wellbeing is understood to be determined by the external 
environment and the individual’s patterns of responding within the environment. BA is 
based on empirically supported principles of (behaviour) change including the 
principles of operant conditioning. 
The BA techniques discussed in this chapter are components shared by BA and 
BATD and form the core of the BA model for anxiety investigated in the present study. 37      
 
 
 
Focused activation is the central technique within BA aimed at increasing the ratio of 
response-contingent positive reinforcement for ‘healthy’ behaviours to response-
contingent negative reinforcement for avoidance behaviours. BA therapy places a 
strategic emphasis on addressing the high frequency of avoidance and escape 
behaviours typically shown by the depressed or anxious individual. These behaviours 
limit the opportunity for the reinforcement of other behaviour, thereby holding the 
individual within a context that regularly elicits depressed or anxious thoughts and 
feelings. Targets for activation are revealed in goal-setting exercises and initial and 
ongoing functional analyses. Outcomes are regularly evaluated using subjective and 
objective measures, and changes are discussed with the client with a focus on trends in 
the data and the functional relations between events and behaviours. Barriers to 
treatment typically are met with even more focused activation and breaking goals into 
more immediately attainable steps. 
BA is different from other popular behavioural-analytic approaches such as FAP 
and ACT because BA emphasises out-of-session behaviour change, and on modifying 
the direct environmental contingencies acting on client behaviours in everyday contexts. 
There are two main differences between the predominant BA models. BA is longer than 
BATD (20 to 24 sessions compared to 10 to 12) and has more procedures. BA focuses 
on altering patterns of avoidance behaviours whereas BATD focuses on increasing 
‘pleasurable’ and ‘masterful’ activities. In practice, BA is closer to applied behaviour 
analysis (Sulzer-Azaroff & Mayer, 1991) than BATD with a clear emphasis in BA on 
the functional analysis of client behaviours. Both models, however, are based on 
operant principles and each has received empirical support, although the evidence to 
support the use of BA is stronger as is shown in chapter 3.  
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CHAPTER 3 
 BEHAVIOURAL ACTIVATION: RESEARCH OUTCOMES POST-1996 
 
3.1 Chapter Overview 
Contemporary behavioural activation therapy initially developed from the 
seminal component analysis study by Jacobson et al. (1996) of Beck and colleague’s 
cognitive behavioural therapy for depression (1979; ‘CT’, synonymous to ‘CBT’), in 
which Jacobson and colleagues showed that the behavioural component alone was as 
effective in the treatment of adult depression as the complete CBT protocol. The authors 
concluded that, “If BA treatments are as effective as CT….not only the theory but also 
the therapy may be in need of revision” (p. 303). However, historically, BA was formed 
from earlier functional explanations of depression (Ferster, 1973; Lewinsohn, 1974; 
Skinner, 1953), and BA-type interventions have been reported at least since the 1970s 
(Lewinsohn & Graf, 1973; McLean, Ogston, & Grauer, 1973; Shaw, 1977).  
There was a decline in reports of BA after the emergence of more cognitive-
oriented models of depression (Beck et al., 1979), and this situation continued until the 
re-conceptualisation of CBT by Jacobson et al. (1996). It was subsequent to this latter 
study that there has been an ever expanding body of literature regarding BA treatment 
for depression as well as other clinical-psychological conditions. Given that the present 
study is concerned with the application of contemporary BA, and the importance of 
early investigations notwithstanding, this chapter will focus on research relating to BA 
that has been published post-1996.  
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3.2 Meta-Analytical Reviews 
A computer search through key databases including PubMed, PsycINFO, and 
Science Direct revealed four meta-analyses published since 1996 that have included 
BA-related studies (Cuijpers, van Straten, Andersson, & Oppen, 2008; Cuijpers, van 
Straten, & Warmerdam, 2007; Ekers, Richards, & Gilbody, 2008; Mazzucchelli, Kane, 
& Rees, 2009).  
The most recent of these was by Mazzucchelli et al. (2009) who conducted a 
systematic search of a database of over 580 articles, chapters, and theses generated from 
a comprehensive search of PsycINFO and MEDLINE databases. The authors included 
studies that compared the effects of BA treatment on adults with clinical or elevated 
levels of depression-related symptomatology to a control condition or another 
psychological or psycho-pharmacological treatment in a randomised controlled trial. BA 
was defined as “treatments for depression that require patients to increase overt 
behavior to bring them in contact with reinforcing environmental contingencies” (p. 
383).  
There were 34 studies with a total of 2,055 participants included in the analysis. 
In 16 comparisons of BA to no-treatment control conditions, the pooled Hedge’s g 
effect size estimate was 0.78 (large; 95% CI = 0.42 to 1.15), although adjustment for 
selection bias reduced g to 0.65 (medium; 95% CI = 0.34 to 0.96). In 15 comparisons of 
BA to cognitive-behavioural therapy (CBT) or cognitive therapy (CT) the pooled g was 
– 0.01 (95% CI = - 0.17 to 0.16), indicating negligible difference between the 
alternative treatments. In 17 comparisons of BA to other interventions (e.g., non-
directive therapy, anti-depressant medication) the pooled g was 0.33 (medium; 95% CI 
= 0.16 to 0.49) (adjusted to 0.31 – medium; 95% CI = 0.06 to 0.55 to account for bias), 
indicating BA to be more effective overall. Comparisons of BA with control conditions, 
CBT/CT, and other treatments across a range of monthly follow-up times (1-3, 4-6, 7-40      
 
 
 
12, 13-24) revealed that the gains associated with BA were maintained beyond 
treatment at levels equivalent to CBT and higher than other psychotherapies including 
non-directive therapy. The significant differences in outcomes between BA and control 
conditions were also maintained at follow-up. 
The authors also compared BA to other conditions in treating participants with a 
clinical diagnosis of major depressive disorder (MDD). In 3 comparisons of BA to no-
treatment control conditions the pooled g was 0.74 (large; 95% CI = 0.31 to 1.17), 
indicating BA was superior. In 6 comparisons of BA treatment of major depression to 
CBT/CT, the pooled g was 0.04 (95% CI = - 0.16 to 0.23), indicating equivalence 
between the treatments. In 4 comparisons of BA to other interventions in the treatment 
of major depression the pooled g was 0.11 (small; 95% CI = - 0.23 to 0.45), slightly 
favouring BA ahead of the other interventions. Comparisons of BA with control 
conditions, CBT/CT, and other treatments at follow-up revealed that there was no 
difference between BA and CBT/CT at follow-up and BA was superior to other 
interventions including non-directive therapy at follow-up. The significant differences 
in outcomes between BA and control conditions were maintained at follow-up.  
There were some limitations to this meta-analysis. The authors attempted to 
account for the quality of the studies by including the use of a rating system based on 
the methodological features of research that were considered important. These included 
studies having an adequate sample size and description, the use of reliable and valid 
outcome measures, the reporting of follow-up data, the use of treatment manuals, and 
adequate therapist training and monitoring (see Chambless & Hollon, 1998). However, 
there were no independent allocation of studies to the analysis, and “disagreements 
regarding study quality were dealt with by discussion” (Mazzucchelli et al., 2009, p. 
387). It can only be assumed that this discussion was ordered according to the 
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any detail within the review regarding how these discussions were organised. As an 
example, a study by Padfield (1976) that compared BA to counselling was included 
within the meta-analysis yet was excluded from an earlier meta-analysis by Ekers et al. 
(2007) because of “insufficient reported data” (p. 613). Furthermore, to enhance the 
analysis Mazzucchelli and colleagues also included unpublished data to avoid any 
biases that might be present within the existing published literature, yet the authors 
noted that overall the quality of all included studies “varied considerably” (p. 406). The 
outcomes of two comparisons required adjustment due to “bias favouring BA”, which 
reduced effect size estimates There were also relatively few studies within some of the 
comparisons made. For example, only 2 studies were included that compared the effects 
of CBT versus BA on major depression at 24 month follow-up, and only 1 study was 
included that compared the effects of BA versus non-CBT psychotherapy at 12 month 
follow-up. 
The two contemporary BA models are ‘contextual’ BA (Martell et al., 2001) and 
BATD (Lejuez et al., 2001). However, this meta-analysis included reports of four 
variants of BA: ‘pleasant activities’ (e.g., Shaw, 1977), ‘self-control’ (e.g., Fuchs & 
Rehm, 1977), ‘contextual’ (e.g., Jacobson et al., 1996), and ‘BATD’ (e.g., Hopko, 
Lejuez, LePage, Hopko, & McNeil, 2003). The authors placed all these behavioural 
approaches to the treatment of depression within the broader BA class. Only four 
reports of contemporary BA compared with CBT and medication were included in this 
meta-analysis. Three of these were contextual: Dimidjian et al. (2006); Jacobson et al. 
(1996); (Wagner, Zatzick, Ghesquiere, & Jurkovich, 2007) and one was BATD: Hopko 
et al. (2003). Another two reports by Dobson, Hollon, Dimidjian, Schmaling, 
Kohlenberg, et al. (2006) and Gortner, Gollan, Dobson, and Jacobson (1998) described 
follow-up data from Dimidjian et al. (2006) and Jacobson et al. (1996). These 
limitations notwithstanding, the meta-analysis provided clear evidence for the 42      
 
 
 
effectiveness of ‘BA-type’ interventions in the treatment of adult depression with 
outcomes comparable to CBT/CT post-treatment and at follow-up, and exceeding those 
of other approaches such as counselling and non-directive therapy.  
Cuijpers et al (2008) conducted a systematic search of a database of 832 articles 
generated from an examination of 6,947 abstracts relating to the psychological treatment 
of depression sourced from a comprehensive search of the databases of PubMed, 
PsycINFO, EMBASE, and the Cochrane Central Register of Controlled Trials. The 
authors included studies that compared the effects of a psychological treatment for 
adults with clinical or elevated levels of depression-related symptomatology to another 
psychological treatment in a randomised controlled trial. BA was defined as “activity 
scheduling when the registration of pleasant events and the increase of positive 
interactions….were the core elements of the treatment”.  
There were 53 studies, with a total of 2,757 participants within the meta- 
analysis including 15 studies and 21 comparisons involving BA, CBT (38/56), non-
directive therapy (21/31), psychodynamic therapy (10/16), problem-solving therapy 
(7/7), interpersonal psychotherapy (6/8), social skills training (5/7), and other 
psychotherapies (15/17). Overall, there was little difference between any treatment with 
pooled Cohen’s d (effect size estimates) ranging from -0.26 to 0.40 (small). Non-
directive therapy was slightly less effective than other treatments with a pooled d of – 
0.17 (small; 95% CI = - 0.32 to – 0.03) and interpersonal therapy was slightly more 
effective than other treatments with a pooled d of – 0.21 (small; 95% CI = 0.01 to 0.42). 
In 11 comparisons between BA and CBT, the pooled d was – 0.08 (95% CI = - 0.29 to 
0.13) indicating equivalence. However, the relative risk of drop-out during treatment 
was significantly higher with CBT compared to BA. Analysis also showed no difference 
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therapy at follow-up (range = 1 to 24 months). The problem-solving and interpersonal 
therapies were excluded from the analysis due to insufficient data.  
There were some limitations to this meta-analysis. In relation to BA, the 15 
studies included were fewer than in Mazzucchelli et al’s. (2009) meta-analysis. Also, 
although a strength of the analysis was the overall inclusion of a large number of 
comparisons, the number of comparisons including different treatments varied 
considerably (e.g., CBT = 38, interpersonal psychotherapy = 6). The studies themselves 
were not independently selected for inclusion within the review, and the authors noted 
that the quality of many studies included was “not optimal” (p. 919). In relation to the 
lack of available data for some follow-up comparisons, the analysis was unable to 
provide evidence of effectiveness beyond the completion of treatment for problem-
solving therapy, interpersonal psychotherapy and “other” psychotherapies (i.e., 
undefinable). The meta-analysis contained a broad class of BA-type interventions, 
including ‘pleasant events’ scheduling, ‘self-control’ training, and even social-skills 
training. Only two studies reporting the outcomes of contemporary BA compared with 
CBT and medication were included (Dimidjian et al., 2006; Jacobson et al., 1996). No 
studies of BATD were included. As with Mazzucchelli et al. (2009) , the results of this 
meta-analysis indicated ‘BA-type’ interventions were as effective as other 
contemporary psychological approaches to the treatment of adult depression with 
equivalent outcomes when compared to CBT, yet with a lower probability of recipients 
dropping-out of treatment (BA compared to CBT).  
In a third meta-analysis, Ekers et al. (2008) conducted a systematic search of a 
database of 3,353 studies generated from a search of the databases of Medline, 
EMBASE, PsycINFO, the Cochrane Library, CINAHL, AMED, and the British Nursing 
Index. The authors included studies that involved comparisons of behavioural 
interventions for adult depression with other psychotherapies (e.g., CBT/CT, supportive 44      
 
 
 
therapy) and no-treatment control conditions within the context of randomised 
controlled trials. The authors defined behavioural therapy (BT) as treatment that 
involved “the rescheduling of activities to reintroduce positive reinforcement and reduce 
avoidance” (p. 612) that was similar to contemporary definitions of BA (Martell et al., 
2001).  
There were 17 studies with 1,109 participants included in the meta-analysis of 
which 12 compared behavioural therapy (BT) to control conditions, 12 compared BT to 
CBT/CT, 3 compared BA to brief psychotherapy, and 3 compared BT to supportive 
therapy. In comparisons of BT to no-treatment control conditions the pooled 
standardised mean difference (SMD; effect size estimate) was – 0.70 (large; 95% CI = - 
1.00 to - .039) indicating BT was superior. When BT was compared to CBT/CT the 
pooled SMD was 0.08 (95% CI = - 0.14 to 0.30) indicating equivalence between 
treatments. In comparisons between BT and brief psychotherapy and BT and supportive 
therapy the pooled SMDs were – 0.56 (large; 95% CI = -1.00 to - 0.12) and – 0.75 
(large; 95% CI = - 1.37 to – 0.14) respectively, indicating BT was superior to both 
alternative treatments.  
The authors compared treatments at an average follow-up period of 4-months 
and in relation to drop-out rates. With drop-out rates there were no differences between 
BT and any other control conditions or treatments, although BT was not compared to 
supportive therapy due to the unavailability of sufficient data. In comparisons between 
gains associated with BT and CBT/CT at follow-up the pooled SMD was 0.25 (95% CI 
= - 0.21 to 0.70) indicating equivalence between the treatments. When BT was 
compared to brief psychotherapy at follow-up the pooled SMD was – 0.50 (medium; 
95% CI = - 0.90 to – 0.09) indicating BT was superior. There were insufficient data 
available to compare BT and supportive therapy at follow-up.  45      
 
 
 
Recovery rates were calculated as a dichotomous variable. BT was superior 
when compared to no-treatment controls with 52% of participants receiving BT 
recovering from depression as defined by clinical interview (unspecified) and BDI 
scores against 21% of those waiting for treatment. Comparisons of BT to CBT/CT 
revealed no difference between treatments with a co-occurring rate of 55% of 
participants recovering from depression. When compared to brief psychotherapy, BT 
was superior with 57% of participants recovering from depression compared to 36% of 
participants who received brief psychotherapy. There were insufficient data available to 
compare recovery rates between recipients of BT and supportive therapy.  
The limitations of this meta-analysis included the small number of studies that 
compared BT to brief psychotherapy (n = 3) and to supportive therapy (n = 2), and the 
inclusion of some low quality studies that produced results that “deviated considerably 
from the overall picture” (Ekers et al., 2008, p. 620). More importantly the meta-
analysis included a broad class of behavioural therapies and failed to list the different 
types, simply labelling all BT as ‘behavioural’. A closer examination of the original 
reports included revealed that four contemporary BA reports were part of the analysis. 
Thus, this meta-analysis provides some support for the use of ‘BA-type’ interventions in 
the treatment of adult depression. 
Finally, Cuijpers et al. (2007) conducted a systematic search of a database of 
777 articles generated from an examination of 5,178 abstracts relating to the 
psychological treatment of depression found in the Pubmed, PsycINFO, EMBASE, and 
the Cochrane Central Register of Controlled Trials databases. The authors also 
examined the primary studies included in an earlier meta-analysis of psychological 
treatments for depression (Cuijpers & Dekker, 2005) and the reference list from a 
review of activity-scheduling (National Institute for Clinical Excellence, 2004). The 
authors included studies that compared the effects of BA-type interventions (defined as 46      
 
 
 
those that focused on ‘activity scheduling’) for adults with clinical or elevated levels of 
depression-related symptomatology to other psychological treatments, psycho-
pharmacological treatments, or a no-treatment control condition in a randomised 
controlled trial. 
In total, 16 studies with 780 participants were included within this meta-
analysis. In 10 comparisons of BA to control conditions the pooled Cohen’s d was 0.87 
(large; 95% CI = 0.60 to 1.15). In 18 comparisons of BA to all other treatments (e.g., 
CT/CBT, counselling, supportive therapy) the pooled Cohen’s d was 0.12 (95% CI = - 
0.05 to 0.29) indicating BA was an as effective yet not necessarily superior treatment. In 
10 comparisons of BA to CT the pooled Cohen’s d was 0.01 (95% CI = - 0.22 to – 
0.24), indicating equivalent outcomes. When activity scheduling was included within 
CT and compared to BA in 3 studies the pooled Cohen’s d was – 0.01 (95% CI = - 0.34 
to 0.33), again indicating equivalence. In the one study that compared BA to anti-
depressant medication the Cohen’s d was 0.26, suggesting BA was slightly superior to 
medication. 
Follow-up data were also analysed. At 2 months to 12 month periods the gains 
from BA treatment were maintained at comparable rates to other treatments with a small 
but statistically insignificant improvement (d = 0.18; 95% CI = - 0.25 to 0.31) found in 
comparisons with all other treatments that included data collected up to 3 months. 
Compared to CT alone, there was no difference between the treatments in relation to 
outcomes up to 3 months follow-up with a Cohen’s d of 0.02 (95% CI = - 0.47 to 0.51) 
and up to 6 months follow-up with a Cohen’s d of – 0.13 (95% CI = - 0.46 to 0.20).  
There were several limitations in this meta-analysis. There were relatively few 
studies included. For instance, Mazzucchelli et al. (2009) included 34 studies whereas 
this analysis included 16. Also, some of the comparisons were based on relatively small 
sample sizes and in some areas of analysis, such as the comparison of BA to medication 47      
 
 
 
and to CT at 12 month follow-up, there was only one comparison in each analysis from 
which to calculate effect size estimates. Finally, the authors conceded that the overall 
quality of the studies included within the meta-analysis was “not optimal” (Cuijpers et 
al., 2007, p. 323). Within the meta-analysis, only two reports of contemporary BA were 
included. Nonetheless, the results are equivalent to those produced from the recent 
meta-analyses show ‘BA-type’ interventions to be as effective as CT/CBT in the 
treatment of adult depression. 
In summary, the four meta-analyses discussed show that in the treatment of adult 
depression, contemporary BA and other BA-type approaches are more effective than 
no-treatment, and are as effective as CBT/CT with gains maintained at follow-up. There 
was also some evidence that BA-type treatment was more effective compared to brief 
psychotherapy and supportive therapy (Ekers et al., 2008) and equivalent or possibly 
superior to medication (Cuijpers et al., 2007; Mazzucchelli et al., 2009). Although there 
were limitations within each meta-analysis each included a number of quality studies 
that reported comparisons between CT/CBT and BA-type approaches.  
Overall, there were only 3 studies included that investigated contemporary 
contextual models of BA and 1 that investigated BATD. There were 2 follow-up 
investigations of contextual BA. Thus, the majority of studies included within these 
analyses were of ‘BA-type’ interventions versus control conditions or other treatments. 
This is not due to a lack of quality within existing randomised controlled trials 
involving contemporary BA, but simply due to an overall low number of experimental 
trials.  
 
3.3 Randomised Controlled Trials 
A computer search through key databases (e.g., PubMed, PsycINFO, Science 
Direct) revealed eight randomised controlled trials (RCTs) published since 1996 that 48      
 
 
 
investigated the effectiveness of BA compared to either no-treatment control conditions 
or alternative treatments. Aside from the well-established scientific advantages such as 
controlling for factors common to all therapies (Behar & Borkovec, 2003), RCTs are 
considered important within the field of psychology because technically the criteria 
established by the Task Force on Promotion and Dissemination of Psychological 
Procedures of Division 12 (Clinical Psychology) of the American Psychological 
Association (APA) for identifying empirically supported therapies (Taskforce; 
Chambless & Ollendick, 2001) mostly relies on evidence from RCTs to determine 
whether a therapy receives the highest level of endorsement (i.e., is considered well-
established). For example, non-specific behaviour therapy (essentially any behavioural 
technique within a typical CBT protocol) is considered a well-established empirically 
supported therapy for unipolar depression (Chambless & Ollendick, 2001, p. 693).  
Foa and Meadows (1997) outlined “gold standards” to apply to the review of 
psychological outcome research. These standards were also used by Spates et al. (2006) 
in their review of BA treatment for major depression and they will be used to guide this 
section. The standards include: 1) clearly defined target symptoms, 2) reliable and valid 
measures, 3) use of blind evaluators, 4) assessor training, 5) manualised, replicable, 
specific treatment programs, 6) unbiased assignment to treatment, and 7) treatment 
adherence (see pp. 453 – 455 for definitions). Commentary within this section is further 
guided by the checklist of 27 recommendations for high-quality outcome research 
proposed by Behar and Borkovec (2003). 
As noted, contemporary models of BA (Martell et al., 2001) initially developed 
from a randomised controlled trial in the early 1990s (reported in Jacobson et al., 1996) 
that compared the effectiveness of the complete cognitive and behavioural therapy 
protocol (originally called ‘CT’ and synonymous with what is now called ‘CBT’ ; Beck 
et al., 1979), BA alone which was comprised of behavioural strategies from the Beck et 49      
 
 
 
al. protocol, and a third condition, BA with strategies to address automatic thoughts 
(AT). There was a large sample of outpatient (n = 151; 80% referred, 20% respondents 
to public service announcements) participants diagnosed with moderate to severe major 
depression. All diagnoses were made by independent trained assessors using the 
Structured Clinical Interview for DSM-III-Axis I Disorders (SCID-III; Spitzer, 
Williams, & Gibbon, 1987). The BA alone condition was comprehensive, essentially 
incorporating behavioural techniques to address common problems associated with 
depression. Techniques included (a) daily self-monitoring of activities, (b) assessment 
of the pleasure and mastery associated with activities, (c) graded task engagement (i.e., 
from easy to difficult), (d) imaginal rehearsal of future engagement in specific activities, 
(e) identification of wide problems (e.g., sleep) and the prescription of relevant 
behavioural strategies for treatment, and (f) social skills training (Jacobson et al., 1996, 
p.297).  
The research team made considerable effort to establish integrity within the 
study. The participants were randomly assigned to 20 sessions of one of the treatment 
conditions and parametric analyses included the entire sample. Four experienced 
cognitive therapists (average 14.8 years postgraduate experience) provided treatment in 
the three conditions. All sessions were audio-recorded and 18% of sessions (3 sessions 
from 9 participants in each condition) were randomly selected and rated for therapist 
adherence to the treatment condition by independent trained coders who were blind to 
the participant’s treatment condition using a modified version of the National Institute 
of Mental Health Collaborative Study Psychotherapy Rating Scale (CSPRS; Hollon, 
Evans, Elkin, & Lowery, 1984) that outlined protocol procedures, prescribed, and 
proscribed treatment techniques for each treatment condition. Ratings were made on a 
Likert-type scale ranging from not at all (0) to extensively or frequently (6). According 
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interventions were made” (p. 299). Importantly, internationally recognised experts in 
CT were involved in the study, including Keith Dobson who supervised all CT 
therapists and rated CT therapists using the Cognitive Therapy Scale (CTS; Young & 
Beck, 1980), a validated and reliable measure of CT therapists’ competence. This was 
used to control for the standard of therapist in the CT condition and countered any 
potential bias given most of the research team were of a behavioural orientation. No 
comparable measure of BA therapist competence was available so competency was not 
formally evaluated in the BA condition. Both CT and BA supervisors would meet 
together monthly to discuss treatment integrity issues.  
The results were “as clear as they were surprising” (Martell et al., 2001, p. xxiii). 
There was no significant difference between conditions at post treatment and at 6-month 
follow-up. Whether the participant received BA, AT, or CT post-treatment recovery 
rates were similar (BA = 46%, AT = 51%, CT = 56%) as were the rates of improvement 
(BA = 61%, AT = 58%, CT = 68%). At 6-month follow-up, the no-relapse rates also 
were similar (BA = 85%, AT = 92.3%, CT = 81%). There was also no significant 
difference in relation to drop-out rates between treatments and treatment gains from 
each treatment were maintained to 6 months. Presented data showed a high degree of 
adherence within each treatment condition including BA according to CSPRS ratings. 
Interrater reliability averaged 0.81. There was a high level of therapist competency 
within the CT condition according to CTS ratings.  
These findings prompted the researchers to question whether “not only the (CT) 
theory but also the therapy may be in need of revision” (Jacobson et al., 1996, p. 303) 
and that BA may actually be considered more useful than CT due to its relative straight-
forwardness and capacity for peer administration, thus obviating the need for the total 
CT-package when treating depression. A subsequent investigation found no difference 51      
 
 
 
between treatment outcomes for the original participants at 2-year follow-up (Gortner, 
et al., 1998).  
The study by Jacobson and colleagues (1996) met all seven criteria that 
characterise “gold standard” treatment outcome studies as outlined by Foa and 
Meadows (1997). The researchers clearly defined target symptoms and provided 
delineation of inclusion criteria. They used reliable and valid measures (e.g., Beck 
Depression Inventory (BDI; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961); 
Hamilton Rating Scale for Depression (HRSD; Hamilton, 1967). Assessments were 
independently conducted by trained assessors blind to the treatment condition. 
Specifically trained assessors and therapists were involved. Research therapists used 
and provided (on request) detailed manuals for each of the treatment conditions. 
Participants were randomly assigned to treatment conditions and the researchers 
provided treatment adherence and competency ratings. Thus, the methodology 
employed within this study was of the highest quality.  
More recently, Dimidjian and colleagues (2006) conducted a similar type of 
study in which 241 outpatient participants (27% referred, 62% recruited through 
advertising, 11% by other means including word of mouth) diagnosed with major 
depression were randomly assigned to either 24 sessions of full cognitive behavioural 
therapy (‘CT’, also known also as ‘CBT’ and based on the manuals of Beck et al., 1979 
and Beck, 1995) or BA (based on the manual of Martell et al., 2001); or anti-depressant 
medication (ADM; selective serotonin reuptake inhibitor), or a pill placebo (PLA) 
condition. All diagnoses were made by independent trained assessors using the 
Structured Clinical Interview for DSM-IV-Axis I Disorders (SCID-IV, First, Spitzer, 
Gibbon, & Williams, 1997). As was the case with Jacobson et al. (1996), the delivery of 
treatment within the CT condition was overseen by experts in CT (Keith Dobson and 
Steven Hollon). All treatment sessions from each condition were audio-taped and 52      
 
 
 
treatment adherence in a random sample of 33.3% of sessions was assessed by trained 
observers blind to the treatment condition with the same rating system (CSPRS; Hollon 
et al., 1984) used by Jacobson et al. (1996) along with the same therapist competence 
rating (CTS; Young & Beck, 1980) for the CT condition. A comparable measure of BA 
therapist competency was not available. BA was provided by three experienced 
(average 7 years) practitioners, CT by three experienced practitioners (average 14 
years), and ADM and PLA by five pharmacotherapists (average 12 years).  
Consistent with earlier findings, the results showed that all active conditions 
represented equally effective treatments for the less severely ‘depressed’ participants. 
Placebo medication was also as effective as ADM among less depressed participants. 
However, with high-severity participants (i.e., > 20; HRSD), ADM and BA 
outperformed both CT and PLA. BA was considered the most efficacious treatment 
given that regardless of depression severity the ADM condition had a significantly 
higher attrition rate than BA (36% compared to 9%). Drop-out rates for CT, BA, and 
PLA were equivalent. The results showed that the research therapists strictly adhered to 
the BA and CT treatment modalities. Overall, the therapists in the CT condition 
received high ratings for competency.  
Treatment responders in the CT, BA, and ADM conditions were followed for a 
2-year period, and the results showed that CT, BA, and ADM shared equivalent long-
term outcomes across a range of indicators such as recovery rates, sustained response, 
relapse, although the cumulative direct financial cost of ongoing ADM was significantly 
higher than both BA and CT.  If medication was withdrawn after the first year of 
follow-up, then the average performance of the ADM group deteriorated to the point 
where CT and BA were superior (Dobson et al., 2008).  
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The study by Dimidjian et al. (2006) met six (possibly seven) of the 
methodological criteria outlined by Foa and Meadows (1997). The researchers clearly 
defined target symptoms and provided delineation of inclusion criteria. Reliable and 
valid measures (e.g., BDI-II, HRSD) were used. Assessments were conducted by trained 
evaluators blind to the participants’ treatment condition. Specific manuals for each of 
the treatment conditions were cited and described although they were not made 
available on request. There was randomised assignment of participants to treatment 
conditions and researchers provided treatment adherence data for all treatment groups.  
Competency ratings were obtained only for the CT condition. As was the case with the 
study of Jacobson et al. (1996), the methodology employed in this study was of a high 
quality. 
Cullen, Spates, Pagoto, and Doran (2006) compared a brief (10 session) version 
of BA (Martell et al., 2001) to a no-treatment control condition with a sample of 25 
adult participants diagnosed with depression who were recruited through advertising 
and solicitations to health agencies and allied health professionals. All diagnoses were 
made by independent trained assessors using the Structured Clinical Interview for 
DSM-IV-Axis I Disorders (SCID-IV, First, et al., 1997). The participants were 
randomly assigned to either condition and were evaluated independently of the two 
treating therapists at pretreatment, posttreatment, and 3 months follow-up intervals. The 
therapists had previous training in CBT and had received an additional 12 hours training 
in BA. Therapists were provided with a stepwise protocol for each treatment session and 
all sessions were video-recorded with 11% of sessions randomly selected and rated by 
trained observers using a modified version of the National Institute of Mental health 
Collaborative Study Psychotherapy Rating Scale (CSPRS; Hollon, et al., 1984) that 
included the procedural steps in BA, prescribed techniques (e.g., activity scheduling), 54      
 
 
 
and proscribed techniques (e.g., cognitive strategies). Weekly research meetings were 
held to discuss cases and review therapist performance. 
Statistical procedures showed that BA was more effective than no-treatment 
(waiting list) in reducing self (i.e., BDI-II) and other (i.e., HRSD) reports of depression 
among the participants. Treatment gains were also maintained at a 3-month follow-up. 
Although there were improvements within the no-treatment group, the improvements 
for those who received BA treatment were larger. Post-treatment BDI-II scores were 
evaluated using Jacobson, Roberts, Berns, and McGlinchey’s standard (1999) and they 
showed that a clinically significant decrease had occurred from pre-treatment to post-
treatment measurement (BDI-II) for both treatment and no-treatment groups. The results 
showed that 88% of all treatment delivered was consistent with the BA protocol used in 
this study.  
The study by Cullen et al. (2006) met six (possibly seven) of the methodological 
criteria outlined by Foa and Meadows (1997). The researchers defined target symptoms 
and provided delineation of inclusion criteria. Reliable and valid measures were used 
and assessments were conducted by trained evaluators blind to participants’ treatment 
condition. A specific treatment protocol was used (but not available on request), there 
was randomised assignment of participants to treatment conditions, and researchers 
provided evidence of treatment adherence .  
However, there were several limitations in this study. The investigation was 
conducted using a small sample, diminished due to drop-out rates of 32% overall which 
reduced the number of participants completing treatment to 9 in the BA condition and 8 
in the no-treatment condition. Efforts were made to establish treatment integrity 
consistent with previous approaches yet only 11% of treatment sessions were rated 
compared with 18% in Jacobson et al. (1996) and 33.3% in Dimidjian et al. (2006). 
Behar and Borkovec (2003) recommended that integrity assessment be conducted on a 55      
 
 
 
minimum of 20% of treatment sessions in psychotherapy outcome research. The 
modified version of BA (Martell et al., 2001) used in this study was not described in 
detail nor made available on request to the reader. Finally, although statistical 
procedures controlled for the influence of time, the results clearly showed that in 
relation to the participants’ reporting of depression symptoms both the treatment and 
no-treatment conditions experienced clinically significant decreases that were 
maintained at 3-month follow-up. This suggests that the control group showed 
spontaneous and natural recovery rates comparable to but not as large as the treatment 
group. This brings into question the relative effectiveness of the BA treatment as 
applied in this particular study.  
The effectiveness of brief BA for depression (BATD; Lejuez et al., 2001) was 
investigated within a small sample (n = 25) of inpatient participants within a psychiatric 
facility setting (Hopko, Lezuez, LePage, Hopko, & McNeil, 2003). In this study, 
participants diagnosed with major depression by the hospital psychiatrists were 
randomly assigned to receive either modified BATD (n = 10) or supportive 
psychotherapy (SP; n = 15) for 14 days or until discharge (whichever occurred first; M 
= 12.7 days for BA, M = 14.0 for SP). The participants received 3 x 20 min sessions per 
day. Both groups also received antidepressant medication. Masters’ level therapists 
provided BATD and a single Masters’ level therapist provided SP. BA treatment 
adherence was monitored by weekly supervision meetings by a psychologist 
experienced in BA.  
The results showed that BATD was significantly more effective at treating 
depression than SP. For the participants in the BATD condition, the mean change in 
BDI-II scores from pretreatment to posttreatment was 35.1 (severe) to 19.1 (moderate).  
For the participants in the SP condition, the mean change in BDI scores from 
pretreatment to posttreatment was 37.1 (severe) to 30.2 (severe). When the 56      
 
 
 
posttreatment scores for the BATD condition were compared to the SP condition the 
calculated Cohen’s d (estimated effect size) was 0.73 (medium).  
This study provided a demonstration of the effectiveness of BA compared to SP 
within an inpatient population. Furthermore, the results suggest that BATD may have 
benefits for the patient beyond the “common-factors” of psychotherapy (e.g., attention, 
support, expectancy effects) and beyond any benefits that may have been attributed to 
the effects of anti-depressant medication. Uniquely, the study included a description of a 
participants’ activity log – which provided an example of a critical BA technique 
referred to as ‘activity scheduling’. The results, however, should be interpreted with 
caution. According to Foa and Meadows’ criteria (1997), the study failed to meet many 
of the standards expected of high-quality outcome research.  Random assignment was 
employed and the outcome measure (BDI-II) has good psychometric properties. 
Masters-level therapists were used and supervised by an experienced practitioner. 
However, there was no reporting of data regarding levels of treatment adherence or 
competency for either condition or information regarding the level of experience of the 
research therapists. Although there was reference to a readily accessed BA treatment 
manual (Lejuez et al., 2001), the specific approach used was modified to include the use 
of a token economy with re-organised sessions (3 daily 20 min sessions compared to the 
recommended 1 weekly 60 min session). The format is not typically used in applied 
settings. Tokens were provided to participants in the BATD group for completing 
BATD-related goals and the tokens were able to be exchanged for off-unit ground 
passes, phone cards, snacks, and access to community activities. Token economies are 
used in applied behaviour analysis but are not specifically outlined within the BATD 
manual (Lejuez et al., 2001). A treatment protocol including these modifications to the 
original manual was not provided. Also, the SP condition was briefly outlined but there 
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any steps taken to establish treatment integrity and no tokens were used. The authors 
noted that this form of SP is not an empirically validated treatment, notwithstanding the 
inclusion of common therapy components. Furthermore, the sample size was less than 
would normally be expected of a high-quality RCT and no follow-up data were 
collected.  
The effectiveness of BATD was investigated more recently in the treatment of 
moderately depressed (i.e., BDI-II score of 14 or above) university students (Gawrysiak, 
Nicholas, & Hopko, 2009). A non-clinical sample of 30 participants who responded to 
an online advertisement for students willing to receive brief therapy for depression were 
randomly assigned to either BATD (n = 14) or a no-treatment control condition (n = 
16). Participants were assessed at pretreatment and posttreatment intervals using the 
BDI-II, Beck Anxiety Inventory (BAI; Beck & Steer, 1993), the Environmental Reward 
Observation Scale (EROS; Armento & Hopko, 2007), and the Multidimensional Scale 
of Perceived Social Support (MSPSS; Zimet, Dahlem, Zimet, & Farley, 1988). The 
BATD group received a single individual 90 min session of BATD (Lejuez et al., 2001) 
with materials (activity logs), and the control group received only general information 
about the research design and was told to “engage in their lives as usual” (p. 471) before 
returning in 2 weeks for re-assessment. 
Two clinical-psychology doctoral students delivered the intervention according 
to a structured protocol. To establish treatment adherence the therapist “checked off” (p. 
471) the prescribed BATD steps as each occurred in the session. The results showed 
that there was a significantly greater decrease in mean depression symptoms from pre to 
posttreatment for the BATD group (BDI-II: M = 21.0 to 8.1) compared to the no-
treatment group (BDI-II: M = 19.8 to 14.7) and a significantly greater increase in 
contacting reinforcement was reported by the BATD group (EROS: M = 23.8 to 28.5) 
compared to the no-treatment group (EROS: M = 24.9 to 24.6). Reliable change indices 58      
 
 
 
(Jacobson & Traux, 1991) showed that 93% (n = 13) of the treatment group improved 
on the BDI-II measure compared to 31%  
(n = 5) in the control group. On the EROS measure, 64% (n = 9) of the treatment group 
improved compared to 0% in the control group. There were no notable differences on 
the other dependent variables.  
This study by Gawrysiak et al. (2009) produced promising evidence of the 
effectiveness of a brief (1 session) BA intervention aimed at decreasing depression-type 
symptoms in a non-clinical population. The study, however, met only three (possibly 
four) of Foa and Meadows’ (1997) criteria for high quality outcome research. The study 
included clearly defined target symptoms and used measures with good psychometric 
properties. There was random assignment to either condition and a power-analysis was 
conducted prior to recruitment to determine an appropriate sample-size, which was met 
(i.e., > 26). A brief description of the treatment was provided with reference to the 
manual on which it was based (Lejuez et al., 2001), although the actual treatment 
protocol was not made available. Nevertheless, there was inadequate evidence regarding 
treatment adherence with no rating of competency, and participant evaluations were not 
conducted by independent assessors. Other limitations included the very brief 
assessment period (2 weeks,) the absence of follow-up data, and no use of any formal 
diagnostic measure. The study sample was not a clinically –depressed group and a 
single-session treatment is unusual in applied settings, and further caution must be 
exercised before results found within a non-clinical student sample are considered 
generalisable to clinically-depressed individuals.  
BA has been investigated as a treatment for depression among adult illicit drug 
users (Daughters, Braun, Sargeant, Reynolds, Hopko, Blanco, et al., 2008). A sample of 
44 participants diagnosed with depression according to DSM-IV criteria (Mini-
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Janavs, et al., 1998) and receiving inpatient-treatment for substance abuse (e.g., cocaine, 
marijuana, alcohol) were randomly assigned to receive either treatment as usual (TUA) 
or TUA with BA (“LETS Act”) for 6 sessions over a 2 week period. TUA included 
being taught stress and anger management strategies, education and work-related skills, 
and daily Alcoholics/Narcotics Anonymous meetings. The BA components 
incorporated into TUA were from the BATD manual including ‘activity scheduling’ 
(Lejuez et al., 2001). LETS Act sessions (but not TAU) were audio recorded and 20% 
of sessions were randomly selected and rated for treatment adherence and competency 
by a single independent evaluator with expertise in BA (D.R. Hopko) using a 9-point 
Likert scale ranging from 0 (no adherence/competence) to 8 (complete 
adherence/competence). LETS Act sessions were conducted by two specifically trained 
doctoral-level therapists. Dependent variables included measures of depression 
symptoms (HRSD; BDI-II), anxiety (BAI), environmental rewards (EROS), and 
treatment satisfaction (CSQ; Client Satisfaction Questionnaire, Larsen, Attkission, & 
Hargreaves, 1979). Assessments were conducted by independent trained assessors blind 
to the participants’ treatment condition at pretreatment, posttreatment and 2 week 
follow-up intervals.  
The results showed that clinician-rated depression within the LETS Act 
condition reduced significantly from pre to posttreatment (M = 12.4 to M = 6.7) 
compared to the TAU condition (M = 14.1 to M = 14.9). There were no differences in 
pre- to post-treatment reductions in self-reported depression (BDI-II) between groups 
and equivalent rates of improvement shown. However, the LETS Act group continued 
to improve at 2-week follow-up (M = 13.6 to M = 11.3) whereas the TAU group had an 
increase in BDI-II scores over the same period (M = 14.4 to M = 15.7). Follow-up data 
on the other measures (HRSD, BAI, EROS, TSQ) were not collected. Post-treatment 
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ACT condition and the level of treatment satisfaction was higher. There were no 
differences between groups based on BAI scores. Treatment adherence ratings averaged 
7.3 out of a possible 9 and competency rating averaged 7.1 out of a possible score of 9 
suggesting a high level of treatment adherence and competency within the Lets ACT 
condition. Drop-out rates between conditions were equivalent (2 versus 2).  
The study by Daughters et al. (2008) is a good demonstration of the 
effectiveness of a BA intervention for treating depression among individuals with 
alcohol and/or other drug problems and adds to contemporary BA literature. The 
methodology employed by the researchers was strong, meeting six (possibly seven) of 
Foa and Meadow’s (1997) standards criteria. The results suggest that adding BA to 
TAU within the context of drug and alcohol treatment is worthwhile. The outcomes, 
however, occurred in a very discrete population of predominantly black, male, 
inpatients with drug and alcohol problems. The participants didn’t receive typical BA 
but a hybrid treatment consisting of BA strategies embedded within TAU. Furthermore, 
assessments were conducted over a relatively brief period (1 month) without adequate 
follow-up assessments.  
BA in a group format was evaluated by Porter, Spates and Smitham (2004) 
among a sample of 26 individuals seeking mental health services for depression. 
Assessments including the BDI-II and HRSD were conducted pre-treatment, post-
treatment and at 3 month follow-up. All diagnoses were made by trained assessors using 
the SCID-IV (First, et al., 1997). Participants were randomly assigned to either a 10-
week group BA treatment or a no-treatment (waiting list) condition. A total of eight 
Masters’ level therapists delivered treatment. A specific treatment protocol based on 
Jacobson et al. (1996) was developed, described, and made available on request from 
the first author. The treatment was briefer (10 sessions compared to 20) and 
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behaviour, identification of habitual avoidance behaviours, and increased activation. 
Sessions were longer (95 min compared to 60 min).  
The results showed a significant reduction in depression symptoms for the 
treatment group from pre- to post-treatment and at a 3-month follow-up. Symptom 
levels remained stable in the no-treatment group until they received group BA when 
they experienced equivalent rates of improvement. In total, 100% of all participants (n = 
26) met the criteria for major depression pretreatment and 26% (n = 7) met the same 
criteria at post-treatment and 3-month follow-up. Thus, three-quarters of the participants 
experienced clinically significant outcomes and these gains were maintained at follow-
up. 
This study achieved five of seven standards of quality outcome research (Foa & 
Meadows, 1997). The major limitations included the absence of any treatment integrity 
data, the relatively small sample size, and assessments that were not conducted by 
independent assessors blind to treatment condition. Also, the therapist characteristics 
and training levels were not clearly detailed and the majority of participants (89%) were 
female. Notwithstanding these limitations, the study did provide evidence that BA may 
be effectively delivered in a group format which has appeal especially in terms of cost-
effectiveness. 
The final BA-related RCT published post-1996 was conducted by Wagner et al 
(2007). In this study, a small sample of 8 patients recovering from physical trauma, such 
as vehicle crashes and assaults, who also met the diagnostic criteria for PTSD and MDD 
were randomly assigned to either an out-patient BA or treatment as usual (TAU) 
condition. All diagnoses were made by independent trained assessors using the SCID-
IV (First, et al., 1997) and the Clinician-Administered PTSD Scale for DSM-IV (CAPS-
IV; Blake, Weathers, Nagy, Kaloupek, Gusman, et al. 1995).  BA was based on the 
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identification of avoidance behaviours, activity scheduling, goal setting, ‘attention to 
experience’ strategies (mindfulness), and discussion of the role of the ‘significant other’ 
in supporting behaviour change. The original manual was modified to a 6 session format 
with treatment lasting an average of 10 weeks across participants. BA treatment was 
provided by the lead author. TAU was provided by the trauma care facility but the 
treatment was not described. PTSD, depression and general health assessments were 
conducted pre- and post-treatment by a Masters’ level independent evaluator blind to 
condition assignment.  
The results from this study were somewhat surprising in that the only difference 
between either condition occurred on the measure of PTSD symptoms, the PTSD 
Checklist (PCL; Weathers, Litz, Herman, Huska, & Keane, 1994), with the BA group 
reporting a greater decrease in symptom severity from pre- to post-treatment (M = 54.2 
to M = 39.0) compared to the TAU group (M = 55.5 to M = 57.7). On all other measures 
(The Center for Epidemiological Studies Depression Scale, Radloff, 1977; The SF-12 
Health Survey, Ware, Kosinski, & Keller, 1996) the groups were equivalent. The 
change in PCL scores for the BA group must be interpreted with caution given the 
authors’ note that scores of 44 and above typically correspond with a diagnosis of 
PTSD. The change may not actually be clinically significant. In fact, on a case by case 
basis, only 2 participants within the BA group showed clinically significant 
improvement on the PTSD measure and 1 actually worsened.  
The study fails to meet most of the standards expected of high quality outcome 
research (Foa & Meadows, 1997), although the authors make efforts to note that it was 
intended as a preliminary study. In particular, there was no reference to any attempts to 
establish treatment integrity for either condition, treatment was delivered by a single 
therapist, and there was scarce description of the TAU condition or who delivered the 
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to show any long-term improvement that may have occurred in either condition or 
whether the (albeit small) treatment gains were actually maintained post-treatment. 
In summary, an extensive search of the relevant databases revealed eight 
randomised controlled trials (RCTs) published post-1996 involving contemporary BA. 
RCTs are an important type of psychotherapy outcome research because the design 
controls for or holds equivalent the many variables that may influence change in 
participants’ behaviour other than the (treatment) variable under investigation (Behar & 
Borkovec, 2003). The American Psychological Association (APA) Division 12 Task 
Force criteria for identifying empirically supported therapies requires any treatment to 
have been shown effective within the context of at least two high quality between-
groups experiments before it is considered a well-established treatment (Chambless & 
Ollendick, 2001).  
Contemporary BA is a relatively new therapy with an emerging body of 
evidence supporting its use. The first RCT that studied contemporary BA was published 
in 1996 (Jacobson et al.) and only seven subsequent trials of varying quality having 
been published since. In contrast, between 1977 and 1997 there were at least 75 similar 
trials published investigating CBT for depression (Gloaguen, Cottraux, Cucherat, & 
Blackburn, 1998). Nonetheless, the studies by Jacobson et al. (1996) and Dimidjian et 
al. (2006) deserve attention because they are RCTs of the highest quality and they show 
that BA alone can be as effective as any other well-established approach to treating 
depression – and possibly more effective for severely depressed individuals (Dimidjian 
et al., 2006). Furthermore, participants in both studies were followed for 2 years and the 
maintenance of gains achieved with BA was equivalent to those obtained from CBT 
(Dobson et al., 2008; Gortner et al., 1998). 
For any therapy to be considered well-established based on only two RCTs, the 
studies should be conducted by independent research teams (Chambless & Ollendick, 64      
 
 
 
2001). Some, though not all, of the researchers involved in Jacobson et al’s. study 
(1996) were also involved in Dimidjian et al’s. study (2006). Thus, if that specific 
criterion was stringently applied, contemporary BA currently meets the criteria for 
‘probably efficacious treatments’ of unipolar depression (Chambless & Ollendick, 
2001). Although the other RCTs published post-1996 add further support to the 
effectiveness of BA-interventions, the quality of these studies is not of the standard of 
Jacobson et al. (1996) and Dimidjian et al. (2006) and only three (Cullen et al., 2006; 
Porter et al., 2004; Wagner et al., 2007) investigated the model of BA as used in the 
former two studies. This was either abbreviated (i.e., 10 sessions compared to 20/24 
sessions) or abbreviated in a group-format (Porter et al., 2004) . The three other studies 
investigated brief BA for depression (BATD). One was within the context of drug and 
alcohol treatment (Daughters et al., 2008), another was a 1-session format within a non-
clinical population (Gawrysiak et al., 2009), and the third was BATD with the addition 
of a token-economy (Hopko et al., 2003). These studies also had substantial limitations 
as pieces of research including (but not limited to) inadequate treatment descriptions for 
replication, a lack of data regarding treatment integrity, and limited or a complete 
absence of follow-up data. Thus, in the context of the APA’s criteria for well-
established treatments (Chambless & Ollendick, 2001), contemporary BA may not be 
(technically) regarded as such based on the evidence from RCTs alone.  
In contrast, however, in Barlow’s latest edition of Clinical Handbook of 
Psychological Disorders (2008) BA is recommended as an evidence-based treatment for 
depression alongside CT and interpersonal psychotherapy (IPT), with a chapter included 
in the volume describing BA therapy (Dimidjian et al., 2008). BA was not included in 
the previous edition of this handbook (Barlow, 2001) with only CT and IPT detailed in 
that particular volume as evidence-based treatments for adult depression. Thus, within 
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has been considered sufficiently developed and established, in the various RCTs, single-
group and single-subject studies, as to be recommended as a front-line treatment for 
depression. As a final point, the APA Division 12 Taskforce lists empirically supported 
treatments at http://www.PsychologicalTreatments.Org, and has categorised BA as 
having strong research support which the website defines as the treatment having met 
the Taskforce’s criteria as a ‘well-established treatment’.  
 
3.4 Single Group and Single-Subject Studies  
A computer search of key databases (e.g., PubMed, PsycINFO, Science Direct) 
revealed that, following Jacobson et al’s (1996) important work, there have been at least 
twenty published single group or single participant studies of BA applied across a range 
of clinical and non-clinical populations including cancer patients (Hopko, Bell, 
Armento, Hunt, & Lejuez, 2005), elderly people (Meeks, Teri, Van Haitsma, & Looney, 
2006), people from Latino backgrounds (Santiago-Rivera et al., 2008), suicidal people 
(Hopko, Sanchez, Hopko, Dvir, & Lejuez, 2003, adolescents and young adults (Gaynor 
& Harris, 2008), and obese people (Pagota, Bodenlos, Schneider, Olendzki, & Spates, 
2008).  
Hopko et al. (2005) provided nine individual sessions of BA to six cancer 
patients with diagnoses of major depression. The results showed that 5 out of 6 
participants experienced clinically significant decreases from pre- to post-treatment on 
self- and other-report measures of depression (e.g., BDI, HRSD), and their improvement 
continued through to 3-month follow-ups with effect size estimates (Cohen’s d) ranging 
from 1.3 to 2.3 (large). Pagota et al. (2008) applied BA therapy to a group of 14 obese 
individuals diagnosed with major depression. After 12 weeks of BA there was a 
significant overall reduction in mean BDI (M = 26.7 to M = 6.71) and HRSD scores (M 
= 16.0 to M = 5.85) for the group. At post-treatment follow-up, 72% of participants (n = 66      
 
 
 
10) no longer met the clinical criteria for depression. Bottonari, Roberts, Thomas, and 
Read (2008) introduced BA therapy to a 62-year-old outpatient who had already 
received 21 sessions (147 days) of CT for depression. Until the introduction of BA, the 
participants’ depression symptoms had remained stable with a trend towards a 
worsening of his condition. Subsequent to the introduction of a course of BA, there was 
significant improvement in the first 147 days of treatment compared to the 147 days of 
CT with an effect size estimate (Cohen’s d) of 1.37 (large).  
Generally, the effects of BA in these experimental, though less methodologically 
rigorous studies, are equivalent to those found in the larger-scale RCTs. Unfortunately, 
due to many limitations in the conduct of these studies the outcomes may not be 
considered appropriate to consider as evidence of treatment-efficacy outside of the 
context of the case itself. The Division 12 Task Force criteria (Chambless & Ollendick, 
2001) consider a treatment as well-established if supported by evidence gained from 
well-designed RCTs or a large series of well designed single-case experiments. Single-
case experiments may provide as many valid inferential possibilities as RCTs if the 
methodology is sound (e.g., repeated measurement, baseline/follow-up data, clearly 
defined and replicable treatment). Indeed, single-case research has particular relevance 
to applied clinical psychology (Barlow et al., 1984) due to the focus on intra-subject 
variability, and frequent measurement of change that is closer to the clinical reality of, 
say, working with a client for one session per week compared to simply observing 
changes in a homogenous group’s mean scores at pre and posttreatment intervals as 
with RCTs. Methodologically sound single-case experimental design is the cornerstone 
of behaviour analysis (see flagship publications: Journal of Applied Behavior Analysis, 
Journal of the Experimental Analysis of Behavior). 
There is not the space to review every single-case study published investigating 
BA. However, there are some essential elements of single-case experiments that are 67      
 
 
 
missing from the extant BA literature and should be considered. In single-case design, 
variables extraneous to the main independent variable (treatment) are controlled by 
using repeated measurement across a baseline phase. This phase should be continued 
until stability (i.e., an absence of upward or downward trend) in the data is established. 
Then, the treatment phase can begin and any subsequent changes in the targeted 
dependent variable(s) may be, all things being equal, taken to be due to the treatment 
itself. However, only one small series of clinical replications, investigating BA for 
adolescent depression (Gaynor & Harris, 2008), has included what would probably 
qualify as adequate baseline data (see Barlow et al., 1984; Shernoff, Kratochwill, & 
Stoiber, 2002 for guidelines). Typically, in published single-case investigations of BA, 
there has been no or only brief follow-up assessment with a narrow range of outcome 
measures (Bottonari et al., 2008; Hopko et al., 2003; Yon & Scogin, 2009). For 
instance, only one BA study (Gaynor & Harris, 2008) has included ‘activity levels’ as 
an outcome variable despite the aim of ‘increased activation’ as central in BA treatment 
(Martell et al., 2001) and this involved a simple checklist of whether the client engaged 
in scheduled between-session activities. Surprisingly, given its philosophical and 
conceptual roots, BA has rarely been investigated within the recommended parameters 
of behaviour-analytic single-case research methodology (Gaynor & Harris, 2008).  
 
3.5 Research Investigating Behavioural Activation for Anxiety 
Given the obvious functional similarities between depression and anxiety (e.g., 
negative reinforcement and avoidance behaviour), the effects of BA on measures of 
anxiety have been investigated mostly within the context of treatment for individuals 
with a principal diagnosis of depression. A computer search of key databases including 
PubMed, PsycINFO, and Science Direct revealed only two single-group studies, one 
group comparison, and five single-case studies that investigated BA and anxiety or 
anxiety-related disorders. Of these, no study investigated the effectiveness of BA with 68      
 
 
 
participants who only met the clinical criteria for types of anxiety. Instead, the studies 
included participants diagnosed with both major depressive disorder (MDD) and PTSD 
(Jakupcak et al., 2006; Mulick & Naugle, 2004; Wagner et al., 2007), MDD and 
generalised anxiety disorder (GAD; Armento & Hopko, 2009; Chu, Colognori, 
Weissman, & Bannon, 2009), MDD, pain disorder, and social anxiety disorder (SAD; 
Lundervold, Talley, & Buermann, 2006), dysthymic disorder and panic disorder with 
agoraphobia (Hopko, Lejuez, & Hopko, 2004), and MDD, social anxiety disorder, and 
specific phobia (Hopko, Robertson, & Lejuez, 2006). Thus, there has been no published 
research investigating BA for referred problems of anxiety alone. 
Nonetheless, these studies do provide an indication of the effectiveness of BA 
therapy on reported anxiety symptoms. Jakupcak et al. (2006), for example, conducted 
16 sessions of individual BA (Martell et al., 2001) in the treatment of PTSD and MDD 
with an outpatient group consisting of 10 war veterans (all male) and 1 victim of sexual 
assault (female). The participants were formally diagnosed and assessed pre- and post-
treatment by a clinical evaluator independent of the therapy team who at posttreatment 
was blind to pretreatment scores. Diagnosis was determined using the SCID-IV (First, et 
al., 1997). Assessments included the Clinician Administered PTSD Scale (CAPS; Blake 
et al., 1995), the BDI-II, and the Quality of Life Inventory (QOLI; Frisch, 1994). Three 
doctoral level psychologists trained in BA delivered the interventions, with all sessions 
audio recorded and reviewed by an expert in BA (Martell) who also provided weekly 
supervision.  
The results from this study were unimpressive. Two participants dropped out of 
treatment, and within the remaining group (including data to week 15 for one of the 
drop-outs) there was a significant change in pre-treatment to post-treatment scores only 
on the PTSD measure (CAPS) with an estimated effect size (Hedge’s g) of 0.58 (small 
to medium). A case by case analysis showed that only five participants actually 69      
 
 
 
demonstrated reliable symptom reduction on the CAPS and one deteriorated. 
Interestingly, there was no improvement in depression ratings with four deteriorating. 
This trend of non-improvement was also found by Wagner et al. (2007; see RCT review 
in this chapter) who investigated MDD and PTSD among 8 injury-trauma victims. 
Unfortunately, neither study provided any data relating to treatment adherence and 
competency and the treatment manual used in either study was not provided to the 
reader, although Wagner et al. (2007) provided a brief session overview.  
Other limitations of Jakupcak et al’s study (2006) include the absence of 
baseline and follow-up assessment, an almost all-male sample (15 males, 1 female). 
Anti-depressant medication use was not controlled for dose or frequency over the 
duration of the study, and all participants except one were ex-soldiers. The study failed 
to control for variables external to the treatment that may have influenced the outcomes 
and its limitations would make any attempt at replication difficult.  
Chu et al. (2009) held 10 sessions of group BA (adapted from Martell et al., 
2001) to five junior-high school students who had been nominated by school-
counsellors as having a range of diagnoses including major depressive disorder (MDD); 
generalised anxiety disorder (GAD); and social anxiety disorder (SAD). Diagnoses were 
made using the Anxiety Disorders Interview Schedule for DSM-IV Child Interview 
(ADIS-IV-C; Silverman & Albano, 1996). Treatment outcomes were assessed at pre- 
and post-treatment with well-validated instruments by trained evaluators. The group BA 
was delivered by a clinical psychologist with 13 years experience and a trained clinical 
psychology doctoral student. The treatment protocol was comprehensively described in 
a stepwise fashion although there was no reference to any attempts to establish 
treatment integrity. 
In terms of therapeutic outcomes the results were mixed. One child failed to 
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self-reports indicated that participant 1 demonstrated clinically significant improvement 
on both anxiety (MASC-C; Multidimensional Anxiety Scale for Children, March, 
Parker, Sullivan, Stallings, & Conners, 1997) and depression (CESD; Center for 
Epidemiologic Studies Depression Scale, Radloff, 1977) measures, although according 
to his parents’ ratings (MASC-Parent Version, CESD-Parent Version) – there was no 
change. Participant 2 reported a clinical improvement in depression, yet her parents 
reported an improvement in her anxiety and not depression. Participant 3 did not report 
any improvement, but her parents reported improvements in her anxiety and depression. 
There was no change in any depression or anxiety ratings for the final participant 5. 
Interestingly, the one child who failed to complete treatment (participant 4) was actually 
the only participant who met criteria for an anxiety-related disorder alone. The authors 
reported that “all treatment completers reported a reduction in avoidance” (p. 417). 
However, no data were presented to support this claim. The authors stated that 3 of the 5 
participants showed “clinically significant change in their principal diagnoses” (p. 417) 
and that at posttreatment 2 of the 5 participants no longer met DSM-IV criteria for any 
disorder. All 5 had met DSM-IV criteria pre-treatment.  
There are several limitations within this study. Recruitment was potentially 
biased as it involved school counsellors selecting students whom they considered to be 
suitable for group BA. Assessments were not conducted independently of the research 
team. The treatment protocol was well-defined but there were no attempts to establish 
treatment integrity. The study used a pre- to post-treatment design with no controls and 
no continuous data were collected over an extended period. The authors still concluded 
that the “results suggest that students experiencing significant anxiety and depression 
may benefit from the group” (p. 418), which is surprising given the reported data 
showed little changed for most of the participants.  71      
 
 
 
The studies by Armento and Hopko (2009), Hopko et al. (2004), and Hopko et 
al. (2006) were single-case investigations of the application of BATD to the treatment 
of adult major depression and anxiety. These studies tended not to have an extended 
baseline, follow-up assessments and assessments of treatment integrity but they did 
provide a thorough description of the participant characteristics, case conceptualisation, 
treatment approach, and both qualitative and quantitative data. Valid measures (BAI; 
Beck Anxiety Inventory, BDI-II; Beck Depression Inventory, HRSD; Hamilton Rating 
Scales for Depression) were taken pre- and post-treatment, and Armento & Hopko 
(2009) included follow-up assessments. All three cases involved female adult 
participants who had presented for outpatient therapy. 
Armento & Hopko (2009) provided eight weekly 1-hr sessions of BATD 
(Hopko & Lejuez, 2007) for a 58-year-old breast cancer sufferer who met DSM-IV 
criteria for MDD and GAD. Treatment was successful with clinically significant 
decreases pre to posttreatment on the BDI-II (25 to 0), BAI (15 to 0), and the HRSD (25 
to 0). There were also increases on the Environmental Reward Observation Scale 
(EROS; Armento & Hopko, 2007) and the Quality of Life Inventory (QOLI; Frisch et 
al., 1994). The gains were maintained up to 6-months following the ending of treatment. 
The authors included a sample of an activity log used by the participant throughout the 
course of the study which provided examples of the activities she engaged in during 
treatment. 
Hopko et al. (2004) also reported promising, but less impressive outcomes for a 
28-year-old student who met DSM-IV criteria for panic disorder with agoraphobia and 
dysthymic disorder. The participant received 10 weekly individual 1-hr sessions of 
BATD (Lejuez et al., 2001). She had just completed 18-months of CBT prior to her 
involvement in the study with little reported change in the degree of her 
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occurred on the State Trait Anxiety Inventory (STAI; Speilberger, Gorsuch, Lushene, 
Vagg, & Jacobs, 1983), BAI, BDI-II and the QOLI. There were no follow-up data. An 
example of an activity log showed scheduled activities included calls to sister, walking 
dogs, attending church, and watching a favourite TV program.  
Hopko et al. (2006) conducted 9 weekly 1-hr individualised sessions of BATD 
(Lejuez et al., 2001) with a 31-year-old female who met DSM-IV criteria for major 
depression, social anxiety, and specific phobia. Assessments were conducted pre- and 
post-treatment. Outcome measures showed modest reductions occurred on the HRSD, 
BDI-II, and the BAI. There were no follow-up data.  
Mulick and Naugle (2004) employed a more experimental methodology in their 
investigation of the effects of 11 weekly 1-hr individual sessions of BA (Martell et al., 
2001) on a 37-year-old male police officer/military veteran who met DSM-IV criteria 
for major MDD and PTSD. Diagnosis was confirmed using the SCID-I (First et al., 
1997). A range of assessments were applied at repeated intervals during and between 
sessions, and after a 1 month posttreatment follow-up period. The participant was 
stabilised on antidepressant medication 9 months prior to the commencement of and 
during therapy. Each treatment session was recorded, and one session was randomly 
selected and rated for adherence to BA treatment protocol and therapist competency by 
an expert in BA using a modified version of the National Institute of Mental health 
Collaborative Study Psychotherapy Rating Scale (CSPRS; Hollon, et al., 1984) that 
included 11 items relating to BA techniques and ‘therapeutic skill’. For each item, the 
therapist’s behaviour was rated using a Likert-Scale (0 = poor to 6 = excellent). The 
treatment was described with reference to the manual on which it was based (Martell et 
al., 2001).  
The results showed a pre to posttreatment reduction in scores on measures of 
PTSD, including the Clinician Administered PTSD Scale for DSM-IV (Blake et al., 73      
 
 
 
1997), and from pretreatment to 1-month follow-up on the PTSD Symptom Scale (Foa, 
Riggs, Dancu, & Rothbaum, 1993). On the quantitative measure of depression (BDI-II) 
there also was a reduction pretreatment to 1 month follow-up. Posttreatment and at 
follow-up, the participant no longer met DSM-IVcriteria for MDD or PTSD. Therapist 
competency averaged 4 (‘good’) out of a maximum of 6 (‘excellent’) across all 11 
items.  
A major strength of Mulick and Naugle’s study (2004) was the use of repeated 
measures which tends to increase the precision of evaluation (Barlow et al., 1984). In 
this study, the change in dependent variables session by session and week by week was 
clearly identified. Interestingly, change was not linear with many peaks and troughs 
throughout the data series. This intra-subject variability probably matches clinical 
reality (Barlow & Nock, 2009). Only around week 8 of treatment did scores begin to 
move into the ‘non-clinical’ range. Thus, the study provides a good description of the 
topography of change as it may occur when applying BA to MDD and PTSD within a 
clinical setting. The treatment was well described for replication and treatment 
outcomes appear promising. In common with other evaluations, however, efforts to 
establish treatment integrity were inadequate with only 1 treatment session reviewed for 
competency and treatment adherence using a subjective rating scale. Although well-
defined, the treatment manual used was not made available. There was a reference made 
to the longer (20 to 24 session) BA protocol (Martell et al., 2001) and a lone practitioner 
delivered the treatment and conducted all assessments. Also, the author referred to a 
baseline phase yet closer inspection revealed that the baseline actually consisted of a 
pre-treatment assessment and then 2 treatment sessions (“Session 1” and “BA session 
1”). The author explained this by stating, “No specific therapeutic techniques were used 
during this session (1)” and “BA was initiated during session 2” – with no description of 
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psychotherapy that may change targeted behaviour beyond specific therapy techniques 
(Behar & Borkovec, 2003). For example, high levels of self-reported in-session 
experiences of private events (e.g., emotional arousal) and independent ratings of the 
‘alliance’ between the therapist and client have been shown to be related to 
improvement during cognitive therapy (Castonguay, Goldfried, Wiser, Raue, & Hayes, 
1996) and these variables are not unique to cognitive therapy.  
In summary, no published studies have investigated BA for anxiety alone. The 
studies that have been conducted have involved participants who have met DSM-IV 
criteria for both depression and anxiety. In clinical settings clients meet criteria for 
anxiety and depression in approximately 1 out of every 2 cases (Greer & Trivedi, 2005).  
The symptom overlap between both disorders (APA, 2000) decreases the external 
validity of these BA studies and generally, the methodological standard of these studies 
is only moderate. Thus, only limited inferences may be drawn from the single-case 
studies that have shown BA therapy to be associated with decreases in anxiety (Hopko 
et al., 2006; Mulick & Naugle, 2004).  
Of greater importance is that many of the BA treatments of these studies 
included techniques that are more typically employed in mainstream CBT approaches to 
anxiety treatment. For example, they included graded exposure (Chu et al., 2009; Hopko 
et al., 2004); graded exposure with relaxation training (Armento & Hopko, 2009; Hopko 
et al., 2006); and relaxation training (Lundervold et al., 2006). Only the studies by 
Jakupcak et al. (2006), Mulick and Naugle (2004) and Wagner et al. (2007) appear to 
have applied BA alone to the treatment of anxiety within the context of mixed 
anxiety/depression symptomatology.  
Finally, no study investigating the effect of BA treatment on anxiety presented 
quantitative evidence of the changes that occurred in the participant’s activity levels 
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BA is to activate the individual in socially important ways. Although a focus on the 
reduction of private responses is valid due to the reporting of such responses within the 
typical clinical presentation, it nonetheless represents an incomplete analysis from a 
behavioural perspective. If the claim is to be made that a functional relationship exists 
between the individual’s activity levels and his or her reporting of private events such as 
anxiety or depression, then it would be desirable to have a measure of both overt and 
covert dependent variables. Certainly behaviour analysis (Skinner, 1953; Sulzer-Azaroff 
& Mayer, 1991) has long recognised the need to measure and account for the main 
variables under investigation. It would seem reasonable to suggest that, if the basis of 
BA therapy is indeed the eliciting of change in an individual’s activity levels, then this 
change ought to be demonstrated. 
 
3.6 Summary 
There is an emerging body of evidence supporting the use of contemporary 
behavioural activation (BA) in the treatment of adult depression including meta-
analyses, randomised controlled trials, single group designs, and single case studies. 
These studies have demonstrated that BA is as effective as other front-line treatments 
including CT/CBT and antidepressant medication, and may be more effective when 
attrition rates, level of depression, and the financial costs of medication and longer-term 
treatment are accounted for. Indeed, although there is a need for more research 
including better designed single-case experiments, BA could be considered a well-
established treatment for adult depression according to current standards (Chambless & 
Ollendick, 2001).  
However, there are limitations within the extant literature. The studies by 
Jacobson et al. (1996) and Dimidjian et al. (2006) are of the highest methodological 
quality and represent the core of contemporary BA evidence, yet technically they may 
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from these two studies, there is significant variability in terms of experimental rigour 
within the remaining literature reporting evaluations of BA. The investigation of 
different treatment protocols, although in principle they are all BA (e.g., Lejuez et al., 
2001; Martell et al., 2001), further limits the conclusions of current best evidence. To 
this point, there may be a requirement for a component analysis of BA to be conducted, 
similar to Jacobson et al’s. 1996 study that compared the full CT package to BA only, to 
establish the most parsimonious (BA) approach to treatment. Greater control is also 
needed if research is to show the complex functional relationships between activity and 
private events that are assumed to relate to the development and maintenance of 
clinically healthy behaviour. No study exists that has provided quantitative 
measurement of the real-time activity levels of individuals receiving BA therapy. 
Despite functional similarities with depression, little research has been 
conducted on BA therapy for anxiety. As far as can be ascertained, no study has 
investigated BA therapy for anxious behaviours alone. Existing studies that have 
focused on anxiety with other DSM-IV diagnoses such as depression have 
methodological limitations and have reported mostly equivocal and/or clinically-
insignificant findings. Yet, given common principles, it can be argued that BA ought to 
be as effective in the treatment of anxiety as for depression. Future investigations 
require more rigorous experimental control with a focus on anxiety alone. The use of 
well controlled single-case experimental designs would have a distinct advantage over 
current research that has relied heavily on between group comparisons and single group 
designs in that the putative functional relationship between treatment and anxiety could 
be systematically analysed within individuals undergoing BA therapy during the course 
of their treatment.  77      
 
 
 
CHAPTER 4 
 RATIONALE FOR THE PRESENT STUDY 
 
4.1 Rationale 
From a behaviour-analytic perspective, the functional similarities between 
‘depression’ and ‘anxiety’ suggest that behavioural activation treatment for anxiety 
(BATA; described in Chapter 5) may provide as effective a treatment for anxiety as has 
been shown with depression. As best as can be known, BA has not been trialled with 
adults who fulfilled DSM-IV criteria only for an anxiety-related disorder, and within a 
single-case experimental research design. These two points prompted the development 
of the present study and it was designed as a preliminary investigation into the 
effectiveness of BA as a stand-alone treatment for anxiety among a clinical adult 
population using an experimental single-case methodology. 
  
4.2 Behavioural Activation Treatment of Anxiety (BATA) 
BATA is composed of the essential elements of BA (Lejuez et al., 2001; Martell 
et al., 2001) as outlined in Chapter 2. At the conceptual level, it is consistent with 
exposure therapy as the client is encouraged to come into contact with aversive stimuli 
with the aim of extinguishing the conditioned anxiety/fear response. However, BATA is 
different from exposure therapy because it is more concerned with the analysis and 
application of operant behavioural principles – the relations among antecedents and 
behaviours and consequences. Although it is expected that classically conditioned 
responses will extinguish with time, whether the client engages in approach or goal 
oriented behaviour is not dependent on this having occurred. BATA has a broader 
contextual focus than typical exposure therapies. Riggs, Cahill, and Foa (2006) describe 
how typical exposure therapies emphasise classically conditioned relations and 
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that the extinction outcome will lead to generalised improvement in behaviour in 
everyday life. In BATA, the therapist helps clients to establish contexts in which the 
interlocking antecedents and consequences (contingencies) that act upon anxiety-related 
behaviour are altered such that their natural environment becomes more supportive of 
‘healthy’ non-anxious behaviours and less supportive of ‘unhealthy’ anxiety-related 
behaviours.  
Symptom reduction is an important outcome but is not the sole focus of BATA. 
It is expected that if clients increase approach behaviour and come into contact with 
people, places, objects and events that were once avoided then they will also report 
gradual reductions in anxiety symptoms. However, these broader, contextual changes 
may be a gradual process whereas changes in overt symptom behaviour can occur 
relatively quickly. Unquestionably, anxiety, by degrees, may continue to be a feature of 
many clients’ lives during and beyond therapy. Crucially, with BATA, clients’ 
behaviour should become more under the control of scheduled, goal-related activities 
and the contingencies of reinforcement operating in the environments where these 
activities take place. The lesson for clients is to continue to engage in ‘meaningful’ 
activity regardless of their respondent (anxious) processes. In this way, there is an 
increased likelihood of reductions in anxiety occurring because of increased, regular 
contact with fear-eliciting situations - and clients’ actions in important areas of their 
lives are not interfered with by the habitual avoidance typical of anxiety-sufferers.   
Applied forms of psychology have always acknowledged the influence of 
avoidance on continuing psychopathology (Freud, trans. 1914). In basic science, if a rat 
receives an electric shock in a chamber, it will act to avoid returning to the chamber 
(Blanchard & Blanchard, 1968). The rat will decrease its rate of lever pressing in the 
presence of an auditory conditioned stimulus even if this results in less food (Kamin, 
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lever pressing, the rat will act to perform this action (Sidman, 1953). This has clear 
evolutionary advantages in that the ability to effectively respond to stimuli that signal 
danger may allow the avoidance of actual physical harm. 
The tendency for the anxiety-sufferer to engage in avoidance behaviour is a 
central part of the diagnostic criteria for anxiety-related disorders (APA, 2000) 
alongside feelings of marked and persistent fear (distress). When the avoidance and 
distress interfere with routine everyday functioning then essentially the individual fulfils 
clinical diagnostic criteria. Avoidance contributes to psychopathology because 
classically conditioned fear is maintained and because effective avoidance strategies 
lead to a narrow, restricted repertoire of behaviour and experiences that leads the 
anxiety-sufferer to experience a reducing quality of life. Thus, co-occurring depression 
is present in 50% of anxiety cases and the onset of anxiety results in a persistent risk for 
the development of depression (Greer & Trivedi, 2005). Numerous recent studies (Kahn 
& Garrison, 2009; Plumb, Orsillo, & Luterek, 2004; Tull, Gratz, Salters, & Roemer, 
2004) have shown that elevated levels of avoidance are predictive of depression, 
somatisation, and high levels of general distress co-occurring with anxiety. Countering 
avoidance is critical in treating anxiety-related disorders. 
BATA concentrates on behaviour change that occurs within clients’ natural 
settings, therefore it does not rely on in-therapy changes translating to change in 
important areas of the clients’ day to day life for improvements to occur. The use of 
broadly identified natural contingencies of reinforcement that support behaviour change 
are likely to be more effective than discrete artificial conditions in maintaining change 
over time (Kohler & Greenwood, 1986). BATA goes straight to promoting behaviour 
change within real-life contexts outside of therapy. Notwithstanding that some elements 
of therapy may hold equivalent functions to those that occur within clients’ day to day 
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to the broader contexts within which clients operate will occur (as in FAP; Kohlenberg 
& Tsai, 1991). Although the BATA therapist may apply contingencies of reinforcement 
to support aspects of client in-session behaviour (see Chapter 5), the primary focus is 
actually on clients’ out of session behaviour.  
BATA should be an acceptable therapy for clients. Any exposure-type practices 
would occur within natural settings determined by clients’ preferred activities. Thus, the 
anxiety-sufferer is not exposed to aversive stimuli only in order to remove previously 
established respondent functions. Any added discomfort will occur within contexts that 
match the verbally stated, short’ medium, and long term goals of the client. The 
therapist’s task is to guide or coach the client through the therapy process, but the 
client’s goals are his or her own.  
Finally, an important characteristic of BATA is the possibility of ‘behavioural 
cusps’ (Rosales-Ruiz & Baer, 1997) occurring. As discussed in Chapter 2, ‘cusps’ are 
behaviour changes that produce large expansions of the individual’s behavioural 
repertoire, far beyond that expected from the discrete properties of the change itself. 
These might be the ‘unplanned’ beneficial consequences of the systematic programmed 
activation in BATA. Thus, this study will attempt to identify and describe potential 
cusps if they have occurred during each participant’s course of treatment. To date, there 
has been no discussion or reporting of cusps in the BA literature, or in other forms of 
clinical behaviour analysis (e.g., ACT; Hayes et al., 1999). As they have not been 
systematically programmed in the present study, potential cusps cannot be quantified 
and properly analysed with other behaviour changes (e.g., self-reported anxiety). 
Nevertheless, the qualitative descriptions herein can provide examples of possible cusps 
and function to highlight specific behaviour changes that probably were influential in 
any other change in the main dependent variables (e.g., anxiety, activity). 
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4.3 The Present Study 
A core question in this study was whether increased activation in important life 
areas was associated with decreased self-reports of anxiety over time. The research also 
aimed to address several limitations within the extant BA literature and some key 
features of this study have not been found in prior BA-related research. For example, 
participants were included in the study if they met criteria for an anxiety disorder but 
excluded if there were signs of co-morbidity (e.g., depression). Effort went into 
employing single-case experimental methodology expected of behaviour analytic 
research including establishing an adequate baseline before beginning treatment, using 
measures of real-time activity levels, and including a measure of treatment fidelity from 
a random sample of 33.3% of all treatment sessions. Assessment of treatment integrity 
based on samples of more than 20% of digital audio recordings made of all treatment 
sessions is rare in BA-related research and only 36% of studies published between 2000 
and 2004 within major psychiatry and clinical psychology journals ‘approached 
adequacy’ in relation to establishing treatment integrity (Perepletchikova, Treat, & 
Kazdin, 2007). Treatment integrity is considered essential to the interpretation of results 
from psychotherapy research (Waltz, Addis, Koerner, & Jacobson, 1993). Without 
integrity checks it is difficult to show that treatment effects are due to the treatment 
having been implemented as intended. Further, cross-study comparisons of treatment 
effects cannot provide evidence of replication if there are no data to show that a 
protocol was adhered to and if the standard of methods for establishing integrity varies 
considerably between studies.  
The BA approach utilised included only what the author concluded are the 
essential elements of BA. These were selected because they are common elements of 
the main contemporary BA models (e.g., BA, BATD) and are supported by principles of 
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training). A treatment protocol was developed especially for use in this study and is 
presented in Appendix I. It was designed to match the format of treatment protocols 
found in typical clinical handbooks (e.g., Barlow, 2001) and included a procedural 
account of BATA. A narrative account of BATA in practice based on transcripts from 
the treatment sessions with the first participant is also in the protocol. It is expected that 
research therapists will be able to follow the protocol in further investigations of BATA 
while referring to other BA treatment manuals (e.g., Martell et al., 2001) if necessary.  
Finally, a measure was used that attempted to account for any variance in the 
‘therapeutic relationship’ that may have occurred during treatment and potentially been 
associated with clinical outcomes.  The therapeutic relationship (or ‘alliance’) is a so-
called ‘common factor’ in psychotherapy (Horvath & Luborsky, 1993).  The use of this 
measure is important because the therapist/client ‘relationship’ has been considered 
influential to change in all forms of psychotherapy and have been claimed to be the pre-
eminent ‘cause’ of any therapeutic success (Lambert & Barley, 2001). It has been 
suggested that specific therapeutic techniques account for only 15% of psychotherapy 
outcome variance whereas the ‘common factors’ that define the therapeutic relationship 
(e.g., ‘empathy’, ‘positive regard’) account for 30% (Lambert & Barley, 2001). 
Measures of the therapeutic relationship have been completely overlooked in published 
accounts of pure BA research and often so in accounts of clinical behavioural 
interventions more generally (Lejuez, Hopko, Levine, Gholkar, & Collins, 2006). 
Further, practitioners of behaviour analysis in clinical settings will need to show that 
their technologies are based on established and discrete scientific principles if they are 
to differentiate themselves from allied workers in the mental health field, including 
‘para-psychologists’, who might emphasise the function of difficult to operationalise 
variables such as the ‘therapeutic relationship’ in order to account for their therapeutic 
approach and any co-occurring clinical outcomes.  83      
 
 
 
CHAPTER 5 
 METHODOLOGY 
 
5.1 Participants 
Twenty-three adults were recruited from the community via an advertisement in 
a local community newspaper (Appendix A) asking for “anxiety sufferers” to be 
involved in a study investigating a new treatment for anxiety. They all completed a 
comprehensive intake assessment and ten were deemed eligible for participation due to 
having met the criteria for an anxiety-related disorder according to the DSM-IV (APA, 
2000). The DSM-IV uses descriptive topographical criteria to classify clinically-
relevant behaviours into diagnostic categories. For example, DSM-IV diagnostic criteria 
for Generalised Anxiety Disorder: 
A.  Excessive anxiety and worry (apprehensive expectation), occurring more days 
than not for at least 6 months, about a number of events or activities (such as 
work or school performance). 
B.  The person finds it difficult to control the worry. 
C.  The anxiety and worry are associated with three (or more) of the following six 
symptoms (with at least some symptoms present for more days than not for the 
past 6 months). 
(1) restlessness or feeling keyed up or on edge 
(2) being easily fatigued 
(3) difficulty concentrating or mind going blank 
(4) irritability 
(5) muscle tension 
(6) sleep disturbance (difficulty falling or staying asleep, or restless 
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    (D)  The focus of the anxiety and worry is not confined to features of an Axis I 
disorder,      e.g., the anxiety or worry is not about having a Panic Attack (as in 
Panic Disorder), being embarrassed in public (as in Social Phobia), being 
contaminated (as in Obsessive-Compulsive Disorder), being away from home or 
close relatives (as in Separation Anxiety Disorder), gaining weight (as in 
Anorexia Nervosa), having multiple physical complaints (as in Somatisation 
Disorder), or having serious illness (as in Hypochondriasis), and the anxiety and 
worry do not occur exclusively during Posttraumatic Stress Disorder. 
    (E)  The anxiety, worry, or physical symptoms cause clinically significant distress or 
impairment in social, occupational, or other important areas of functioning. 
    (F)  The disturbance is not due to the direct physiological effects of a substance (e.g., 
a drug of abuse, a medication) or a general medical condition (e.g., 
hypothyroidism) and does not occur exclusively during a Mood Disorder, a 
Psychotic Disorder, or a Pervasive Developmental Disorder. (APA, 2000, p. 
476). 
Diagnosis was confirmed using the Structured Clinical Interview for the DSM-
IV Axis I Disorders (SCID-I; First, et al., 1997). The SCID-I includes questions for the 
respondent that are matched to the various topographical markers of the diagnostic 
categories of the DSM-IV. The SCID-IV relies on self-report as well as the 
interviewer’s clinical judgement, and further information can be obtained by using other 
clinical instruments at the time of interview (e.g., BDI-II). The SCID-I is commonly 
used within clinical and research settings to determine diagnosis, and the SCID-I 
manual cites a number of studies which have investigated its reliability with reported  
kappa values ranging from .70 to 1.00 (First et al., 1997, p. 46). Potential participants 
were excluded if they also met criteria for another Axis I disorder such as major 
depressive disorder, bipolar 1 disorder, schizophrenia, or alcohol dependence. 85      
 
 
 
All participants were given written information pertaining to the study and 
provided written consent prior to their involvement. Of the ten participants included in 
the study, three were excluded during the baseline phase; two due to ongoing non-
completion of self-monitoring baseline requirements, and one due to self-reported 
improvements in anxiety-related behaviour. Ultimately, seven participants aged between 
38 and 70 years (4 males: M = 51.75 years; SD = 10.71; 3 females: M = 61.66 years; 
SD = 8.50) received what was termed ‘Brief Behavioural Activation Treatment for 
Anxiety’ (BATA). Figure 5.1 presents details of the participants who were engaged in 
the study. 
 
5.2 Experimental Design 
The research study employed time-series methodology (Hayes, 1981). A single-
case within-subject experimental (A/B/C) design was used for each participant. The A 
phase was baseline; B was treatment; and C was maintenance/follow-up. Standardised 
repeated measures were collected during all phases. Participants were only required to 
self-monitor during baseline and treatment in an attempt to control for the potential 
therapeutic effects of self-monitoring during the maintenance phase (Barlow, et al., 
1984). Each successive case represented a precise clinical replication of the 
administration of BATA (Barlow et al., 1984).  
 
 
Figure 5.1. Participant flow chart. 
Completed Intake Assessment  N = 23 
Excluded  N = 13 
Included  N = 10 
Behavioural Activation  N = 7 
Completed  N = 6 
Did Not Continue After Session 10   N = 1 
Excluded During Baseline  N = 3 86      
 
 
 
5.3 Procedure 
Potential participants who responded via telephone to the community newspaper 
advertisement (Appendix A) were scheduled to complete the individual intake 
assessment on-site at Murdoch University. This assessment was conducted by the 
author, an Honours (psychology) graduate who was in his second year of Doctoral-level 
clinical-psychology training. Initially, potential participants were provided with an 
information letter (Appendix B) explaining the features of the study and given the 
opportunity to ask questions or state any concerns. Once formal consent was obtained 
with the participant completing a consent form (Appendix C) the SCID-I (First, et al., 
1997) was administered along with the Beck Anxiety Inventory (BAI; Beck & Steer, 
1993) and the short version of the Depression Anxiety Stress Scales (DASS-21; 
Lovibond & Lovibond, 1995a). The DASS-21 is publicly available from 
http://www2.psy.unsw.edu.au/groups/dass/). If participants met DSM-IV (APA, 2000) 
criteria for an anxiety-related disorder, without also meeting criteria for a non-anxiety-
related disorder, they were included in the study. Selected participants were then 
provided with materials and instructions for self-monitoring and were required to return 
on-site at weekly intervals for approximately 15 to 20 mins to submit monitoring forms, 
receive new forms, and complete the standardised measures until the commencement of 
treatment. 
 
Phase A: Baseline 
During baseline, each participant was required to complete daily self-monitoring 
of anxiety and activity levels using self-monitoring diaries developed for this study (see 
page 90). The participants were required to return on-site weekly to submit monitoring 
forms and receive new forms. Also, at each weekly meeting, participants were 
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mins duration. No treatment was conducted during the weekly meetings and any 
discussion was perfunctory and limited to the procedural concerns of assessments and 
self-monitoring. The duration of the baseline varied across participants and was 
determined by the length of time required to adequately establish stability in the 
obtained self-monitoring data using times-series analysis procedures implementing the 
treatment phase (Hayes, 1981). Baseline duration ranged from 16 to 35 days (M = 
26.28; SD = 6.07).  
 
Phase B: Treatment 
The duration of phase B was 84 days. The treatment was termed ‘Behavioural 
Activation Treatment of Anxiety’ (BATA). The treatment combined what were 
understood to be the essential principle-based elements of contemporary behavioral 
activation (BA; Martell, et al., 2001) and brief behavioral activation treatment for 
depression (BATD; Lejuez, et al., 2001). Each participant received the same treatment 
presented in a step-wise manner according to the BATA protocol (Appendix I) 
developed by the author and his supervisor (David Leach) for use in the present study.  
Treatment consisted of twelve weekly 60-min individual sessions. All treatment 
sessions with each participant were audio-recorded using a Digitech ™ Digital Voice 
Recorder. One-third of the recordings of each participant’s treatment sessions were 
randomly selected and independently rated for treatment integrity. Treatment was 
delivered by the author on-site at Murdoch University in a standard-size, regularly 
furnished consulting room.  
 
Treatment Description 
The aim of BATA was to increase the amount of approach-oriented socially 
important behaviour in a client’s daily life while producing corresponding decreases in 
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their overt behaviour more under the control of life goals and scheduled activities. 
BATA was delivered in an individual format with 60 min weekly sessions.  
The key components of BATA are: 
•  Self-monitoring 
•  Psycho-education 
•  Functional Analysis 
•  Goal-setting 
•  Activity Scheduling  
•  Activity Reviewing 
 
Phase C: Maintenance 
The duration of phase C was 84 days (3 months) and the phase commenced 
immediately following the completion of the treatment protocol. This phase technically 
was not a return to baseline due to participants’ not having to complete formal self-
monitoring. The aim was to observe participant behaviour independent of the structural 
variables inherent in the earlier baseline and treatment phases. During maintenance, 
participants were only required to return on-site for approximately 15 to 20 mins at 1 
week, 2 weeks, 4 weeks, 8 weeks, and 12 weeks only for administration of the BAI and 
the DASS-21.  
 
5.4 Measures 
Diagnostic measures 
The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I; First et al., 
1997).  
The SCID-I is a semi-structured clinical interview that applies DSM-IV (APA, 
2000) Axis 1 diagnostic criteria to the adult interviewee’s verbal responses, thus 89      
 
 
 
providing a diagnosis. Axis I criteria account for the various disorders and conditions a 
clinician may encounter except for personality disorders and mental retardation which 
are on Axis II (APA, 2000). The SCID-I is commonly used within clinical and research 
settings to facilitate diagnosis, and the SCID-I manual includes information supporting 
the instrument’s validity and reliability. The SCID-I has well-established psychometric 
properties and acceptable reliability within clinical settings with test-retest coefficients 
across diagnostic categories ranging from .70 to 1.00 (First et al., 1997). The SCID-I 
also contains a user’s guide that provides detailed instruction regarding administration, 
and guidelines and materials to facilitate training in the use of the interview prior to 
administration.  
 
Anxiety-Related Measures 
Beck Anxiety Inventory (BAI; Beck & Steer, 1993).  
The BAI is a 21-item self-report measure of anxiety symptoms and is considered 
“one of the most widely used and well-researched measures of anxiety” (Antony, 
Orsillo, & Roemer, 2001, p. 51). The BAI asks respondents to rate on a four-point 
severity scale the degree to which they have been ‘bothered’ by various anxiety 
symptoms during the previous week (e.g., “How much have you been bothered by fear 
of losing control?”) and is administered in 5 to 10 mins. The BAI manual (Beck & 
Steer, 1993) contains interpretations of raw scores and provides sample mean and 
normative data from clinical and non-clinical populations.  
The BAI has strong, well-established psychometric properties (Beck, Epstein, 
Brown, & Steer, 1988). Reported test – retest reliability data showed a coefficient of .75 
over one week (Beck et al., 1988). The BAI is highly correlated with other measures of 
anxiety (Antony, Orsillo, & Roemer, 2001). It has been used across a range of 
populations including young adolescent inpatients (Jolly, Aruffo, Wherry, & 90      
 
 
 
Livingston, 1993) and older adult outpatients (Kabacoff, Segal, Hersen, & Van Hasselt, 
1997), and has been used to differentiate anxiety from depression in large community 
samples (Creamer, Foran, & Bell, 1995).  
 
Depression Anxiety Stress Scales – Short Version (DASS-21; Lovibond & Lovibond, 
1995a).  The DASS-21 is a 21-item version of the larger 42-item DASS. Each item 
requires the respondent to rate the degree on a 4 point scale that specific depression, 
anxiety and stress symptoms (e.g., ‘I found it hard to wind down’, ‘I found it difficult to 
relax’, ‘I felt down-hearted and blue’) were present during the previous week. The 
DASS-21 is composed of three separate scales and scores for each are obtained by 
adding the raw scores corresponding to each scale. Interpretative guidelines are 
provided in the DASS manual (Lovibond & Lovibond, 1995a).  
The DASS and the DASS-21 have strong psychometric properties, correlate 
highly with other anxiety and depression measures, and normative data are available for 
both clinical and non-clinical adults aged 20 to 60 years (Antony et al., 2001; Lovibond 
& Lovibond, 1995a).The DASS-21 also has strong psychometric properties when used 
with older adults aged 60 to 88 years (Gloster, Rhoades, Novy, Klotsche, Senior, et al., 
2008). The main advantage of the instrument is the reduced administration time (5 to 10 
mins) which is especially useful in repeated administrations. The shorter DASS-21 
maintains strong psychometric properties and is considered a valid and reliable measure 
equivalent to the longer version (Antony, Cox, Enns, Bieling, & Swinson, 1998; Henry 
& Crawford, 2005; Lovibond & Lovibond, 1995a). Some have suggested that the 
DASS-21 “may be preferable to the full 42-item DASS” due to the fact that it reduces 
the administration time by 50% and holds equivalent psychometric properties to the 
larger version (Antony et al., 1998, p. 181).  91      
 
 
 
Scores on the DASS Stress scale has been found, above other standard anxiety 
measures to differentiate generalised anxiety disorder from other types of anxiety 
disorders (Brown, O’leary, & Barlow, 2001) and is strongly correlated with a primary 
GAD self-report measure, the Penn State Worry Questionnaire (Meyer, Miller, Metzger, 
& Borkovec, 1990). The DASS Depression scale is highly correlated with the Beck 
Depression Inventory and the DASS Anxiety scale is highly correlated with the BAI 
(Lovibond & Lovibond, 1995b).  
 
Self-Monitoring Anxiety and Activity Measures 
The Daily Anxiety Rating Scale (DARS).   
The DARS (Appendix D) is a daily self-monitoring instrument utilising a 
subjective rating scale (0 = no anxiety to 100 = extreme anxiety), with participants 
rating the average intensity of their private anxiety during six time periods – waking to 
9.00, 9.00 to 12.00, 12.00 to 3.00, 3.00 to 6.00, 6.00 to 9.00, and 9.00 to bedtime. 
Scores for each time period were summed and divided by the number of periods (i.e., 6) 
to calculate a daily average. The data generated from the DARS were used to account 
for variability in the participants’ reported levels of anxiety during the baseline phase. A 
minimum of 8 data points are required for statistical time-series procedures (Tryon, 
1982). As there were not enough data points obtained from the weekly standardised 
measures for time-series analysis of the participants’ baseline anxiety, the DARS was 
constructed especially for the present study as a daily quantitative measure of private 
‘anxiety’ based on instructions for designing self-monitoring devices (Barlow et al., 
1984). The use of such a measure has not been reported in BA research. The cues to 
self-rate anxiety were the time periods marked on the form. Anxiety was defined to 
participants as, “the co-occurrence of any two or more of the symptoms listed on the 
standardised measures that you have completed”.  92      
 
 
 
The Behaviour Self-Monitoring Diary (BSMD).  
The BSMD (Appendix E) is a daily diary for recording minutes of activity 
during three time periods (waking to 12.00, 12.00 to 6.00, 6.00 to bedtime) under four 
categories of broad classes of overt behaviour (see Appendix F for operational 
definitions): 1) self and other (e.g., pet) care, 2) housekeeping, errands, and house 
maintenance, 3) paid or volunteer work, and 4) interests, hobbies and recreation (e.g., 
reading, education, visiting friends). Participants were instructed to record the time 
spent on a particular activity to the nearest 15 minute interval. They were also asked to 
record whether the reported activity was conducted inside or outside of the home and 
whether they were alone or with others at the time.  
Participants were provided with a Step-Meter® Model Y-2026 pedometer with 
clear written and verbal operating instructions including a demonstration by the 
therapist. Participants were instructed to reset the pedometer each morning, wear it all 
day, and record the total daily distance travelled in their diaries in kilometres each night 
before bed. This provided a measure of overall daily physical activity that might be 
correlated with treatment outcomes (Strathopoulou, Powers, Berry, Smits, & Otto, 
2006). Similar to the DARS, the BSMD was constructed especially for the present study 
based on previous instructions for designing self-monitoring devices (Barlow et al., 
1984). Again, the use of such a measure has not been reported in BA research.  
 
Therapist-Client Relationship Measure 
Barrett-Lennard Relationship Inventory: Observer Form (OS-64; Barrett-Lennard, 
1986).  
The OS-64 is a 64-item self-report questionnaire which asks respondents to rate 
on a 6-point scale (-3, No (!), I strongly feel that it is not true, to +3, Yes (!), I strongly 
feel that it is true) aspects of a particular therapist/client relationship. Items include, 93      
 
 
 
“He/she wants to understand how I see things”, “He/she cares for me”, “He/she 
expresses his/her true impressions and feelings with me”, and “He/she finds me rather 
dull and uninteresting”. Each of the 64-items corresponds with one of four scales: ‘level 
of regard’; ‘empathy’; ‘unconditionality’; and ‘congruence’. Total scores are obtained 
by summing the raw item scores. Administration is recommended after each three to six 
hours of therapy (Barrett-Lennard, 1986). Overall, and in relation to each total scale 
score the “level adequate in helping relationships” is a score of 50% or above the total 
possible obtained score (p. 456).  According to Barrett-Lennard, who developed the 
scale from a person-centred, non-directive ‘Rogerian’ model of therapy, level of regard 
is defined as, “the composite ‘loading’ of the distinguishable feeling reactions of one 
person towards another, positive and negative, on a single abstract dimension” (p. 440). 
Empathy is “active and purposeful engagement with the other. The region or focus of 
this engagement….is the communication, experiencing and (felt) meanings of the other” 
(p. 442). Unconditionality is, “the extent that the regarding person’s response 
experientially implies that the recipient person is more or less pleasing, worthy, valued, 
trusted, liked or disliked if he or she manifests certain self-attributes than if or when he 
or she manifests others” (p. 443). Congruence is, “the degree to which one person is 
functionally integrated in the context of his relationship with another, such that there is 
absence of conflict or inconsistency between his total experience, his awareness, and his 
overt communication” (p. 444). According to Barrett-Lennard, these are the most 
important and influential variables within the therapeutic relationship that affect therapy 
outcomes.  
Others too have claimed that variables such as these are significant predictors of 
treatment success regardless of the psychotherapy model applied (Horvath & Luborsky, 
1993). However, relationship variables are typically not accounted for in cognitive and 
behavioural research (Lejuez et al., 2006). The purpose of assessing them in the present 94      
 
 
 
study was to evaluate how participants rated the ‘therapist/client relationship’ during 
BATA which is a purely behavioural therapy, and whether the ratings co-varied with 
reported behaviour change across treatment sessions. This has never previously been 
reported in BA research. 
The OS-64 has well-established psychometric properties and good reliability 
within the typical therapy setting with test-retest coefficients across the sub-scales 
typically exceeding .80 (Barrett-Lennard, 1986).  In the present study, the OS-64 was 
administered during the treatment phase at 4 weeks, 8 weeks, and 12 weeks. The 
participants were required to complete the OS-64 between sessions and the 
questionnaires were left unscored until after the collection of the final administered OS-
64 at week 12 and the participants were informed of this procedure. This was an attempt 
to control for any biased responses such as inflated ratings that might function to attract 
positive social reinforcement from the therapist during therapy.  
 
Treatment Integrity Measure 
Treatment integrity (TI; sometimes referred to as fidelity) is the degree to which 
treatments are implemented as planned. TI focuses on accuracy and consistency in the 
actual therapeutic model of intervention or technique being used (Peterson, Homer, & 
Wonderlich, 1982). Establishing TI strengthens possible conclusions regarding the 
effectiveness of the treatment. Data show that in psychotherapy research about 60% of 
reports ‘inadequately’ assess TI, 36% ‘approach adequate’, and only 3.5% ‘adequately’ 
assess TI (Perepletchikova et al., 2007). In a parallel area, 70% of all school-based 
experimental studies published in the Journal of Applied Behavior Analysis between 
1991 and 2005 (n = 152) failed to provide TI data (McIntyre et al., 2007). When used, 
TI measures typically rely on subjective evaluations of ‘adherence’ and ‘competence’ 
with a rater using a Likert-type scale (e.g., 1 (‘none’) to 8 (‘excellent’). Even then they 95      
 
 
 
may not include specific prescribed techniques such as BATD (Hopko et al., 2005), nor 
define techniques that characterise particular modes of practice (Hopko et al., 2005; 
Twohig et al., 2007). For example, the ACT for OCD rating scale has a single item 
relating to competence (Twohig et al., 2007). These measures are highly subjective and 
technically only provide ordinal data because the differences between the values are not 
clear.   
Criteria have been proposed for assessing adherence and competency (Waltz, et 
al., 1993), yet psychotherapy researchers cite a lack of ‘conventional criteria’ as a 
barrier to establishing TI (Perepletchikova & Kazdin,  2005). Waltz et al. (1993) state 
that treatment adherence does not necessarily equate to therapist competence, yet 
current TI measures in some psychotherapy research provide only loose assessments of 
competency. For example, what is the difference beyond value assignment between a 
therapist who averages a 6.0 competency rating across treatment sessions compared to a 
therapist who averages 7.2?  Is it really possible for any therapist to display “complete 
competence” (Hopko et al., 2005, p. 240)? Behar and Borkovec (2003) argue that 
adherence to the treatment protocol is most important in psychotherapy outcome 
research and recommended that TI should be based on adherence checks with clear and 
stringent criteria. Without a stringent assessment of TI, it is clear that evaluation results 
may vary widely because of variance in the therapeutic method, even when therapies 
bear the same label. It is possible that attempts to synthesise research findings in 
coherent statements are marred by significant variations in how treatments of the same 
name are actually delivered to clients. The present study included a measure of 
treatment integrity that was specifically developed for this study. It focused solely on 
the BA therapist’s verbal behaviour and his adherence to the BATA treatment model.  
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The Coded Recording System for Behavioural Activation Therapy Sessions (CRS-
BATS). 
The CRS-BATS (Appendix G) was designed as a measure of observed therapist 
verbal behaviour (TVB) during a BATA session. Applying partial interval time-
sampling, the CRS-BATS required raters of a BATA session to listen to 20 sec intervals 
and classify TVB during that time period using coding sheets (Appendix H) that 
contained 24 discrete blocks of symbols matching the defined categories of TVB in the 
CRS-BATS. These categories were of TVB compatible or incompatible with BATA. 
The use of partial interval time-sampling with categories of ‘prescribed’ and 
‘proscribed’ techniques is different from other attempts to establish treatment integrity 
in BATD (and ACT research) (Hopko et al., 2005; Towhig et al., 2007) because it 
provides a real-time ratio measurement of therapist behaviour. For example, in BATD 
(Hopko et al., 2005) the use of prescribed techniques by the therapist is simply rated on 
a subjective Likert-type scale accompanying technique labels (e.g., ‘psychoeducation’, 
‘treatment rationale’, ‘life goal assessment’) without any definitions of the listed 
techniques. The use of proscribed techniques is identified by a single question, “Did the 
therapist use any techniques/skills not included in the manual for this session?”, and “If 
yes, please list”. It is not clear how this information could be quantified and included in 
an objective analysis of treatment integrity.  
In the present study, 33.3% of the digital audio recordings of each participant’s 
treatment sessions were randomly selected for rating. The recordings were played-back 
on a Dell Dimension 3100™ desk-top computer. The raters would listen to 20 secs of 
audio and then play-back would be stopped. The raters would then independently code 
the TVB using the coding sheet. If a period of TVB was not able to be categorised 
according to the CRS-BATS (i.e., ‘unclassifiable’) it was recorded as being 
incompatible with the treatment modality. This would occur if the therapist and the 97      
 
 
 
participants were observed to each speak for 10 secs of the 20 sec time interval or if the 
TVB was not able to be coded to any of the categories on the coding sheet. If 
participants were heard to speak for more than 10 secs of the 20 sec interval then a line 
would be placed through that interval and it would not be calculated as TVB. The CRS-
BATS was constructed for the present study based on prior instructions for measuring 
treatment integrity (Waltz, et al., 1993) and behavioural recording methods (Sulzer-
Azaroff & Mayer, 1991).  
 
5.5 Data Analyses 
The data were presented in standard graphical form for single-case experimental 
research (Kazdin, 1982). With self-monitoring data (DARS, BSMD) a visual aid was 
provided by superimposing a horizontal middle line, based on the phase median, across 
the baseline and treatment phases. This technique can improve the accuracy of visual 
inspection and interpretation of single-case data (Fisher, Kelley, & Lomas, 2003; Ma, 
2006). To further improve the accuracy of the visual analysis, no-count rates (i.e., 0-
mins) were omitted from the graphical display (White & Haring, 1980) but remained 
within the statistical analysis. Graphs were constructed using Microsoft Word ™ with 
techniques based on instructions for single-case designs previously reported in the 
Journal of Applied Behavior Analysis and The Behavior Analyst Today (Carr & 
Burkholder, 1998; Grehan & Moran, 2005).  
Adjunctive non-parametric statistical analyses were applied to the data. A 
simplified time-series analysis (Jones, 2003; Tryon, 1982) based on Young’s C statistic 
(Young, 1941) was used to provide statistical analysis of phase A self-monitoring 
(DARS, BSMD) data and phases A/B/C weekly (BAI, DASS-21) self-report data. 
Essentially, the C statistic (calculated using Equation 1) compares the overall variability 
in the data set to the variability that occurs from data point to data point and thereby 98      
 
 
 
identifies whether any systematic movement away from random variation (i.e., a trend) 
is evident in the data set.  
(1) 
The ratio of the C statistic and the standard error produces a standardised score  
(Z = C/Se) which is used to test for statistical significance. If n is greater than or equal 
to 8, the critical z value for the one-tailed .05 level of significance is 1.64. Equation 2 
shows how the standard error of the C statistic is calculated.  
(2) 
The simplified time-series analysis has particular utility in applied single-case 
research because it may be applied to a time-series containing as few as 8 values. The 
time-series analyses were conducted using a program designed for Microsoft Excel ™ 
based on the appropriate equations provided by Tryon (1982) and more recently by 
Jones (2003).  
Baseline/treatment differences in self-monitored data from the DARS and the 
BSMD were assessed using the split-middle technique (Kazdin, 1982) which has been 
shown to enhance the accuracy of analysis in single-case research and reduce Type I 
and Type II error rates (Fisher, Kelley, & Lomas, 2003; Ma, 2006). The technique 
involves calculating the baseline median and, assuming the baseline data are stable, the 
null hypothesis is that if the treatment has no effect the data points will remain variable 
(i.e., 50%/50%) around the treatment median. Binomial testing is then employed to 
determine the significance of any change (Sheskin, 2000) with the test statistic 
transformed to a standardised score using the following equation: Z = (X/n – p)/(√ 
pq/n). The percentage of treatment phase data points above or below may also be 99      
 
 
 
interpreted as an effect size with scores of .9 and above indicating highly effective, .7 to 
.9 moderately effective, .5 to .7 mild or questionable, and below .5 considered 
ineffective (Ma, 2006). Binomial testing was conducted using SPSS ™ Version 11.5.  
Treatment integrity was shown as the percentage of time the BATA therapist 
emitted verbal behaviour both compatible and incompatible with the prescribed 
treatment modality based on codings of the therapist’s verbal behaviour in 33.3% of 
each participant’s treatment sessions (see section 5.4 for description of the treatment 
integrity measure and assessment procedure). Inter-rater agreement was calculated by 
dividing the number of 20 sec intervals in which the raters agreed on the classification 
of therapist verbal behaviour (agreements) by the number of agreements plus 
disagreements and multiplying the result by 100% (Sulzer-Azaroff & Mayer, 1991, p. 
65).  
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CHAPTER 6 
 CASE 1 
6.1 Characteristics 
“Jim” was a 63-year-old semi-retired male. At the time of his initial involvement 
in the study, Jim was receiving a disability pension due to structural physical complaints 
(back pain) and was engaged in casual paid and unpaid work as a trade assistant/handy 
man. Jim was living with his female partner of 2 years. He was once married and 
divorced, and had no children. Jim was a home-owner and lived in an average size 
home in a northern metropolitan suburb of Perth, Western Australia.  
 
6.2 Intake assessment 
At intake, Jim reported having experienced clinical features of anxiety including 
agitation, an inability to relax, muscle tension, fear of social embarrassment and 
humiliation, and intense self-attending (“I always feel that people are looking at me”) 
typically in social contexts. He also reported generalised aspects of anxiety, including 
persistent, excessive and uncontrollable worry about a number of areas in his everyday 
life, including personal health, finances, interpersonal relationships, and work (“I worry 
whether everything will be alright”). Jim reported irregular though longstanding 
experiences of sudden and reportedly un-cued ‘panic attacks’. He said that the onset of 
these symptoms occurred subsequent to a traumatic childhood experience and had 
strengthened throughout adulthood with occasional, though repeated, episodes of 
depression and alcohol misuse. Jim stated that anxiety had significantly impacted on his 
life (“It’s interfered with my life in every direction”) especially in the areas of personal-
relationships and employment. He reported that after a brief marriage in his 30s he had 
“walked-out on” his wife because he “couldn’t handle the hurt of feeling the way I did 
and staying with her”. He had spent the majority of his working life in manual trade 101      
 
 
 
occupations that required little social interaction such as brick-laying. He reported that 
typically he would avoid all social occasions that required his verbal interactions with 
others, including his family members. These occasions included family gatherings, 
speaking on the telephone and public speaking. Jim stated, “All my life I’ve knocked 
back (social) invites here, there and everywhere”, and said he would promptly escape 
from many social situations at the earliest signs of anxiety. Jim reported his private that 
his private “worry behaviour” included patterns of chronic procrastination, with a large 
amount of time spent ruminating, planning, and making lists in relation to anticipated 
problems – mostly with unproductive outcomes. Jim stated that he was briefly admitted 
to a psychiatric hospital at age 27 due to a “nervous breakdown”. Sporadic engagement 
with GP services had occurred from age 17 subsequent to his experiencing episodes of 
panic. Thereafter, Jim had a history of occasional anti-depressant medication use though 
no current use was reported. Jim reported that generally he was in average physical 
health, and was a non-smoker and consumed 2 to 3 standard drinks of alcohol per week. 
Jim reported that he had been receiving ongoing medication treatment (Alprazolam® 
1.25 mgs/daily) for anxiety from his General Practitioner (GP) for four years, and had 
been attending a weekly community-based support group for sufferers of a variety of 
mental illnesses for approximately eight years. He continued his medication routine 
(unchanged dosage and frequency) and attending his weekly meetings with his support 
group throughout the treatment phases. 
Based on his responses to the semi-structured interview (SCID-I; First et al., 
1997), Jim fulfilled DSM-IV-TR (APA, 2000) criteria for 300.23 Social Anxiety 
Disorder (SAD) and 300.02 Generalised Anxiety Disorder (GAD). At intake, Jim scored 
31 on the BAI (severe; Beck & Steer, 1993), 8 on the DASS-21 depression scale 
(normal), 26 on the DASS-21 anxiety scale (extremely severe), and 26 on the DASS-21 
stress scale (severe) (Lovibond & Lovibond, 1995).  102      
 
 
 
6.3 Anxiety-Related Outcomes 
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Figure 6.1. Case 1: BAI raw scores at baseline, treatment, and maintenance phases. 
Note: Scores below 7 = normal, 8-15 = mild, 16-25 = moderate, and above 26 = severe. 
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Figure 6.2. Case 1: DASS-21 Depression raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 9 = normal, 10-13 = mild, 14-20 = moderate, 
21-27 = severe, and above 28 = extremely severe. 
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Figure 6.3. Case 1: DASS-21 Anxiety raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 7 = normal, 8-9 = mild, 10-14 = moderate, 15-
19 = severe, and above 20 = extremely severe. 
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Figure 6.4. Case 1: DASS-21 Stress raw scores at baseline, treatment, and maintenance 
phases. Note: Scores below 14 = normal, 15-18 = mild, 19-25 = moderate, 26-33 = 
severe, and above 34 = extremely severe. 
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Jim’s BAI raw scores are presented in Figure 6.1. Analysis of the scores across 
phases confirmed a downward trend, Z = 3.22, p < .001. This change is clinically 
significant because Jim’s scores moved from above the mean for individuals with SAD 
(M = 17.77) and GAD (M = 18.83) to within the range of the non-clinical population 
(Beck & Steer, 1993). Figure 6.2 shows Jim’s DASS-21 Depression raw scores through 
all phases. Analysis confirmed a downward trend, Z = 2.62, p < .01. Figure 6.3 shows 
Jim’s DASS-21 Anxiety raw scores. Analysis confirmed a downward trend, Z = 2.62, p 
< .01. This change is clinically significant because Jim’s scores moved from above the 
mean for individuals with SAD (M = 11.66) and GAD (M = 11.34) to within the range 
of the non-clinical population (Brown, Chorpita, Korotitsch, & Barlow, 1997). Figure 
6.4 shows Jim’s DASS-21 Stress raw scores. Analysis confirmed a downward trend, Z = 
2.93, p < .01. This change is clinically significant because Jim’s scores moved from 
above the mean for individuals with SAD (M = 17.73) and GAD (M = 22.36) to within 
the range of the non-clinical population (Brown et al., 1997). 
 
6.4 Self-Monitored Anxiety and Activity Outcomes 
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Figure 6.5. Case 1: Daily Anxiety Rating Scale (DARS) scores across baseline and 
treatment phases. 
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Jim’s DARS scores are presented in Figure 6.5. Jim completed a 16 day 
baseline. Analysis of the baseline phase revealed an absence of trend within the data, Z 
= 1.34, p > .05. Compared to baseline, there was a significant decrease during the 
treatment phase in daily anxiety with 83% of scores below the baseline median point, Z 
= 6.11, p < .001. This represents a mean decrease during treatment of 4.8 points (14.5%) 
in Jim’s DARS scores.  
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Figure 6.6. Case 1: Minutes spent per day on Self- and Other-Care across baseline and 
treatment phases. 
 
Jim’s self- and other-care data across baseline and treatment phases are 
presented in Figure 6.6. Analysis of the baseline phase revealed an absence of trend 
within the data, Z = 0.060, p > .05. Compared to baseline, there was a significant 
increase during the treatment phase in the amount of time Jim spent on self- and other-
care with 96% of scores above the baseline median point, Z = 8.51, p < .001. This 
represents a mean increase during the treatment phase of 39 minutes (30%) per day.  
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Figure 6.7. Case 1: Minutes spent per day on Housework and Errands across baseline 
and treatment phases. 
Jim’s Housework and Errands data across baseline and treatment phases are 
presented in Figure 6.7. Analysis of the baseline phase revealed an absence of trend 
within the data, Z = 1.022, p > .05. Compared to baseline, there was a significant 
increase during the treatment phase in the amount of time Jim spent on housework and 
errands with 62% of data above the baseline median point, Z = 2.22, p < .05. This 
represents a mean increase during the treatment phase of 16 minutes (11%) per day. 
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Figure 6.8. Case 1: Minutes spent per day on Paid and Unpaid Work across baseline 
and treatment phases. 
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Jim’s Paid and Unpaid Work data across baseline and treatment phases are 
presented in Figure 6.8 (zero rates were omitted). Analysis of the baseline phase 
revealed an absence of trend within the data, Z = 0.137, p > .05. Compared to baseline, 
there was a significant decrease during the treatment phase in the amount of time Jim 
spent on paid or unpaid work with 76% of data below the baseline median point, Z = 
4.81, p < .001. This represents a mean decrease during the treatment phase of 91 
minutes (41%) per day.  
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Figure 6.9. Case 1: Minutes spent per day on Interests, Hobbies, and Recreation across 
baseline and treatment phases. 
 
Jim’s Interests, Hobbies, and Recreation data are presented in Figure 6.9. 
Analysis of the baseline phase revealed an absence of trend within the data, Z = 1.50, p 
> .05. Compared to baseline, there was no significant change during the treatment phase 
in the amount of time Jim spent on interests, hobbies and recreation with 54% of data 
below the baseline median point, Z = 0.74, p > .05. This represents a mean decrease 
during the treatment phase of 16 minutes (4%) per day.  
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Figure 6.10. Case 1: Minutes spent per day Out of the Home across baseline and 
treatment phases.  
Jim’s Out of the Home data across phases are presented in Figure 6.10. Analysis 
of the baseline phase revealed an absence of trend within the data, Z = 0.71, p > .05. 
Compared to baseline, there was a significant increase during the treatment phase in the 
minutes Jim spent out of the home with 71% of data above the baseline median point, Z 
= 3.88, p < .001. This was a mean increase during the treatment phase of 43 minutes 
(14%) per day.  
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Figure 6.11. Case 1: Minutes spent per day Out of the Home with Others across 
baseline and treatment phases.  
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Jim’s Out of Home with Others data across baseline and treatment phases are 
presented in Figure 6.11 (zero rates were omitted). Analysis of the baseline phase 
revealed an absence of trend within the data, Z = 0.46, p > .05. Compared to baseline, 
there was a significant increase during the treatment phase in the amount of time Jim 
spent out of the home with others with 62% of data above the baseline median point, Z 
= 2.22, p < .05. This represents a mean increase during the treatment phase of 57 
minutes (30%) per day.  
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Figure 6.12. Case 1: Distance Walked per day across baseline and treatment phases.  
 
Jim’s Distance Walked per day data across baseline and treatment phases are 
presented in Figure 6.12. Analysis of the baseline phase revealed an absence of trend 
within the data, Z = 0.22, p > .05. Compared to baseline, there was a significant 
decrease during the treatment phase in the daily distance that Jim walked with 75% of 
data below the baseline median point, Z = 4.62, p < .001. This represents a mean 
decrease during the treatment phase of 356 meters (12.5%) per day.  
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6.5 Therapist/Client Relationship  
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Figure 6.13. Case 1: OS-64 Assessment of Therapy Relationship Variables across the 
treatment phase. 
Jim’s total scale scores across the treatment phase from the Barrett-Lennard 
Relationship Inventory: Observer Form (OS-64) are presented in Figure 6.13. Total raw 
scale scores were converted to a percentage to aid visual analysis. The OS-64 was 
administered at 4, 8, and 12 week periods during treatment. Analysis shows that the 
level of regard and congruence scores remained relatively stable across the repeated 
measurements with an absence of any definitive trends. From week 4 to week 12 there 
was a 16.7% increase in the rated amount of empathy within the therapist’s approach, 
and a 22.9% decrease in the rated amount of unconditionality across the same period.  
 
6.6 Behavioural Cusps 
Although more difficult to quantify, the participant engaged in activities which 
could qualify as behavioural cusps when formal activity scheduling commenced at week 
3. Activity examples for Jim include him phoning an estranged sibling, attending a 
medical check-up, organising and attending lunch with his partner, regular dog walking, 111      
 
 
 
celebrating a birthday with family and friends, resolving a long-standing pension-related 
matter, and reconciling his relationship with a cancer-stricken long-time friend. 
Engagement in these activities occurred within the context of treatment and were 
potentially important for the participant’s expanding repertoire of clinically ‘healthy’ 
behaviours. In this particular case, Jim commenced activity scheduling following the 
third week of treatment (week 5/day 37) and large decreases across anxiety-related 
measures are clearly identifiable at that point. When asked at 3-month follow-up to 
identify the behaviour change which was most important to him during treatment, Jim’s 
verbal response was “When I began accepting invitations from my family and friends”. 
This action in retrospect may have proven to have been a ‘cusp’ behaviour. 
 
6.7 Treatment Integrity 
All of Jim’s treatment sessions were audio-recorded and 33.3% (n = 4) of 
sessions were randomly selected and independently scored for treatment integrity. Inter-
observer agreement averaged 93.75 % across scored sessions with 97.5 % of therapist 
in-session behaviour compatible and 2.5 % incompatible with the treatment modality 
(BATA). Please refer to Appendix G for items that define ‘compatible’ and 
‘incompatible’.  
 
6.8 Post-Treatment Diagnosis 
At the end of the treatment phase, Jim reported a significant and consistent 
decrease in his everyday stress and anxiety levels especially within social contexts. He 
reported that his worry behaviour had substantially diminished and that he was 
functioning well in the major areas of his life. After treatment, Jim no longer met DSM-
IV criteria for Social Anxiety Disorder and Generalised Anxiety Disorder and this 
maintained for 3 months indicating that the changes in his behaviour were robust and 
maintained without contact with therapy.  112      
 
 
 
CHAPTER 7 
 CASE 2 
7.1 Characteristics 
“Susan” was a 70-year-old female and a retired school-teacher. At the time of 
her initial involvement in the study, she was receiving an aged-pension and was 
engaged in casual unpaid work within her local church organisation in a counselling–
type role. Susan was living alone with her husband in an average size home in a 
southern metropolitan suburb of Perth, Western Australia. She had four adult children.  
 
7.2 Intake assessment 
At intake, Susan reported often feeling tense, restless, stressed and irritable. She 
reported excessive worry, often uncontrollable, regarding general areas of her life, such 
as her own and her family’s health, interpersonal relationships, household 
responsibilities, and finances. According to Susan, she often felt tired from worry and 
stress, was beginning to experience difficulties in concentrating on tasks, and was 
increasingly concerned about her level of anxiety (“Am I going to become one of those 
(anxious) people”). In addition, Susan reported having developed two specific fears that 
she was often worried about: 1) being bitten or knocked down by a dog; and, 2) falling 
over when walking. Susan also stated that she had experienced irregular panic attacks in 
the past (“I always think – is this going to happen again?”). She reported that the onset 
of the general symptoms occurred subsequent to her retirement at age 65, and that the 
more specific fears of falling and being harmed by a dog had developed subsequent to 
major knee surgery she had had 18-months prior to her involvement in the study. Susan 
stated that her anxiety was beginning to significantly impact on her day to day life and 
that, although she believed “it hasn’t gotten out of hand quite yet”, she wanted treatment 
before “it got any worse”. In terms of overt behaviour, she reported that typically she 113      
 
 
 
would avoid many occasions that required ambulatory behaviour. These occasions 
included walking, going to places where stairs might need to be used (e.g., shopping 
centres), and attending social events that involved conditions she believed increased the 
likelihood of a fall especially when they took place at night, outdoors, or on ‘uneven 
ground’. Susan stated, “I often take the easy option” in relation to her avoidance of 
these conditions. She reported having ceased regular walking near home because of the 
close proximity to parks, where “dogs are often bouncing around off their leads”. She 
had even restricted her visits by car to these and other parks visited by dogs and their 
owners. Susan reported she engaged in behaviour to facilitate escape from situations in 
the event of a panic attack, such as deliberately sitting in the aisle-seat at movies and 
sitting near the exits at church. 
Susan reported never having experienced, nor having required treatment for 
psychological problems until relatively recently. She stated her present condition was 
“something new”. She stated she was in good physical health other than her ongoing 
requirement to rehabilitate her knee subsequent to surgery. She reported that she was 
not using any psychopharmacological medication or other substances, and consumed an 
average of 2 to 3 standard alcoholic drinks per week. 
Based on her responses to the semi-structured interview (SCID-I; First et al., 
1997), Susan fulfilled DSM-IV-TR (APA, 2000) criteria for 300.02 Generalised 
Anxiety Disorder (GAD). At intake, Susan scored 14 on the BAI (mild; Beck & Steer, 
1993), 6 on the DASS-21 Depression scale (normal), 16 on the DASS-21 Anxiety scale 
(severe), and 18 on the DASS-21 Stress scale (mild) (Lovibond & Lovibond, 1995).  
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7.3 Anxiety-Related Outcomes 
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Figure 7.1. Case 2: BAI raw scores at baseline, treatment, and maintenance phases. 
Note: Scores below 7 = normal, 8-15 = mild, 16-25 = moderate, and above 26 = severe. 
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Figure 7.2. Case 2: DASS-21 Depression raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 9 = normal, 10-13 = mild, 14-20 = moderate, 
21-27 = severe, and above 28 = extremely severe. 
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Figure 7.3. Case 2: DASS-21 Anxiety raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 7 = normal, 8-9 = mild, 10-14 = moderate, 15-
19 = severe, and above 20 = extremely severe. 
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Figure 7.4. Case 2: DASS-21 Stress raw scores at baseline, treatment, and maintenance 
phases. Note: Scores below 14 = normal, 15-18 = mild, 19-25 = moderate, 26-33 = 
severe, and above 34 = extremely severe. 
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Susan’s BAI scores are presented in Figure 7.1. Time-series analysis of Susan’s 
BAI raw scores through all phases revealed evidence of a downward trend within the 
data, Z = 3.72, p < .001. Figures 7.2, 7.3 and 7.4 show DASS-21 scores through all 
phases. Analysis of Susan’s DASS-21 raw scores confirmed the presence of a 
downward trend for Depression scores, Z = 4.17, p < .001, Anxiety scores, Z = 1.84, p < 
.05, and Stress scores, Z = 3.86, p < .001.  The change in DASS-21 Anxiety is clinically 
significant because Susan’s scores moved from above the mean for individuals with 
GAD (M = 11.34; Brown et al., 1997) to within the range of the non-clinical population.  
 
7.4 Self-Monitored Anxiety and Activity Outcomes 
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Figure 7.5. Case 2: Daily Anxiety Rating Scale (DARS) scores across baseline and 
treatment phases. 
Susan’s DARS scores across phases are presented in Figure 7.5. Susan 
completed a 21 day baseline. Analysis of the baseline phase revealed an absence of 
trend within the data, Z = 0.11, p > .05. Compared to baseline, there was a significant 
decrease during the treatment phase in self-monitored anxiety with 81% of scores below 
the baseline median point, Z = 5.74, p < .001. This represents a mean decrease during 
the treatment phase of 2.1 points (14%) in Susan’s DARS scores. 
        Baseline                                                                                 Treatment                                                                        117      
 
 
 
0
100
200
300
400
500
1 8 15 22 29 36 43 50 57 64 71 78 85 92 99
Days
M
i
n
u
t
e
s
 
S
p
e
n
t
 
o
n
 
S
e
l
f
 
a
n
d
 
O
t
h
e
r
 
C
a
r
e
Figure 7.6. Case 2: Minutes spent per day on Self- and Other-Care across baseline and 
treatment phases. 
 Susan’s self- and other-care data across phases are presented in Figure 7.6. 
Analysis of the baseline phase revealed an absence of trend within the data, Z = 1.20, p 
> .05. Compared to baseline, there was a significant decrease during the treatment phase 
in the amount of time spent on self- and other-care with 77% of scores below the 
baseline median point, Z = 5.00, p < .001. This represents a mean decrease during the 
treatment phase of 19 minutes (10.8%) per day. 
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Figure 7.7. Case 2: Minutes spent per day on Housekeeping and Errands across baseline 
and treatment phases.  
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Susan’s Housekeeping and Errands data across baseline and treatment phases are 
presented in Figure 7.7. Analysis of the baseline phase revealed an absence of trend 
within the data, Z = 0.93, p > .05. Compared to baseline, there was no significant 
change during the treatment phase in the amount of time Susan spent on housekeeping 
etc. with 54% of data below the baseline median point, Z = 0.74, p > .05. This 
represents a mean increase during the treatment phase of 22 minutes (10%) per day.  
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Figure 7.8. Case 2: Minutes spent per day on Paid and Unpaid Work across baseline 
and treatment phases. 
 
Susan’s Paid and Unpaid Work data across baseline and treatment phases are 
presented in Figure 7.8 (zero rates were omitted). Analysis of the baseline phase 
revealed an absence of trend within the data, Z = 0.20, p > .05. Compared to baseline, 
there was a significant decrease during the treatment phase in the amount of time Susan 
spent on paid or un-paid work with 88% of data below the baseline median point, Z = 
7.00, p < .001. This represents a mean decrease during the treatment phase of 35 
minutes (78%) per day.  
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Figure 7.9. Case 2: Minutes spent per day on Interests, Hobbies, and Recreation across 
baseline and treatment phases.  
Susan’s Interests, Hobbies, and Recreation data across phases are presented in 
Figure 7.9. Analysis of the baseline phase revealed an absence of trend within the data, 
Z = 0.45, p > .05. Compared to baseline, there was a significant increase during the 
treatment phase in the amount of time spent on interests, hobbies and recreation with 
77% of data above the baseline median point, Z = 5.40, p < .001. This represents a mean 
increase during the treatment phase of 94 minutes (25%) per day. 
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Figure 7.10. Case 2: Minutes spent per day Out of the Home across baseline and 
treatment phases.  
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Susan’s Out of the Home data across baseline and treatment phases are 
presented in Figure 7.10. Analysis of the baseline phase revealed an absence of trend 
within the data, Z = 0.02, p > .05. Compared to baseline, there was a significant increase 
during the treatment phase in the amount of time Susan spent out of the home with 68% 
of data above the baseline median point, Z = 3.33, p < .001. This represents a mean 
increase during the treatment phase of 43 minutes (14%) per day.  
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 Figure 7.11. Case 2: Minutes spent per day Out of the Home with Others across 
baseline and treatment phases.  
 
Susan’s Out of Home with Others data across baseline and treatment phases are 
presented in Figure 7.11(zero rates were omitted). Analysis of the baseline phase 
revealed an absence of trend within the data, Z = 0.66, p > .05. Compared to baseline, 
there was a significant increase during the treatment phase in the amount of time she 
spent out of the home with others with 62% of data above the baseline median point, Z 
= 2.22, p < .05. This represents a mean increase during the treatment phase of 56 
minutes (22%) per day.  
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Figure 7.12. Case 2: Distance Walked per day across baseline and treatment phases.  
Susan’s Distance Walked per day data across phases are presented in Figure 
7.12. Analysis of the baseline phase showed an absence of trend within the data, Z = 
1.18, p > .05. Compared to baseline, there was a significant increase during treatment in 
the daily distance that she walked with 63% of data above the baseline median point, Z 
= 2.40, p < .05. This represents a mean increase during treatment of 274 meters (14%) 
per day. 
7.5 Therapist/Client Relationship 
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Figure 7.13. Case 2: OS-64 Assessment of Therapy Relationship Variables across the 
treatment phase. 122      
 
 
 
Susan’s total scale scores across the treatment phase from the Barrett-Lennard 
Relationship Inventory: Observer Form (OS-64) are presented in Figure 7.13. Total raw 
scale scores were converted to a percentage to aid visual analysis. The OS-64 was 
administered at 4, 8, and 12 week periods during treatment. Analysis shows that 
unconditionality and congruence scores remained stable across the repeated 
measurements with an absence of any definitive trends. From week 4 to week 12 there 
was a 16.7% increase in the rated amount of empathy with the therapist, a 6.25% 
decrease in the amount of level of regard, and a 6.2% decrease in the amount of 
congruence across the same period.  
 
7.6 Behavioural Cusps 
Susan engaged in activities which could qualify as behavioural cusps when 
formal activity scheduling commenced following the third week of treatment (week 
7/day 42). Activity examples included recreational walking, visiting her children, 
hosting friends for dinner, exercising in the local swimming-pool, baby-sitting 
grandchildren, attending medical appointments, gardening, writing, reading, sending a 
difficult personal letter to a close friend, and attending her grandchildren’s school 
functions including school plays. Her engagement in these activities occurred within the 
context of treatment and was potentially important in relation to changes in her 
clinically ‘healthy’ behaviours. When asked at 3-month follow-up to identify the 
behaviour change which was most important over the course of treatment, Susan’s 
verbal response was, “When I started to do things and go places without worrying about 
falling”. This activity, in retrospect, may have proven to be a ‘cusp’ behaviour. 
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7.7 Treatment Integrity 
All of Susan’s treatment sessions were audio-recorded and 33.3% (n = 4) of 
sessions were randomly selected and independently scored for treatment integrity. Inter-
observer agreement averaged 93.5 % across scored sessions with 88.9 % of therapist 
verbal behaviour compatible and 11.1 % incompatible with the treatment modality. 
Please refer to Appendix G for items that define ‘compatible’ and ‘incompatible’. 
 
7.8 Post-Treatment Diagnosis 
At the completion of the treatment phase, Susan reported a significant and 
consistent decrease in her everyday stress and anxiety. She was experiencing 
substantially less worry and she had a significant decrease in her fear response to 
activities that involved walking. She believed she was functioning well in the major 
areas of her life. Thus, subsequent to treatment, Susan no longer fulfilled DSM-IV 
criteria for Generalised Anxiety Disorder and this maintained for 3 months indicating 
that the changes in her behaviour were maintained without contact with therapy. 
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CHAPTER 8 
CASE 3 
8.1 Characteristics 
“Jason” was a 38-year-old male. At the time of his initial involvement in the 
study, he was receiving a disability pension due to chronic mental health problems and 
had been unemployed for a number of years. He was living with his long-term female 
partner who also was unemployed and received a benefit to care for Jason. Jason and his 
partner were living in an average size home in a southern metropolitan suburb of Perth, 
Western Australia.  
 
8.2 Intake assessment 
At intake, Jason reported having experienced physical signs of anxiety including 
an accelerated heart beat, hot flashes, sweating, shaky hands, fast breathing, and feeling 
fidgety. This occurred in company and when he was alone. He reported excessive 
worry, often uncontrollable, regarding his future performance on various mundane tasks 
such as servicing his car, answering the phone, doing the weekly grocery shopping, and 
about past his performances. He said, “I always feel everything is going to go wrong”. 
He also reported that he often worried about his health and relationships and whether he 
would find suitable employment. According to Jason, he tended to “over-react” in 
everyday situations and that daily obstacles and challenges, including food shopping 
and everyday social interactions, tended to “set him off”. Jason reported he often 
observed distressing and unwanted thoughts in the form of internal verbal statements 
including, “I’m not good enough”, “I’m a waste of space”, and “I’m not like other 
people”. These typically occurred in social situations. He reported observing images of 
himself becoming contaminated and ill following physical contact with things in his 
environment such as dogs, ashtrays, fences, doors, and toilets. He reported worrying 125      
 
 
 
about whether household appliances were switched off and that he had images of 
significant harm occurring to those close to him due to his negligence.  
According to Jason, he would attempt to manage his daily discomfort by 
engaging in certain activities such as checking doors, locks, appliances, washing his 
hands, and “chanting to himself”. He stated that in the past he had washed his hands to 
the point where they became “sometimes red raw, bleeding, and cut”. He had recently 
started using antiseptic hand-gel which he claimed reduced the physical consequences 
of excessive hand washing. Jason reported certain routines he had been conducting 
before he went to bed at night and before leaving the house, including systematically 
checking ashtrays, locks on doors, appliances, and taps – often up to 40 cycles on every 
occasion. He stated this often caused lengthy time delays, disrupted his plans for the 
day, and led to conflict with his partner. He spent the majority of his time indoors at 
home, and either alone or with his partner. He said he mostly left the house to walk his 
dog or buy food with occasional social visits. When invitations to social engagements 
occurred he would agree to attend and then became “preoccupied by negative thinking 
about the event”. Subsequently, he would avoid most social activities. In social contexts 
he would often engage in ‘positive’ and repetitive self-talk saying, “I’m a good person”, 
and construct statements about the intentions of others, or focus his attention on aspects 
of his private responses such as how he was breathing. Jason reported that his anxiety 
had developed to the point where, “I don’t want to go anywhere”. He stated, “In a way I 
do want to go, but at the same time I’m so anxious about going”. 
Jason reported an adult history of chronic psychological problems including 
major depression, anxiety, and occasional psychotic features including hallucinations 
and delusions beginning at around age 18. He claimed these problems peaked in their 
severity 4 years prior to his involvement in the present study when he was hospitalised 
for what he labelled as “a breakdown”. He said he had received various treatments 126      
 
 
 
including cognitive behavioural therapy, electroconvulsive therapy, supportive 
counselling, and medication. He also had read several “self-help” books for anxiety and 
depression. At the time of intake, Jason reported having been receiving 
psychopharmacological treatment during the previous 4 years (Clomipramine® 75 
mgs/daily; Alprazolam® 2 mgs/daily). This was ongoing and unchanged through his 
involvement in the present study. Jason reported daily nicotine smoking (approximately 
40 cigarettes per day) and he consumed 1 to 2 standard drinks of alcohol per day.  
Based on his responses to the semi-structured interview (SCID-I; First et al., 
1997), Jason fulfilled DSM-IV-TR (APA, 2000) criteria for 300.3 Obsessive-
Compulsive Disorder. At intake, Jason scored 31 on the BAI (severe; Beck & Steer, 
1993), 24 on the DASS-21 Depression scale (severe), 30 on the DASS-21 Anxiety scale 
(extremely severe), and 34 on the DASS-21 Stress scale (extremely severe) (Lovibond 
& Lovibond, 1995).  
 
8.3 Anxiety-Related Outcomes 
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 Figure 8.1. Case 3: BAI raw scores at baseline, treatment, and maintenance phases. 
Note: Scores below 7 = normal, 8-15 = mild, 16-25 = moderate, and above 26 = severe. 
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 Figure 8.2. Case 3: DASS-21 Depression raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 9 = normal, 10-13 = mild, 14-20 = moderate, 
21-27 = severe, and above 28 = extremely severe.  
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Figure 8.3. Case 3: DASS-21 Anxiety raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 7 = normal, 8-9 = mild, 10-14 = moderate, 15-
19 = severe, and above 20 = extremely severe. 
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 Figure 8.4. Case 3 DASS-21 Stress raw scores at baseline, treatment, and maintenance 
phases. Note. Scores below 14 = normal, 15-18 = mild, 19-25 = moderate, 26-33 = 
severe, and above 34 = extremely severe. 
 
Jason’s BAI scores are presented in Figure 8.1. Time-series analysis of Jason’s 
BAI raw scores revealed an upward trend within the data through phases, Z = 1.77, p < 
.05. This change is not clinically significant because Jason’s scores remained above the 
mean expected for individuals with obsessive-compulsive disorder (OCD) (M = 21.96; 
Beck & Steer, 1993). Jason’s DASS-21 raw scores are presented in Figures 8.2, 8.3, and 
8.4. Analysis of Jason’s DASS-21 raw scores confirmed the presence of an upward 
trend for depression scores, Z = 3.35, p < .001, an absence of trend for anxiety scores, Z 
= 0.02, p > .05, and an absence of trend for stress scores, Z = 1.44, p > .05.  The change 
in DASS-21 depression is not clinically significant because Jason’s scores remained 
above the mean expected for individuals with OCD (M = 16.45; Brown et al., 1997).  
 
 
 
Participant Withdrew 
          Baseline                                                        Treatment                                                                    Maintenance  
    Normal Range 
            Baseline                                                        Treatment                                                                    Maintenance  
    Normal Range 129      
 
 
 
8.4 Self-Monitored Anxiety and Activity Outcomes  
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Figure 8.5. Case 3: Daily Anxiety Rating Scale (DARS) scores across baseline and 
treatment phases. 
Jason’s DARS scores across baseline and treatment phases are presented in 
Figure 8.5. Jason completed a 28 day baseline. Baseline analysis revealed an absence of 
trend within the data, Z = 1.60, p > .05. Compared to baseline, there was no significant 
change during treatment in self-monitored daily anxiety with 59% of scores above the 
baseline median point, Z = 1.08, p > .05. This represents a small mean increase during 
treatment of 1 point (2.5%).  
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Figure 8.6. Case 3: Minutes spent per day on Self- and Other-Care across baseline and 
treatment phases. 
Participant Withdrew 
Participant Withdrew 
              Baseline                                                                                 Treatment                                                                        
             Baseline                                                                                 Treatment                                                                        130      
 
 
 
Jason’s Self- and Other-Care data across baseline and treatment phases are 
presented in Figure 8.6. Analysis of the baseline phase revealed an absence of trend 
within the data, Z = 0.20, p > .05. Compared to baseline, there was a significant increase 
during the treatment phase in the amount of time Jason spent on self- and-other care 
with 81% of scores above the baseline median point, Z = 3.73, p < .001. This represents 
a mean increase during the treatment phase of 63 minutes (26.4%) per day.  
 
Note: Jason’s Paid and Unpaid Work data are not presented due to absolute zero count 
rates across baseline and treatment phases. 
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Figure 8.7. Case 3: Minutes spent per day on Housework and Errands across baseline 
and treatment phases.  
Jason’s Housework and Errands data across baseline and treatment phases are 
presented in Figure 8.7. Analysis of the baseline phase revealed an absence of trend 
within the data, Z = 1.53, p > .05. Compared to baseline, there was no significant 
change during the treatment phase in the amount of time he spent on housework and 
errands with 59% of data above the baseline median point, Z = 1.08, p > .05. This 
represents a mean decrease during the treatment phase of 18 minutes (7%) per day.  
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Figure 8.8. Case 3: Minutes spent per day on Interests, Hobbies, and Recreation across 
baseline and treatment phases.  
Jason’s Interests, Hobbies, and Recreation data across phases are presented in 
Figure 8.8. Analysis of the baseline phase revealed an absence of trend within the data, 
Z = 0.43, p > .05. Compared to baseline, there was a significant decrease during  
treatment in the amount of time he spent on interests etc. with 84% of data below the 
baseline median point, Z = 4.09, p < .001. This represents a mean decrease during the 
treatment phase of 85 minutes (19%) per day.  
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Figure 8.9. Case 3: Minutes spent per day Out of the Home across baseline and 
treatment phases. 
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Jason’s Out of the Home data across baseline and treatment phases are presented 
in Figure 8.9. Analysis of the baseline phase revealed an upward trend within the data, Z 
= 3.47, p < .001. Compared to baseline, there was no significant change during the 
treatment phase in the amount of time he spent out of the home with 62% of data above 
the baseline median point, Z = 1.44, p > .05. This represents a mean decrease during the 
treatment phase of 54 minutes (15%) per day.  
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 Figure 8.10. Case 3: Minutes spent per day Out of the Home With Others across 
baseline and treatment phases. 
 
Jason’s Out of Home With Others data across baseline and treatment phases are 
presented in Figure 8.10. Analysis of the baseline phase revealed an upward trend 
within the data, Z = 3.35, p < .001. Compared to baseline, there was no significant 
change during the treatment phase in the amount of time he spent out of the home with 
others with 62% of data above the baseline median point, Z = 1.44, p < .05. This 
represents a mean decrease during the treatment phase of 79 minutes (27%) per day.  
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Figure 8.11. Case 3: Distance Walked per day across baseline and treatment phases.  
Jason’s Distance Walked per day data across phases are presented in Figure 
8.11. Analysis of the baseline phase revealed an absence of trend within the data, Z = 
0.14, p > .05. Compared to baseline, there was a significant decrease during treatment in 
the daily distance walked with 84% of data below the baseline median point, Z = 4.09, p 
< .001. This represents a mean decrease during treatment of 672 meters (16%) per day.  
 
8.5 Therapist/Client Relationship 
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Figure 8.12. Case 3: OS-64 Assessment of Therapy Relationship Variables across the 
treatment phase. 
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Jason’s total scale scores across the (partial) treatment phase from the Barrett-
Lennard Relationship Inventory: Observer Form (OS-64) are presented in Figure 8.12. 
Total raw scale scores were converted to a percentage to aid visual analysis. Due to 
Jason’s withdrawal from the study, the OS-64 was only administered at 4 and 8 week 
periods during treatment. Analysis shows the level of regard, empathy, and 
unconditionality scores remained stable. However, from week 4 to week 8 there was a 
20.85% decrease in the amount of congruence within the therapist’s approach according 
to Jason. Congruence is, “the degree to which one person is functionally integrated in 
the context of his relationship with another, such that there is absence of conflict or 
inconsistency between his total experience, his awareness, and his overt 
communication” (Barrett-Lennard, 1986, p. 444). 
 
8.6 Behavioural Cusps 
Jason engaged in activities which could qualify as behavioural cusps when 
formal activity scheduling commenced following the third week of treatment (week 
8/day 49). Activity examples included regular pet walking, home-based maintenance 
including cleaning the fish-pond, mowing lawn, and washing the car. He also attempted 
to engage in job-seeking activities. Jason visited his parents, went to the movies, and 
listened to ‘calming’ music. During this period, Jason typically reported he was 
ineffective at generating and verbally stating the activities he planned to engage in and 
that he often was unable to initiate and maintain engagement in scheduled activities. 
Figures 8.1 and 8.2 show an increase in self-reported anxiety around the period when 
Jason was initially prompted by the therapist to increase his engagement in meaningful 
activity. Due to Jason’s withdrawal from the study subsequent to treatment session 10 
there was no opportunity to ask Jason to report whether engagement in any particular 
activity was observed by him as important to his mental-health status. 135      
 
 
 
 
8.7 Treatment Integrity 
All of Jason’s treatment sessions were audio-recorded and 30% (n = 3) of 
sessions were randomly selected and independently scored for treatment integrity. Inter-
observer agreement averaged 93.8% across scored sessions with 86.5 % of therapist 
verbal behaviour compatible and 13.5% incompatible with the treatment modality. 
Please refer to Appendix G for items that define ‘compatible’ and ‘incompatible’. 
 
8.8 Post-Treatment Diagnosis 
Jason withdrew from the study between weeks 10 and 11 of the treatment phase. 
He stated that there had been no change in his anxiety-related behaviour and that he was 
continuing to experience the same problems of agitation, stress, distressing thoughts, 
and repetitive behaviours that he had reported at the time of the intake assessment. 
Jason continued to fulfil the DSM-IV criteria for Obsessive-Compulsive Disorder at that 
time point.  
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CHAPTER 9 
CASE 4 
9.1 Characteristics 
“Frank” was a 51-year-old male. At the time of his initial involvement in the 
study, Frank was employed as a university lecturer, artist, art teacher, and as manager of 
an art gallery. He was also engaged in post-graduate study at the doctoral level. He was 
living alone in an average-sized house in a southern metropolitan suburb of Perth, 
Western Australia, and he had a partner of 1 year.  Frank had been twice married and 
divorced and had two adult children.  
 
9.2 Intake assessment 
At intake, Frank reported experiencing chronic “anxiety” and that it had been a 
“very physical thing”. He reported having observed abdominal discomfort, tightness in 
the throat area, hot flushes, sweating, and rapid breathing. He stated, “I just feel anxious 
all the time and I don’t know why”. Frank also reported that when anxious his “mind 
would be racing” and he would often experience confusion. Also, according to Frank 
his distress would intensify when he engaged in active worry about his anxiety. He said, 
“I always wonder will I always be this way”. According to Frank, there were two broad 
contexts which typically occasioned his anxiety. Firstly, in social situations where there 
was an expectation on him to perform including lecturing and meeting people for the 
first time, and everyday social situations including using public transport and making 
retail purchases. Frank reported that “basically at an underlying level I’m anxious about 
all social situations”. Secondly, Frank stated that his anxiety was often preceded by the 
occurrence of everyday events that required him to complete some type of chore, such 
as paying bills, vehicle refuelling and house cleaning, and that he found these regular 
day to day tasks particularly aversive as they were, “a complete waste of time”. 137      
 
 
 
 In addition, Frank reported that he often engaged in worry about his 
relationships, work, and his long-term life direction. For example, he stated that he had, 
“lost who I really am” and, “if I worked out what I wanted to do with my life maybe I 
wouldn’t feel so anxious”.  
According to Frank, he would often engage in various strategies in order to 
avoid experiencing anxiety or to minimise anxiety if it occurred. Examples included 
controlling his breathing in social situations and when lecturing, mentally rehearsing 
scripted responses to use in social situations when making purchases, delaying 
engagement with everyday tasks (like house cleaning and gardening), procrastinating by 
substituting the reading of books related to his doctorate for writing his doctorate, and 
avoiding certain social responsibilities including important discussions with his partner 
and addressing conflict at work. Frank reported regular patterns of behaviour such as 
staying up late watching television and ‘surfing’ the internet which consumed large 
amounts of his time and resulted in his self-described “zoning-out”.  
Frank reported an adult history of infrequent but persistent psychological 
problems including major depression and anxiety. He reported having first experienced 
anxiety around age 11, and that he had been hospitalised a number of times in his adult 
life due to depression-related behaviour. Frank reported he had engaged in various 
forms of therapy, including supportive counselling, cognitive-behavioural therapy, and 
psychiatric counselling with medication. At the time of intake, he reported having been 
taking Avanza® 30mgs daily which is an anti-depressant medication. This had been 
ongoing during the previous 2 years and was unchanged and continued through his 
involvement in the study. Frank was a non-(nicotine) smoker and he reported 
consuming 3 to 4 standard drinks of alcohol per day with occasional cannabis use. He 
reported his physical health as “ok” but stated he had a sedentary lifestyle. 
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Based on his responses to the semi-structured interview (SCID-I; First et al., 
1997), Frank fulfilled DSM-IV-TR (APA, 2000) criteria for 300.23 Social Anxiety 
Disorder (SAD; generalised) and 300.02 Generalised Anxiety Disorder (GAD). At 
intake, he scored 20 on the BAI (moderate; Beck & Steer, 1993), 10 on the DASS-21 
Depression scale (mild), 16 on the DASS-21 Anxiety scale (severe), and 24 on the 
DASS-21 Stress scale (moderate) (Lovibond & Lovibond, 1995).  
 
9.3 Anxiety-Related Outcomes 
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Figure 9.1. Case 4: BAI raw scores at baseline, treatment, and maintenance phases. 
Note: Scores below 7 = normal, 8-15 = mild, 16-25 = moderate, and above 26 = severe. 
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Figure 9.2. Case 4: DASS-21 Depression raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 9 = normal, 10-13 = mild, 14-20 = moderate, 
21-27 = severe, and above 28 = extremely severe. 
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Figure 9.3. Case 4: DASS-21 Anxiety raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 7 = normal, 8-9 = mild, 10-14 = moderate, 15-
19 = severe, and above 20 = extremely severe. 
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Figure 9.4. Case 4: DASS-21 Stress raw scores at baseline, treatment, and maintenance 
phases. Note: Scores below 14 = normal, 15-18 = mild, 19-25 = moderate, 26-33 = 
severe, and above 34 = extremely severe. 
 
Frank’s BAI scores are presented in Figure 9.1. Time-series analysis of Frank’s 
BAI raw scores through all phases revealed evidence of a downward trend within the 
data, Z = 4.22, p < .001. This change is clinically significant because Frank’s scores 
moved from above the means for individuals with SAD (M = 17.77; Beck & Steer, 
1993) and GAD (M = 18.83; Beck & Steer, 1993) to within the range of the non-clinical 
population.  
Analysis of Frank’s DASS-21 raw scores confirmed the presence of a downward 
trend within Depression scores, Z = 3.45, p < .001, Anxiety scores, Z = 3.85, p < .001, 
and Stress scores, Z = 3.74, p < .001.  Figures 9.2, 9.3 and 9.4 show DASS-21 scores 
through all phases. The change in the DASS-21 Stress Scale score is clinically 
significant because his scores moved from above the means for individuals with SAD 
(M = 16.57; Antony et al., 1998) and GAD (M = 22.36; Brown et al., 1997) to within 
the range of the non-clinical population.  
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9.4 Self-Monitored Anxiety and Activity Outcomes 
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Figure 9.5. Case 4: Daily Anxiety Rating Scale (DARS) scores across baseline and 
treatment phases. 
Frank’s DARS scores are presented in Figure 9.5. Frank completed a 28 day 
baseline. Analysis of the baseline phase revealed an absence of trend within the data, Z 
= 0.68, p > .05. Compared to baseline, there was a significant decrease during treatment 
in daily anxiety with 77% of scores below the baseline median point, Z = 5.00, p < .001. 
This represents a mean decrease during the treatment phase of 8 points (18%) in his 
DARS scores. 
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Figure 6.6. Case 4: Minutes spent per day on Self- and Other-Care across baseline and 
treatment phases. 
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Frank’s Self- and Other-Care data across baseline and treatment phases are 
presented in Figure 9.6. Analysis of the baseline phase revealed an absence of trend 
within the data, Z = 1.60, p > .05. Compared to baseline, there was a significant increase 
during the treatment phase in the amount of time Frank spent on self- and other-care 
with 82% of scores above the baseline median point, Z = 5.92, p < .001. This represents 
a mean increase during the treatment phase of 11 minutes (27%) per day.  
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Figure 9.7. Case 4: Minutes spent per day on Housekeeping and Errands across baseline 
and treatment phases.  
 
Frank’s Housekeeping and Errands data across baseline and treatment phases are 
presented in Figure 9.7 (zero rates were omitted). Analysis of the baseline phase 
revealed an absence of trend within the data, Z = 0.22, p > .05. Compared to baseline, 
there was no significant change during the treatment phase in the amount of time he 
spent on housekeeping and errands with 52% of data above the baseline median point, Z 
= 0.37, p > .05. This represents a mean increase during the treatment phase of 37.5 
minutes (166%) per day.  
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Figure 9.8. Case 4: Minutes spent per day on Paid and Unpaid Work across baseline 
and treatment phases. 
Frank’s Paid and Unpaid Work data across phases are presented in Figure 9.8 
(zero rates were omitted). Analysis of the baseline phase revealed an absence of trend 
within the data, Z = 0.04, p > .05. Compared to baseline, there was a significant 
decrease during treatment in the amount of time Frank spent on paid or un-paid work 
with 70% of data including zero rates, below the baseline median point, Z = 3.70, p < 
.001. This represents a mean decrease during treatment of 97 minutes (25%) per day. 
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Figure 9.9. Case 4: Minutes spent per day on Interests, Hobbies, and Recreation across 
baseline and treatment phases.  
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Frank’s Interests, Hobbies, and Recreation data across baseline and treatment 
phases are presented in Figure 9.9. Analysis of the baseline phase revealed an absence 
of trend within the data, Z = 0.95, p > .05. Compared to baseline, there was no 
significant change during the treatment phase in the amount of time Frank spent on 
interests, hobbies and recreation with 54% of data above the baseline median point, Z = 
0.74, p > .05. This represents a mean increase during the treatment phase of 28 minutes 
(7%) per day.  
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Figure 9.10. Case 4: Minutes spent per day Out of the Home across baseline and 
treatment phases.  
 
Frank’s Out of the Home data across baseline and treatment phases are presented 
in Figure 9.10 (zero rates were omitted). Analysis of the baseline phase revealed an 
absence of trend within the data, Z = 0.53, p > .05. Compared to baseline, there was a 
significant decrease during treatment in the amount of time he spent out of the home 
with 76% of data including zero rates, below the baseline median point, Z = 4.81, p < 
.001. This represents a mean decrease during the treatment of 104 minutes (20%) per 
day.  
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Figure 9.11. Case 4: Minutes spent per day Out of Home with Others across baseline 
and treatment phases.  
Frank’s Out of the Home with Others data across phases are presented in Figure 
9.11 (zero rates were omitted). Analysis of the baseline phase revealed an absence of 
trend within the data, Z = 0.01, p > .05. Compared to baseline, there was no significant 
change during treatment in the amount of time he spent out of the home with others with 
52% of data above the baseline median point, Z = 0.37, p > .05. This represents a mean 
increase during treatment of 11 minutes (3.5%) per day.  
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Figure 9.12. Case 4: Distance Walked per day across baseline and treatment phases.  
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Frank’s Distance Walked per day data across baseline and treatment phases are 
presented in Figure 9.12. Analysis of the baseline phase revealed an absence of trend 
within the data, Z = 0.39, p > .05. Compared to baseline, there was no significant 
change during treatment in the daily distance that he walked with 57% of data below the 
baseline median point, Z = 1.29, p > .05. This represents a mean increase during 
treatment of 47 meters (1%) per day. 
 
 9.5 Therapist/Client Relationship 
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 Figure 9.13. Case 4: OS-64 Assessment of Therapy Relationship Variables across the 
treatment phase. 
Frank’s total scale scores across the treatment phase from the Barrett-Lennard 
Relationship Inventory: Observer Form (OS-64) are presented in Figure 9.13. Total raw 
scores were converted to a percentage to aid visual analysis. There is variability in the 
data. Overall, from week 4 to week 12 there was an 8.5% increase in the amount of 
level of regard within the therapist’s approach reported by Frank with a peak at week 8. 
There was a 12.6% decrease in the amount of unconditionality from week 4 to week 12 
with an inverse peak at week 8, an 8% decrease in the amount of congruence across the 
same period with a peak at week 8, and a 2.8% decrease in empathy from week 4 to 
week 12. 147      
 
 
 
9.6 Behavioural Cusps 
Frank engaged in activities which could qualify as behavioural cusps when 
formal activity scheduling commenced at the third week of treatment (week 7/day 42). 
Activity examples included gardening, house cleaning, visiting his parents, visiting his 
children, weekly food shopping, creating a web-site, increase art painting, walking, 
working on his PhD, engaging in conversations with his partner, dining out, and 
resolving a long-standing personal matter with his parents. Engagement in these 
activities occurred during treatment and was potentially important for Frank’s 
expanding repertoire of clinically ‘healthy’ behaviours. When asked at 3-month follow-
up to identify the change that was most important during treatment, he said, “just 
scheduling things and then doing them”, and “I feel like if I can do these things just by 
scheduling, then I can do anything I want in my life”.   
 
9.7 Treatment Integrity 
All of Frank’s treatment sessions were audio-recorded and 33.3% (n = 4) of 
sessions were randomly selected and independently scored for treatment integrity. Inter-
observer agreement averaged 98.1% across scored sessions with 94.5% of therapist in-
session behaviour compatible and 5.5% incompatible with the treatment modality. 
Please refer to Appendix G for items that define ‘compatible’ and ‘incompatible’. 
 
9.8 Post-treatment Diagnosis 
At the completion of the treatment phase, Frank reported a significant and 
consistent decrease in his fear response within social situations. He was experiencing 
substantially less worry and he believed he was functioning well in the major areas of 
his life. Thus, subsequent to treatment, Frank no longer met DSM-IV criteria for Social 
Anxiety Disorder and Generalised Anxiety Disorder and this maintained for 3 months 
without therapy contact supporting that the changes in his behaviour were robust.  148      
 
 
 
CHAPTER 10 
CASE 5 
10.1 Characteristics 
“Mary” was a 62-year-old female. At the time of her initial involvement in the 
study, she was retired, receiving a pension and was engaged in unpaid employment as 
an organiser and administrative assistant within an environment conservation 
organisation. She was living with her retired husband in an average-sized house in a 
southern metropolitan suburb in Perth, Western Australia. Mary had migrated to 
Australia from England three years earlier. She had two adult children who remained 
living in England.  
 
10.2 Intake assessment 
At intake, Mary reported feeling significantly anxious in relation to road and 
vehicle related activity. She stated that she had never driven independently and did not 
possess a driving license. She claimed that she had “always been nervous” when 
travelling in cars and buses, and also experienced fear when walking adjacent to or 
crossing highly-populated roads and traffic intersections. According to Mary, on these 
occasions she would experience muscle tension, headache, dryness in the mouth, hot 
flushes, abdominal discomfort, and restlessness. She reported extensive involvement in 
patterns of self-talk characterised by forecasting potential life-threatening outcomes, 
such as a truck colliding with her car, and suitable defensive solutions, such as 
travelling on less-populated roads. When travelling as a passenger in a car, Mary 
reported that she would tightly grab anchor points in the car under the seat or the 
dashboard, lean forward in the seat, and continually scan the environment for other 
vehicles and cyclists. She regularly looked in the driving mirrors and overtly and 149      
 
 
 
covertly engaged in a running commentary of the travelling conditions. She made 
statements including, “Ooh. Look at that truck”, and “He’s driving very close to us”.  
Mary reported more generalised aspects of anxiety including ongoing and often 
uncontrollable concerns about finances, health, relationships, work, and her migration to 
Australia. She reported worrying about “all sorts of things” and that she would worry 
about her worry. She said, “I always wonder why am I like this”, and “It’s just this 
feeling that I feel so anxious and I don’t know what to do”. She often had difficulty 
staying asleep at night and she complained of feelings of irritability and restlessness. 
She stated that she often worried about being late for, or completely missing, scheduled 
appointments.  
According to Mary’s reports, she would often engage in various strategies in 
order to avoid experiencing anxiety, or to minimise anxiety if it occurred. Examples 
included refusing to travel along certain roads, never driving herself, excessive planning 
of everyday travel routes, declining invitations for social outings and avoiding social 
activities with her husband, avoiding important work-related discussions at work (e.g., 
by “acting busy”), and avoiding popular environments like cinemas and theatres. Mary 
stated, “At the very thought of travel I can feel the anxious feeling in my body. It 
doesn’t last but by that stage I’ve already decided that I wouldn’t be going anyway”. 
Mary reported that she had been fearful of cars and car travel since she was a 
child though she couldn’t explain why. In relation to her more generalised anxiety, she 
stated that she began to experience more frequent and intense worry and stress 
subsequent to her migration to Australia three years prior. She reported experiencing a 
fall two years ago and this further exacerbated her anxiety symptoms. She had sought 
referral from a General Practitioner to a Psychotherapist with whom she attended one 
session. Mary reported her physical health was average although she stated she was 150      
 
 
 
“overweight” and needed to engage in more exercise. Mary was a non-smoker and 
consumed 7 to 8 standard alcohol drinks per week.  
Based on her responses to the semi-structured interview (SCID-I; First et al., 
1997), Mary fulfilled DSM-IV-TR (APA, 2000) criteria for 300.29 Specific Phobia 
(situational) and 300.02 Generalised Anxiety Disorder. At intake, Mary scored 12 on 
the BAI (mild; Beck & Steer, 1993), 14 on the DASS-21 depression scale (moderate), 6 
on the DASS-21 anxiety scale (normal), and 20 on the DASS-21 stress scale (moderate) 
(Lovibond & Lovibond, 1995a).  
 
10.3 Anxiety-Related Outcomes 
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Figure 10.1. Case 5: BAI raw scores at baseline, treatment, and maintenance phases. 
Note: Scores below 7 = normal, 8-15 = mild, 16-25 = moderate, and above 26 = severe. 
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Figure 10.2. Case 5: DASS-21 Depression raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 9 = normal, 10-13 = mild, 14-20 = moderate, 
21-27 = severe, and above 28 = extremely severe. 
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Figure 10.3. Case 5: DASS-21 Anxiety raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 7 = normal, 8-9 = mild, 10-14 = moderate, 15-
19 = severe, and above 20 = extremely severe. 
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Figure 10.4. Case 5: DASS-21 Stress raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 14 = normal, 15-18 = mild, 19-25 = moderate, 
26-33 = severe, and above 34 = extremely severe. 
Mary’s BAI scores are presented in Figure 10.1. Data analysis through all phases 
revealed a downward trend, Z = 3.01, p < .001. This change is clinically significant 
because Mary’s scores moved from above the expected mean for individuals with 
specific phobia (M = 15.8; Leyfer, Ruberg, & Woodruff-Borden, 2006) and GAD (M= 
18.83; Beck & Steer, 1993) to within the range of the non-clinical population. Figures 
10.2, 10.3 and 10.4 show DASS-21 scores through all phases. Analysis revealed a 
downward trend for Depression scores, Z = 2.84, p < .01, Anxiety scores, Z = 2.89, p < 
.01, and Stress scores, Z = 3.68, p < .001.  Large changes occurred at the start of activity 
scheduling at week 3 of treatment (week 9). The change in DASS-21 Anxiety is 
clinically significant because her scores moved from above the expected mean for 
individuals with specific phobia (M = 6.69; Antony et al., 1998) and GAD (M = 11.34; 
Brown et al., 1997) to within the non-clinical range. The change in DASS-21 Stress is 
clinically significant because scores moved from above the expected mean for 
individuals with specific phobia (M = 13.29; Antony et al., 1998) and GAD (M = 22.36; 
Brown et al., 1997) to within the non-clinical range.  
              Baseline                                                           Treatment                                                          Maintenance  
    Normal Range 153      
 
 
 
10.4 Self-Monitored Anxiety and Activity Outcomes 
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Figure 10.5. Case 5: Daily Anxiety Rating Scale (DARS) scores across baseline and 
treatment phases. 
Mary’s DARS scores across phases are presented in Figure 10.5. Mary 
completed a 35 day baseline. Analysis of the baseline phase revealed no trend within the 
data, Z = 0.004, p > .05. Compared to baseline, there was a significant decrease during 
the treatment phase in daily anxiety with 71% of scores below the baseline median 
point, Z = 3.88, p < .001. This represents a mean decrease during the treatment phase of 
5 points (18.5%) in DARS scores.  
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Figure 10.6. Case 5: Minutes spent per day on Self- and Other-Care across baseline and 
treatment phase. 
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Mary’s Self- and Other-Care data across baseline and treatment phases are 
presented in Figure 10.6 (zero rates were omitted). Analysis of the baseline phase 
revealed an absence of trend within the data, Z = 0.24, p > .05. Compared to baseline, 
there was no significant change during the treatment phase in the amount of time she 
spent on self- and other-care with 55% of scores below the baseline median point, Z = 
0.92, p > .05. This represents a mean decrease during the treatment phase of 4 minutes 
(3%) per day.  
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Figure 10.7. Case 5: Minutes spent per day on Housekeeping and Errands across 
baseline and treatment phases.  
Mary’s Housekeeping and Errands data across baseline and treatment phases are 
presented in Figure 10.7 (zero rates were omitted). Analysis of the baseline phase 
revealed an absence of trend within the data, Z = 1.46, p > .05. Compared to baseline, 
there was no significant change during the treatment phase in the amount of time she 
spent on housekeeping and errands with 57% of data above the baseline median point, Z 
= 1.29, p > .05. This represents a mean increase during the treatment phase of 48 
minutes (33%) per day. 
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Figure 10.8. Case 5: Minutes spent per day on Paid and Unpaid Work across baseline 
and treatment phases. 
Mary’s Paid and Unpaid Work data across phases are presented in Figure 10.8 
(zero rates were omitted). Baseline analysis revealed an absence of trend within the 
data, Z = 0.39, p > .05. Compared to baseline, there was no significant change during 
the treatment phase in the amount of time she spent on paid or unpaid work with data 
evenly distributed (50/50) around the baseline median point, Z = 0.00, p > .05. This 
represents a mean decrease during the treatment phase of 8 minutes (6.5%) per day.  
0
100
200
300
400
500
600
700
800
1 8 15 22 29 36 43 50 57 64 71 78 85 92 99 106 113
Days
M
i
n
u
t
e
s
 
S
p
e
n
t
 
o
n
 
I
n
t
e
r
e
s
t
s
,
 
H
o
b
b
i
e
s
 
a
n
d
 
R
e
c
r
e
a
t
i
o
n
Figure 10.9. Case 5: Minutes per day spent on Interests, Hobbies, and Recreation across 
baseline and treatment phases.  
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Mary’s Interests, Hobbies, and Recreation data across baseline and treatment 
phases are presented in Figure 10.9. Analysis of the baseline phase revealed instability 
within the data, Z = 3.13, p < .001. Compared to baseline, there was no significant 
change during the treatment phase in the amount of time she spent on interests etc. with 
54% of data above the baseline median point, Z = 0.74, p > .05. This represents a mean 
decrease during the treatment phase of 2 minutes (0.4%) per day.  
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Figure 10.10. Case 5: Minutes spent per day Out of the Home across baseline and 
treatment phases.  
 
Mary’s Out of the Home data across baseline and treatment phases are presented 
in Figure 10.10 (zero rates were omitted). Analysis of the baseline phase revealed 
instability within the data, Z = 3.38, p < .001. Compared to baseline, there was a 
significant increase during the treatment phase in the amount of time she spent out of 
the home with 62% of data above the baseline median point, Z = 2.22, p < .05. This 
represents a mean increase during the treatment phase of 25 minutes (7.8%) per day.  
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Figure 10.11. Case 5: Minutes spent per day Out of the Home With Others across 
baseline and treatment phases.  
Mary’s Out of the Home with Others data across phases are presented in Figure 
10.11 (zero rates were omitted). Baseline analysis revealed an absence of trend within 
the data, Z = 0.22, p > .05. Compared to baseline, there was no significant change 
during the treatment phase in the amount of time she spent out of the home with others 
with 58% of data above the baseline median point, Z = 0.37, p > .05. This represents a 
mean increase during treatment of 17 minutes (5.5%) per day.  
0
1
2
3
4
5
6
1 8 15 22 29 36 43 50 57 64 71 78 85 92 99 106 113
Days
D
i
s
t
a
n
c
e
 
W
a
l
k
e
d
 
i
n
 
K
i
l
o
m
e
t
e
r
s
Figure 10.12. Case 5: Distance Walked per day across baseline and treatment phases.  
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Mary’s Distance Walked per day data across phases are presented in Figure 
10.12. Analysis of the baseline phase revealed instability within the data, Z = 6.09, p < 
.001. Compared to baseline, there was no significant change during treatment in the 
daily distance walked with 57% of data below the baseline median point, Z = 1.29, p > 
.05. This represents a mean decrease during treatment of 245 meters (13%) per day.  
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 Figure 10.13. Case 5: OS-64 Assessment of Therapy Relationship Variables across the 
treatment phase.  
Mary’s scores from the Barrett-Lennard Relationship Inventory: Observer Form 
(OS-64) are presented in Figure 10.13. Total raw scores were converted to a percentage 
to aid visual analysis. Analysis showed decreased scores across treatment, with 
‘unconditionality’ sharply decreasing from week 8 to week 12. Unconditionality is “the 
extent the regarding person’s response experientially implies that the recipient person is 
more or less pleasing, worthy, valued, trusted, liked or disliked if he or she manifests 
certain self-attributes than if or when he or she manifests others” (Barrett-Lennard, 
1986, p. 443).  From week 4 to week 12, there was a reported 6.3% decrease in the 
‘level of regard’ from the therapist, a 10.3% decrease in ‘empathy’, an 18.8% decrease 
in ‘unconditionality’ and a 6.25% decrease in ‘congruence’.  159      
 
 
 
10.6 Behavioural Cusps 
Mary engaged in activities which could qualify as behavioural ‘cusps’ when 
activity scheduling started at week 3 of treatment (week 7/day 42). These included 
responding to overdue emails, attending language classes, visiting the cinema and 
theatre, going to dinner, travelling by train and bus alone and with others, travelling by 
car on populated roads, walking across or adjacent to busy roads and intersections, 
going to the beach, playing bridge with friends, going shopping, attending classical 
music concerts, and cleaning and ordering her house. These activities occurred during 
treatment and were potentially important in expanding Mary’s repertoire of clinically 
‘healthy’ behaviours. When asked at 3-month follow-up to identify the change which 
was most important over the course of treatment, Mary said “I feel like I’ve been doing 
things which are truly about me and not worrying about anyone else”. 
 
10.7 Treatment Integrity 
All of Mary’s treatment sessions were audio-recorded and 33.3% (n = 4) of 
sessions were randomly selected and independently scored for treatment integrity. Inter-
observer agreement averaged 95.3 % across scored sessions with 90.7 % of therapist in-
session behaviour compatible and 9.3 % incompatible with the treatment modality. 
Please refer to Appendix G for items that define ‘compatible’ and ‘incompatible’. 
 
10.8 Post-treatment Diagnosis 
At the end of treatment, Mary reported a significant and consistent decrease in her fear 
response in vehicle-related situations. She was no longer avoiding vehicle-related 
contexts and she was experiencing substantially less worry. Overall she was functioning 
well in the major areas of her life. Thus, subsequent to treatment Mary no longer met 
DSM-IV criteria for Generalised Anxiety Disorder or Specific Phobia (situational) and 
the changes were maintained at 3 month follow-up.  160      
 
 
 
CHAPTER 11 
 CASE 6 
11.1 Characteristics 
“Stacey” was a 53-year-old female. At the time of her initial involvement in the 
study, she was engaged in paid full-time employment as a ‘review officer’ within a state 
government organisation. She was divorced and had four adult children. She lived with 
her youngest two daughters in an average-size home in a southern metropolitan suburb 
of Perth, Western Australia.   
 
11.2 Intake assessment 
At intake, Stacy reported having experienced a large amount of stress and that 
her life had been “out of my control”. She said, “There’s too much going on in my 
head” and “I feel anxious all the time”. She reported that her physical signs of anxiety 
included an accelerated heart-rate, “tingling” in her hands, light headedness, chest 
tightness, dryness in the mouth, difficulty swallowing, and muscle tension. She said that 
she often “finds it hard to relax” and that she had experienced difficulty concentrating 
and remaining on-task for long lengths of time. She believed this was especially true 
when she was feeling anxious. Stacey reported that she had experienced brief and 
intense panic previously. She complained of past difficulties with self-management and 
that she had been unable to be assertive with family, friends, and work colleagues.  
Stacey reported that her feelings of anxiety would often be occasioned in 
everyday social situations especially in her workplace. She said that when she had been 
asked to undertake some particular task by a work colleague or a family member or 
friend, typically she would acquiesce regardless of her personal preference. She 
reported that this resulted in her having engaged in least-preferred activities. She 
complained that she had mismanaged her time and that she would “always feel rushed” 161      
 
 
 
and “not get things done that I want to do”. She reported that in home, work and social 
settings she had engaged in worry behaviours. These included ruminating and 
complaining to others about her finances, health, and work-situation. She had spent 
large amounts of time discussing her relationship with her children. Stacey stated that 
she had avoided conversations when she anticipated conflict. She avoided publicly 
stating her wants and needs and disagreeing with others including family members. She 
hadn’t been able to take concrete steps towards her goals including work and health-
related goals. For example, she said that she had recently had her work hours increased 
and had experienced increased feelings of stress yet she had avoided discussing this 
with her manager because she was “fearful” of the outcome.  
Stacey reported that her first experience of anxiety had occurred in young 
adulthood. She said she had “suffered for years” and that her condition had gradually 
worsened over time. She attributed her feelings of stress and anxiety to her marriage 
which she described as “traumatic” and had involved episodes of financial stress and 
legal matters relating to her then husband’s business practices. After separating from her 
husband she experienced a “major breakdown” and was subsequently hospitalised for 
treatment. One year prior to her involvement in the present study she had spent 2 weeks 
in a private clinic for treatment of anxiety and depression. For 1 year she had been 
taking anti-depressant medication (Effexor® 150mgs per day) and this continued 
unchanged during the study. Stacey stated that she smoked daily and consumed on 
average 2 to 3 standard drinks of alcohol per day.  
Based on her responses to the semi-structured interview (SCID-I; First et al., 
1997), Stacy fulfilled DSM-IV-TR (APA, 2000) criteria for 300.02 Generalised Anxiety 
Disorder. At intake, Stacy scored 13 on the BAI (mild; Beck & Steer, 1993), 0 on the 
DASS-21 depression scale (normal), 4 on the DASS-21 anxiety scale (normal), and 18 
on the DASS-21 stress scale (mild) (Lovibond & Lovibond, 1995a). 162      
 
 
 
 11.3 Anxiety-Related Outcomes 
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 Figure 11.1. Case 6: BAI raw scores at baseline, treatment, and maintenance phases. 
Note: Scores below 7 = normal, 8-15 = mild, 16-25 = moderate, and above 26 = severe. 
0
5
10
15
20
25
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 21 25 29
Weeks
D
A
S
S
-
2
1
 
D
e
p
r
e
s
s
i
o
n
 
R
a
w
 
S
c
o
r
e
s
 Figure 11.2. Case 6: DASS-21 Depression raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 9 = normal, 10-13 = mild, 14-20 = moderate, 
21-27 = severe, and above 28 = extremely severe.  
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 Figure 11.3. Case 6: DASS-21 Anxiety raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 7 = normal, 8-9 = mild, 10-14 = moderate, 15-
19 = severe, and above 20 = extremely severe. 
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 Figure 11.4. Case 6: DASS-21 Stress raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 14 = normal, 15-18 = mild, 19-25 = moderate, 
26-33 = severe, and above 34 = extremely severe.  
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Stacy’s BAI scores are presented in Figure 11.1. Analysis of Stacey’s BAI raw 
scores through all phases revealed evidence of a downward trend within the data, Z = 
2.59, p < .01. This change is clinically significant because her scores moved from above 
the expected mean for individuals with GAD (M= 18.83; Beck & Steer, 1993) to within 
the range of the non-clinical population.  
Figures 11.2, 11.3 and 11.4 show DASS-21 scores through all phases. Analysis 
of Stacy’s DASS-21 raw scores showed an absence of trend within Depression scores, Z 
= 0.07, p > .05, and evidence of a downward trend within Anxiety scores, Z = 2.52, p < 
.01 and Stress scores, Z = 4.14, p < .001.  The change in DASS-21 Anxiety is clinically 
significant because Stacey’s scores moved from above the mean for individuals 
diagnosed with GAD (M = 11.34; Brown et al., 1997) to within the range of the normal 
non-clinical population. The change in DASS-21 Stress is clinically significant because 
her scores moved from expected above the mean for individuals diagnosed with GAD 
(M = 22.36; Brown et al., 1997) to within the range of the non-clinical population.  
 
11.4 Self-Monitored Anxiety and Activity Outcomes 
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Figure 11.5. Case 6: Daily Anxiety Rating Scale (DARS) scores across baseline and 
treatment phases. 
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Stacy’s DARS scores across baseline and treatment phases are presented in 
Figure 11.5. Stacy completed a 32 day baseline. The first 4 entries were missing from 
her diary during the baseline phase. Analysis of the baseline phase revealed an absence 
of trend within the data, Z = 1.29, p > .05. Compared to baseline, there was a significant 
decrease during the treatment phase in self-monitored daily anxiety with 89% of scores 
below the baseline median point, Z = 7.22, p < .001. This represents a mean decrease 
during the treatment phase of 14 points (35%) in Stacy’s DARS scores.  
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Figure 11.6. Case 6: Minutes spent per day on Self- and Other-Care across baseline and 
treatment phases.  
 
Stacey’s Self- and Other-Care data across baseline and treatment phases are 
presented in Figure 11.6. Analysis of the baseline phase revealed an absence of trend 
within the data, Z = 1.38, p > .05. Compared to baseline, there was a significant increase 
during the treatment phase in the amount of time she spent on self- and other-care with 
79% of scores above the baseline median point, Z = 5.37, p < .001. This represents a 
mean increase during the treatment phase of 23 minutes (30%) per day.  
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Figure 11.7. Case 6: Minutes spent per day on Housework and Errands across baseline 
and treatment phases.  
Stacey’s Housework and Errands data across phases are presented in Figure 
11.7. Baseline analysis revealed an absence of trend within the data, Z = 0.03, p > .05. 
Compared to baseline, there was no significant change during the treatment phase in the 
amount of time she spent on housework and errands with 56% of data above the 
baseline median point, Z = 1.11, p > .05. This represents a mean increase during 
treatment of 19 minutes (7%) per day.  
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Figure 8.8. Case 6: Minutes spent per day on Paid and Unpaid Work across baseline 
and treatment phases. 
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Stacey’s Paid and Unpaid Work data across baseline and treatment phases are 
presented in Figure 11.8 (zero rates were omitted). Analysis of the baseline phase 
revealed an absence of trend within the data, Z = 0.20, p > .05. Compared to baseline, 
there was a significant decrease during the treatment phase in the amount of time she 
spent on paid or un-paid work with 68% of data below the baseline median point, Z = 
3.33, p < .001. This represents a mean decrease during the treatment phase of 102 
minutes (26%) per day.  
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Figure 11.9. Case 6: Minutes spent per day on Interests, Hobbies, and Recreation across 
baseline and treatment phases.  
 
Stacey’s Interests, Hobbies, and Recreation data across baseline and treatment 
phases are presented in Figure 11.9. Analysis of the baseline phase revealed an absence 
of trend within the data, Z = 0.55, p > .05. Compared to baseline, there was no 
significant change during the treatment phase in the amount of time Stacey spent on 
interests etc. with 56% of data above the baseline median point, Z = 1.11, p > .05. This 
represents a mean increase during the treatment phase of 54 minutes (19%) per day.  
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Figure 11.10. Case 6: Minutes spent per day Out of the Home across baseline and 
treatment phases.  
Stacey’s Out of the Home data across phases are presented in Figure 11.10. 
Analysis of the baseline phase revealed an absence of trend in the data, Z = 0.71, p > 
.05. Compared to baseline, there was a significant decrease during the treatment phase 
in the amount of time she spent out of the home with 75% of data below the baseline 
median point, Z = 4.62, p < .001. This represents a mean decrease during treatment of 
100 minutes (17%) per day.  
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Figure 11.11. Case 6: Minutes spent per day Out of Home with Others across baseline 
and treatment phases. 
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 Stacey’s Out of the Home with Others data across baseline and treatment phases 
are presented in Figure 11.11 (zero rates were omitted). Analysis of the baseline phase 
revealed an absence of trend within the data, Z = 1.15, p > .05. Compared to baseline, 
there was a significant decrease during the treatment phase in the amount of time she 
spent out of the home with others with 82% of data below the baseline median point, Z 
= 5.92, p < .001. This represents a mean decrease during the treatment phase of 91 
minutes (17.5%) per day.  
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Figure 11.12. Case 6: Distance Walked per day across baseline and treatment phases.  
 
Stacey’s Distance Walked per day data across baseline and treatment phases are 
presented in Figure 11.12. Analysis of the baseline phase revealed an absence of trend 
within the data, Z = 1.23, p > .05. Compared to baseline, there was a significant 
decrease during the treatment phase in the daily distance that Stacey walked with 77% 
of data below the baseline median point, Z = 5.00, p < .001. This represents a mean 
decrease during the treatment phase of 874 meters (14.5%) per day.  
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11.5 Therapist/Client Relationship 
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Figure 11.13. Case 6: OS-64 Assessment of Therapy Relationship Variables across the 
treatment phase.  
 
Stacey’s total scale scores across the treatment phase from the Barrett-Lennard 
Relationship Inventory: Observer Form (OS-64) are presented in Figure 11.13. Total 
raw scale scores were converted to aid visual analysis. Analysis showed the 4 scale 
scores remained relatively stable from week 4 to week 8. From week 8 to week 12, 
however, there was a reported 14.5% increase in the ‘level of regard’ displayed by the 
therapist, a 16.7% increase in ‘empathy’, a 10.4% increase in ‘congruence’, and a 
33.3% increase in ‘unconditionality’. Unconditionality is “the extent the regarding 
person’s response experientially implies that the recipient person is more or less 
pleasing, worthy, valued, trusted, liked or disliked if he or she manifests certain self-
attributes than if or when he or she manifests others” (Barrett-Lennard, 1986, p. 443).   
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11.6 Behavioural Cusps 
Stacey engaged in activities which could qualify as behavioural cusps when 
activity scheduling started at week 3 of treatment (week 8/day 53). Activity examples 
included gardening, reading, exercising, walking, lunching with friends, phoning family 
members, commencing an on-line training course, writing letters, and playing the piano. 
These activities occurred within the context of treatment and were potentially important 
in relation to the participant’s expanding repertoire of clinically ‘healthy’ behaviours. 
When asked at 3-month follow-up to identify the behaviour change that occurred which 
was most important during treatment, Stacey said “Working out my goals and what I 
wanted to do, and scheduling it in and doing it”. This action may prove to have been a 
‘cusp’ behaviour. 
 
11.7 Treatment Integrity 
All of Stacey’s treatment sessions were audio-recorded and 33.3% (n = 4) of 
sessions were randomly selected and independently scored for treatment integrity. Inter-
observer agreement averaged 93.9% across scored sessions with 91.5% of therapist in-
session behaviour compatible and 8.5% incompatible with the treatment modality 
(BATA). Please refer to Appendix G for items that define ‘compatible’ and 
‘incompatible’. 
 
11.8 Post-treatment Diagnosis 
At the completion of the treatment phase, Stacey reported a significant and 
consistent decrease in her physical symptoms of anxiety. She was experiencing 
substantially less worry and avoiding few, if any, social situations. She believed she was 
generally functioning well in the major areas of her life. Thus, subsequent to treatment, 
Stacey no longer fulfilled DSM-IV criteria for Generalised Anxiety Disorder and this 
maintained for 3 months. 172      
 
 
 
          CHAPTER 12 
CASE 7 
 
12.1 Characteristics 
“Simon” was a 55-year-old male. At the time of his initial involvement in the 
study, he was engaged in paid full-time employment as an applied environmental 
consultant. He was married and had three children. He lived with his wife and children 
in an average-sized home in a southern metropolitan suburb in Perth, Western Australia.  
 
12.2 Intake assessment 
At intake, Simon reported that he had regularly experienced anxiety when 
engaging in everyday activities. He said that he had been worried about “jobs piling up” 
and had found it difficult to manage his time. He had been unable to stay on-task at 
work and when trying to complete home maintenance activities. He stated that this had 
led to incomplete tasks and he was not able to meet his daily responsibilities. He said 
that he regularly worried about his interpersonal relationships, work, health, finances, 
and even about his anxiety. He stated that at times his worry had been uncontrollable. 
He had been physically restless and had experienced disrupted sleep routines. Simon 
reported that his physical symptoms had included chest tightness, ‘butterflies’ in the 
stomach, muscle tension in the neck and back, and “hot headedness”. He said that when 
anxious he had difficulty relaxing, was “fidgety”, and confused and easily distracted.  
Simon reported that his feelings of anxiety occurred at home and work, 
especially in interpersonal situations when demands had been placed on him by others. 
For example, when asked to perform a household task by his partner, Simon had 
experienced physical signs of anxiety and worried about whether he could complete the 
task. According to Simon this resulted in him “backing right off” and delaying 
engagement in the task or ignoring the request. He stated that he had often 173      
 
 
 
procrastinated when faced with tasks in the home and at work, although he was unable 
to directly refuse most requests. This had led to uncompleted tasks. For example, Simon 
reported having a “pile” of invoices that he needed to draft and send to clients of his 
business. He had stayed up late at night ruminating about his daily tasks. His worry had 
also been occasioned by physical sensations such that he was “alarmed” when he 
noticed the “blood pumping past his eardrums” and his heart beating “hard and fast”. 
Simon reported that he had often avoided contact with his family by staying up at night 
and remaining in bed the next morning until they had left the house. When feeling 
anxious he usually thought “here we go again” and he had to “lie down and do nothing 
for a while”. Despite his reported procrastination and task delay, Simon said that he had 
been “doing too much” and he could not “get on top of” his day to day responsibilities.  
Simon reported that he had experienced anxiety since late high school and 
believed it was an “entity” that had “always been with me”. He believed his anxiety was 
due to a difficult childhood, poor self-management, and his partner’s behaviour towards 
him. Simon stated that he had relied on meditation, relaxation strategies and “holding 
back” from engaging in some activities including intimate discussions with his wife. He 
had made attempts to manage his anxiety so that he “would avoid really losing it”. 
However, he said that he had spent large amounts of time worrying about his anxiety 
and his past choices in life. Simon reported that he had engaged in interpersonal 
psychotherapy in the past but had avoided medication. He stated that he was a non-
smoker and a “social drinker” and consumed about 12 standard drinks per week.  
Based on his responses to the semi-structured interview (SCID-I; First et al., 
1997), Simon met DSM-IV-TR (APA, 2000) criteria for 300.02 Generalised Anxiety 
Disorder. At intake, he scored 18 on the BAI (moderate; Beck & Steer, 1993), 16 on the 
DASS-21 depression scale (moderate), 8 on the DASS-21 anxiety scale (mild), and 18 
on the DASS-21 stress scale (mild) (Lovibond & Lovibond, 1995a). 174      
 
 
 
12.3 Anxiety-Related Outcomes 
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 Figure 12.1. Case 7: BAI raw scores at baseline, treatment, and maintenance phases. 
Note: Scores below 7 = normal, 8-15 = mild, 16-25 = moderate, and above 26 = severe. 
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Figure 12.2. Case 7: DASS-21 Depression raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 9 = normal, 10-13 = mild, 14-20 = moderate, 
21-27 = severe, and above 28 = extremely severe.  
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 Figure 12.3. Case 7: DASS-21 Anxiety raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 7 = normal, 8-9 = mild, 10-14 = moderate, 15-
19 = severe, and above 20 = extremely severe. 
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 Figure 12.4. Case 7: DASS-21 Stress raw scores at baseline, treatment, and 
maintenance phases. Note: Scores below 14 = normal, 15-18 = mild, 19-25 = moderate, 
26-33 = severe, and above 34 = extremely severe. 
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Simon’s BAI scores are presented in Figure 12.1. Analysis of Simon’s BAI raw 
scores through all phases revealed evidence of a downward trend within the data, Z = 
4.56, p < .001. This change is clinically significant because his scores moved from the 
expected mean for individuals with GAD (M= 18.83; Beck & Steer, 1993) to within the 
range of the non-clinical population.  
Figures 12.2, 12.3 and 12.4 show DASS-21 scores through all phases. Analysis 
of Simon’s DASS-21 raw scores showed a downward trend for Depression scores, Z = 
2.58, p < .01, Anxiety scores, Z = 2.12, p < .05, and Stress scores, Z = 3.68, p < .001.  
The change in DASS-21 Anxiety is considered clinically significant because the scores 
moved from above the expected mean for individuals with GAD (M = 11.34; Brown et 
al., 1997) to within the range of the non-clinical population. The change in DASS-21 
Stress is clinically significant because his scores moved from above the expected mean 
for individuals with GAD (M = 22.36; Brown et al., 1997) to within the range of the 
non-clinical population.  
 
12.4 Self-monitored Anxiety and Activity Outcomes 
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Figure 12.5. Case 7: Daily Anxiety Rating Scale (DARS) scores across baseline and 
treatment phases. 
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Simon’s DARS scores across baseline and treatment phases are presented in 
Figure 12.5. Simon completed a 38 day baseline. Analysis of the baseline phase 
revealed evidence of an upward trend in the data, Z = 4.11, p < .001. Compared to 
baseline, there was a significant increase during the treatment phase in self-monitored 
daily anxiety with 93% of scores above the baseline median point, Z = 7.96, p < .001. 
This represents a mean increase during the treatment phase of 13 points (46%) in 
Simon’s self-rated daily anxiety.  
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Figure 12.6. Case 7: Minutes spent per day on Self- and Other-Care across baseline and 
treatment phases. 
 
Simon’s Self- and Other-Care data across baseline and treatment phases are 
presented in Figure 12.6. Analysis of the baseline phase revealed an absence of trend in 
the data, Z = 1.37, p > .05. Compared to baseline, there was a significant increase during 
the treatment phase in the amount of time he spent on self- and other-care with 64% of 
scores above the baseline median point, Z = 2.59, p < .01. This represents a mean 
increase during the treatment phase of 29 minutes (19%) per day.  
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Figure 12.7. Case 7: Minutes spent per day on Housework and Errands across baseline 
and treatment phases.  
Simon’s Housework and Errands data across phases are presented in Figure 
12.7. Analysis of the baseline phase revealed instability within the data, Z = 3.10, p < 
.001. Compared to baseline, there was a significant decrease during treatment in the 
amount of time he spent on housework and errands with 67% of data below the baseline 
median point, Z = 3.10, p < .001. This represents a mean decrease during treatment of 
15 minutes (7.5%) per day.  
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Figure 12.8. Case 7: Minutes spent on Paid and Unpaid Work across baseline and 
treatment phases. 
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Simon’s Paid and Unpaid Work data across baseline and treatment phases are 
presented in Figure 12.8 (zero rates were omitted). Analysis of the baseline phase 
revealed a downward trend within the data, Z = 2.34, p < .01. Compared to baseline, 
there was no significant change during the treatment phase in the amount of time he 
spent on paid or un-paid work with 56% of data above the baseline median point, Z = 
1.11, p > .05. This represents a mean increase during the treatment phase of 5 minutes 
(1.5%) per day.  
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Figure 12.9. Case 7: Minutes spent per day on Interests, Hobbies, and Recreation across 
baseline and treatment phases.  
Simon’s Interests, Hobbies, and Recreation data across baseline and treatment 
phases are presented in Figure 12.9 (zero rates were omitted). Analysis of the baseline 
phase revealed an absence of trend within the data, Z = 1.55, p > .05. Compared to 
baseline, there was no significant change during the treatment phase in the amount of 
time he spent on interests, hobbies and recreation with 51% of data below the baseline 
median point, Z = 0.18, p > .05. This represents a mean decrease during the treatment 
phase of 25 minutes (8.5%) per day.  
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Figure 12.10. Case 7: Minutes spent per day Out of the Home across baseline and 
treatment phases.  
Simon’s Out of the Home data across phases are presented in Figure 12.10 (zero 
rates were omitted). Analysis of the baseline phase revealed an absence of trend within 
the data, Z = 1.20, p > .05. Compared to baseline, there was a significant increase during 
treatment in the amount of time he spent out of the home with 71% of data above the 
baseline median point, Z = 3.88, p < .001. This represents a mean increase during the 
treatment phase of 70 minutes (15%) per day.  
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Figure 12.11. Case 7: Minutes spent per day Out of the Home with Others across 
baseline and treatment phases.  
                   Baseline                                                                                Treatment                                                                        
                   Baseline                                                                                Treatment                                                                        181      
 
 
 
Simon’s Out of Home with Others data across baseline and treatment phases are 
presented in Figure 12.11. Analysis of the baseline phase revealed an absence of trend 
within the data, Z = 0.26, p > .05. Compared to baseline, there was a significant increase 
during the treatment phase in the amount of time he spent out of the home with others 
with 73% of data above the baseline median point, Z = 4.25, p < .001. This represents a 
mean increase during the treatment phase of 128 minutes (50%) per day.  
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Figure 12.12. Case 7: Distance Walked per day data across baseline and treatment 
phases.  
 
Simon’s Distance Walked per day data across baseline and treatment phases are 
presented in Figure 12.12. Analysis of the baseline phase revealed instability within the 
data, Z = 2.14, p < .05. Compared to baseline, there was a significant decrease during 
the treatment phase in the daily distance that Simon walked with 71% of data below the 
baseline median point, Z = 3.88, p < .001. This represents a mean decrease during the 
treatment phase of 152 meters (3%) per day.  
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12.5 Therapist/Client Relationship 
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Figure 12.13. Case 7: OS-64 Assessment of Therapy Relationship Variables across the 
treatment phase.  
Simon’s total scale scores across the treatment phase from the Barrett-Lennard 
Relationship Inventory: Observer Form (OS-64) are presented in Figure 12.13. Total 
raw scale scores were converted to a percentage to aid analysis. Analysis showed that 
there was a reported 16.7% increase in the level of regard displayed by the therapist, 
2.1% increase in empathy, 22.85% increase in unconditionality, and a 14.5% increase in 
congruence from week 4 to week 12. From week 8 to week 12 there was a decrease in 
the amount of empathy and unconditionality from the therapist as rated by Simon.  
 
12.6 Behavioural Cusps 
Simon engaged in activities which could qualify as behavioural ‘cusps’ when 
activity scheduling started at week 3 of treatment (week 9/day 59). Examples included 
scheduled family discussions, cycling, swimming at the beach, completing work 
projects, attending a ‘Simon and Garfunkel’ concert with his wife, attending sport 
activities with his children, contacting past friends, home maintenance, and 
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potentially important in helping expand Simon’s repertoire of clinically ‘healthy’ 
behaviours. When asked at 3-month follow-up to identify the behaviour change that was 
most important over the course of treatment, Simon replied, “going back into the 
water”, “riding the bike”, “spending more time with my wife”, “sorting things out with 
my daughter”, and “watching my behaviour”. Any of these actions potentially might 
have proven to be ‘cusp’ behaviours. 
 
12.7 Treatment Integrity 
All of Simon’s treatment sessions were audio-recorded and 33.3% (n = 4) of 
sessions were randomly selected and independently scored for treatment integrity. Inter-
observer agreement averaged 94.5% across scored sessions with 88% of therapist in-
session behaviour compatible and 12% incompatible with the treatment protocol. Please 
refer to Appendix G for items that define ‘compatible’ and ‘incompatible’.  
 
12.8 Post-treatment Diagnosis 
At the completion of the treatment phase, Simon reported a significant and 
consistent decrease in his physical symptoms of anxiety. He was experiencing 
substantially less worry. Although his DARS scores were higher during treatment 
compared to baseline, his self-reported anxiety (BAI, DASS-21) decreased significantly. 
He stated he was avoiding fewer situations that typically had occasioned his anxiety. He 
believed that he was functioning well in the major areas of his life, especially in his 
management of his time and day to day responsibilities. Thus, subsequent to treatment, 
Simon no longer fulfilled DSM-IV criteria for Generalised Anxiety Disorder. These 
gains were maintained for 3 months. 184      
 
 
 
CHAPTER 13 
 DISCUSSION 
 
13.1 Treatment Outcomes 
This study was composed of 7 replicated, single-case experimental evaluations 
of behavioural activation treatment (BATA) applied to chronic adult anxiety. BATA 
was especially created for use in the present study and was based on contemporary 
models of BA treatment for depression (Lejuez et al., 2001; Martell et al., 2001). The 
relatively straight-forward aim of BATA was to set goals and schedule activities that 
brought clients into contact with naturally occurring schedules of positive reinforcement 
for clinically healthy, socially-valid behaviours likely to have long-term anxiolytic 
effects. Dependent variables included self-reported and self-monitored anxiety, activity 
levels, and ratings of the therapeutic relationship. A measure of treatment integrity was 
included. Clinically significant decreases in self-reported anxiety on standardised 
measures were shown for 6 out of 7 participants that were maintained up to a 3 month 
post intervention follow-up. Decreases in self-monitored anxiety (DARS) corresponded 
with decreases in self-reported anxiety for 5 of those 6 participants. In general, the 
introduction of BATA corresponded with decreases in reported anxiety. There were also 
associated increases, relative to baseline, in the activity levels in some key life areas for 
6 out of 7 participants. Treatment integrity data showed that in all 7 cases the therapist’s 
behaviour was reliably rated as highly matching the prescribed techniques outlined in 
the treatment protocol. Unpatterned and modest changes in the ratings of the type or 
quality of the therapy relationship occurred across participants and appeared not to be 
associated with changes in anxiety and activity levels, nor with time spent in therapy.  
These data provide preliminary, promising support for the use of BATA with 
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prior attempts to treat anxiety with BA have been reported. There has also been a 
tendency to confound traditional BA models as described by Martell et al. (2001) and 
Lejuez et al. (2001) with the use of adjunctive treatment modalities when treating 
anxiety, such as gradual exposure and relaxation training (e.g., Hopko et al., 2004; 
Hopko et al., 2006; Lundervold et al., 2006). In this study it would seem that 
participants’ increased approach behaviours replaced avoidance behaviours and were 
maintained by naturally occurring contingencies of reinforcement. It is likely that the 
natural arrangement of response-reinforcer contingencies for approach behaviours led to 
concurrent decreases in avoidant behaviour and gradual extinction of anxiety responses. 
Thus, it may be concluded that BATA, without adjuncts such as graduated exposure or 
relaxation training, can provide an effective model of anxiety treatment for use by 
clinical practitioners, especially those working from a behaviour-analytic perspective.  
The BAI and the DASS-21 as used in the present study are measures of anxiety 
with strong psychometric properties and are widely used in clinical and research settings 
to assess anxiety and evaluate treatment outcomes (Antony et al., 2001). Of the 7 
participants, 6 showed clinically significant decreases on these measures that were 
maintained at 3 month follow-up. For 6 participants the changes in BAI and DASS-21 
scores corresponded with changes in DARS scores, suggesting that the self-monitored 
anxiety measure used in this study possessed a degree of concurrent validity. This is 
important, because the DARS was relied upon to provide a sufficient amount of data for 
establishing a stable ‘anxiety’ baseline before implementing the treatment phase.  
The data provide some preliminary evidence that real-time increases in some of 
the activity-levels recorded were associated with decreases in anxiety. For example, 4 
out of 6 participants who reported decreases in anxiety also reported a significant 
increase in the amount of time they spent out of the home (either alone or with others) 
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significant increases in the amount of time spent on self- and other-care. One responder 
significantly increased the amount of time she walked each day and the amount of time 
she spent on interests, recreation and hobbies. These are potentially clinically relevant 
and socially important behaviours and accord with the principles of change underlying 
BATA. The increased time spent in social contexts might have been especially 
important because exposure to social conditions is a vital component of reducing social 
anxiety (Hofmann & Barlow, 2002). Engagement in social activity requires engagement 
in social behaviours that can and do contact reinforcement. For most people, 
engagement in social activity requires a degree of self-management, such as attending to 
time, and the observation of others can contact vicarious contingencies of reinforcement 
that function to transform established behaviours and result in the learning of new 
behaviours (Baer & Deguchi, 1985). This study, as far as can be ascertained, is the first 
to have applied BA to adults with anxiety using an experimental design that included a 
real-time measure of everyday activity levels. 
The data from all participants did not match all of the expected outcomes based 
on the BATA model. For 2 participants, decreases in anxiety corresponded with 
decreases in the amount of time spent out of home. Only 1 participant showed an 
increase in time spent engaged in interests, recreation, and hobbies during the treatment 
phase. No participant increased the amount of time spent engaged in paid or unpaid 
work. These findings can be explained in at least two ways. Firstly, a self-monitored 
molar measure of activity (BSMD) was created for this study that required participants 
to record their real-time activity levels across broad classes of behaviour in 15 min 
chunks. This has not been previously attempted in BA research. Although it enabled a 
comparison of ratio data between A and B phases, a limitation of molar measurement is 
that it can be relatively insensitive to discrete behaviours that may be related to clinical 
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that were selected to increase access to positive reinforcement for healthy non-anxious 
behaviours while simultaneously decreasing negative reinforcement for avoidance 
behaviours. Some of these activities were scheduled and others were spontaneous. 
Completing these activities might not have altered the overall level of activity within 
broad classes of behaviour if there had been the substitution of approach behaviour for 
behaviour that had functioned as avoidance and had it occurred within the same broad 
class of behaviour, such as ‘interests, hobbies, and recreation’, as defined in the BSMD. 
Spending time with friends, for example, could function to decrease the habitual 
avoidance of social situations that had elicited anxiety. In another context, the same 
activity could function to maintain the avoidance of home-based tasks, such as 
performing maintenance or cleaning. In this instance, and using the BSMD as a 
monitoring device, the daily level of time spent on ‘interests, hobbies, and recreation’ 
might be unchanged. However, engagement in this social activity could have had 
positive ‘cusp’ like consequences for the participant and long-term consequences for 
reducing the participant’s anxious responding.  
Secondly, if the decreases shown in some activity classes for some participants 
were being maintained by schedules of negative reinforcement, such as relief from 
anxiety, then it would be expected that baseline levels of anxiety would be maintained. 
This was the case for only 1 participant, ‘Jason’, who showed decreases and non-change 
across all classes of behaviour except for ‘self- and other-care’. This was associated 
with self-reported increases in anxiety and a withdrawal from the study between 
treatment weeks 10 and 11. For the other 6 participants decreases in some behaviour 
classes were associated with self-reported decreases in anxiety to 3 month follow-up. 
This suggests that, unlike Jason, their actions most likely functioned as approach 
behaviour under the control of contingencies of positive reinforcement. The intake 
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reinforcement as a function of temporary reductions in anxiety. Thus, habitual 
avoidance was common. In treatment, participants were educated at week 2 about the 
function of avoidance and throughout the remainder of treatment sessions they were 
regularly prompted to discriminate the functional properties of their behaviour and to set 
goals and schedule activities to ‘block’ or provide ‘healthy’ alternatives to avoidance.  
 
13.2 Therapeutic Relationship 
The data failed to show a clear correspondence between the participants’ ratings 
on a widely used measure of the therapeutic relationship and their treatment outcomes. 
Only for 2 out of the 6 participants who reported decreases in anxiety were there 
patterned increases in the four scale scores on the Relationship Inventory. Only 1 of 
those cases gave ratings across all scales after the final treatment session that would be 
considered indicative of an ‘adequate’ relationship (i.e., > 50%) in a typical therapeutic 
setting (Barrett-Lennard, 1986). Surprisingly, the data from the other 4 treatment 
responders generally showed a small decrease in ratings of the therapy relationship at 
week 12. Moreover, the participant who withdrew from the study between weeks 10 and 
11 clearly rated only one variable of the therapy relationship (congruence) lower at 
week 8 compared to week 4 with the other ratings remaining relatively stable. There 
was a slight trend with 4 of the 6 treatment responders rating the amount of ‘empathy’ 
shown by the therapist as higher at week 12 compared to week 4. However, the 
evidence supporting the importance of high client ratings of therapist ‘empathy’ for 
treatment outcomes is unequivocal, modest, and generally lacking in scientific rigour 
(see Lambert & Barley, 2001 for a review). The author of the Relationship Inventory 
used in this study stated that empathy is a “pivotal but not sufficient relationship 
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the other putative therapeutic relationship variables including ‘congruence’, 
‘unconditionality’, and ‘level of regard’.  
Generally, the focus on the ‘relationship’ in therapy appears to be based more on 
precedent and theory than on formally established principles (Goldfried & Davila, 2005) 
unless when approached from a functional analytic perspective (e.g., FAP; Kohlenberg 
& Tsai, 1991). Clearly, individual therapy involves a type of relationship between the 
therapist and the client. There are common factors in most therapist/client relationships 
including attending to the presenting problem(s), exposure to sometimes distressing 
content, and non-punishing contact with a trained professional from whom the client has 
sought help. The challenge is to establish any of these variables as mechanisms of 
change above all others. The majority of cognitive and behavioural psychotherapy 
outcome research has not attempted to control for them (Lejuez et al., 2006). However, 
prior studies have demonstrated that the in-session behaviours of the client, including 
the content focus and the direction of the dialogue, are a function of the reinforcement 
provided by the therapist. Truax (1966), for example, analysed a typical Carl Roger’s 
‘non-directive’ therapy session and showed that he selectively responded to certain 
client responses and not others such as to provide schedules of reinforcement contingent 
on client responses that corresponded with his overall aims of the session. Hence, he 
was ‘shaping’ the client’s behaviour. This is interesting because traditionally ‘Rogerian’ 
approaches have not been described in behaviour analytic terms and have been believed 
to operate according to ‘inner processes’ such as ‘transference’, ‘alliance’, ‘hope’, 
‘honesty’, and ‘trust’. Also, the fact that many clients improve without therapy contact 
suggests that there are out-of-session environmental events that affect psychotherapy 
outcomes above the ‘therapeutic relationship’ (Lambert & Barley, 2001). Thus, the 
‘effect’ of the therapist on client behaviours can be explained by operant principles and 
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changes that correspond with the course of therapy. In contrast to most other therapies, 
behaviour analysis systematically describes, applies, and measures those environmental 
events. As noted by Cory (1996) there has been a past view that “the importance of the 
relationship between the client and the therapist is discounted in behaviour therapy” (p. 
309). In the present study, the ‘therapeutic relationship’ was not ignored but measured 
so its influence on treatment outcomes could be accounted for. The data obtained infer 
that the putative elements of the therapy relationship were established after 4 treatment 
sessions of BATA and any subsequent changes that did occur were small and unrelated 
to treatment outcomes. Further, in most cases, an adequate level of these elements (e.g., 
empathy, unconditionality) considered ‘essential’ for effective therapy (Barrett-
Lennard, 1986) was only just reached (or not at all) according to participant ratings..  
 
13.3 Behavioural Cusps 
There were many potential ‘cusp’ behaviours shown by the participants over the 
course of the treatment phase. Cusp behaviours are those that expose the individual to 
new ‘reinforcement-rich’ environments that occasion new behaviours or increase 
existing but under-displayed behaviours (Rosales-Ruiz & Baer, 1997). Among the 
participants’ behaviours potential ‘cusps’ included contacting friends, going on social 
outings, recreational walking, attending the local swimming-pool, baby-sitting 
grandchildren, job-searching, gardening, engaging in (previously avoided) 
conversations with significant others, travelling by public transport, bike riding, 
performing household chores, and attending to financial matters. At present, there is no 
objective measure or assessment of behavioural cusps. Operational guidelines have been 
proposed for the selection of potential cusps (Bosch & Fuqua, 2001). A priori analysis 
of cusps, however, is impossible. In principle, cusps elicit and transform complex 
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post hoc analysis of the effects that follow the introduction of the target behaviour to the 
existing behavioural repertoire of the individual. These effects could be the planned or 
unplanned consequences of treatment.  
It is notable that in the present study the 6 participants who responded well to 
treatment generally showed substantial decreases in self-reported anxiety (BAI, DASS-
21) between weeks 3 and 7 of treatment subsequent to the commencement of activity 
scheduling which is a key strategy of BATA. This suggests that accumulating daily 
engagement in scheduled activities was functionally related to self-reported anxiety. 
However, the formal properties of these relations remain unexplained. It might be the 
case that many of these activities functioned as ‘cusps’ and enabled the participants to 
act within wider contexts rich in positive reinforcement for healthy, non-anxious 
behaviours. But, these activities were largely uncontrolled and more widespread and 
rigorous measurements would have to have been used to formally establish the 
consequences of cusp behaviours. To properly isolate the effects of cusp behaviour it 
would have been necessary to identify behaviours in all situations where a particular 
individual’s healthy, non-anxious behaviours occurred. In behavioural research the 
experimental analysis of cusps is yet to be conducted.  
Kohler and Greenwood (1986) provided examples of evidence that might be 
used to identify and analyse ‘behavioural traps’, including the ‘post-trap’ displays of 
generalisation and maintenance of the target behaviour. Perhaps in the present study the 
emergence of non-anxious behaviour (e.g., increased approach, decreased avoidance) as 
a generalised operant class provides some preliminary evidence of the cusp-like 
properties of various activities the participants engaged in during treatment.  
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13.4 Treatment Failure 
Treatment failure is common in applied research (Barlow, 2002). However, the 
failure of an individual participant to respond to treatment is rarely discussed in 
published psychotherapy outcome research especially in the context of randomised-
controlled trials which focus only on between-group differences (Persons & Mikami, 
2002). The participants in this study mostly met DSM-IV criteria for generalised and 
social anxiety. The participant (‘Jason’) who failed to respond to treatment and 
withdrew form treatment in session 10 met criteria for obsessive-compulsive disorder 
(OCD). The participant received 2 fewer sessions of BATA than the others due to his 
withdrawal, but the trends in his data suggest that there had been little change and this 
would have continued had he attended the remaining 2 weeks of treatment. OCD is 
characterised by self-reports of uncontrolled anxiety-provoking thoughts and images. 
OCD-sufferers tend to report multiple obsessions and compulsions occasioned by 
apparently ubiquitous stimuli (Steketee & Barlow, 2002). An emphasis on the 
topographical aspects of OCD might suggest to some that BATA, as delivered in the 
present study, was ineffective because of its focus on overt behaviour change without 
attempting to directly modify strong, covert thoughts and images. Thus, BATA might 
be an ineffective treatment for OCD. According to Wolpe (1989), however, poor 
outcomes associated with behaviour therapy are likely due to an inadequate functional 
analysis of the clinical problem rather than any particular topographical characteristics 
such as the severity of the disorder.  
Matching Law informs therapists that there are always concurrent schedules of 
reinforcement maintaining client behaviour.  It has been estimated that up to 15% of all 
problem behaviour is maintained by multiple reinforcement contingencies (Hanley, et 
al., 2003). The present study relied on the systematic delivery of a manualised treatment 
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1984). This resulted in restricted flexibility of the therapist’s behaviour. This has been 
referred to as the ‘merits and challenges’ of using manualised treatments in behaviour 
therapy (Eifert, Schulte, Zvolensky, Lejuez, & Lau, 1997). For example, BATA focused 
on the analysis of potential sources of negative reinforcement for anxious behaviour and 
sources of positive reinforcement for non-anxious behaviour. The protocol did not 
provide for the analysis of potential sources of positive reinforcement for anxious 
behaviour including the income provided by government in the form of a disability 
pension, cheap accommodation provided by family, and social support in the form of 
concern, sympathy, and the carrying out of everyday responsibilities on behalf of the 
client by the client’s spouse or partner. Further, the more severe the level of disability 
the greater the degree of difficulty for the client in contacting naturally occurring 
reinforcement for clinically ‘healthy’ behaviours as occurs in the case of an individual 
with limited verbal skills.  
This appeared to have been the case with Jason who was receiving a significant 
amount of social support by the government, his partner, and his family in order to 
alleviate and cope with his psychological distress. He also had few everyday 
responsibilities compared to the typical adult, reported having poor social skills (e.g., 
difficulties in making conversation), and had a very high level of OCD-related 
symptoms. Unfortunately, a key aspect of Jason’s continuing problems was the 
reinforcement of his avoidance behaviours by his partner. She herself became more 
anxious when he targeted change in his ‘independence’ behaviours and she began to 
refuse to drive him to treatment sessions in the weeks leading up to his withdrawal. 
Contemporary BA for depression (Martell et al., 2001) recommends including 
significant others in treatment if indicated by the functional analysis. One of the key 
aims of the present study, however, was to ensure replication. In clinical practice, the 
application of BATA could be individualised more to account for a wider range of 194      
 
 
 
contingencies maintaining problem behaviours. This might involve the client’s partner 
and family as ‘contingency managers’ who could be trained to respond with planned 
reinforcement to the client’s clinically ‘healthy’ behaviours while also withholding 
reinforcement for ‘non-healthy’ anxious behaviours. Further, training of more discrete 
behaviours, including targeted social skills, could improve the likelihood of the client 
contacting reinforcement once he or she engaged in a particular setting with greater 
‘success’. Thus, treatment outcomes might have improved in this case when 
environmental support for the client’s anxiety-related behaviours was withdrawn when 
and more reinforcement contingent on healthy, non-anxious behaviours was given.  
 
13.5 Walking Activities  
A further notable finding of this study is that increased daily walking activities, 
as measured by pedometer, were shown to be associated with decreased self-reported 
anxiety only for 1 participant (case 2, ‘Susan’). Surprisingly, in view of the research 
linking walking to better mental-health outcomes, participants reported decreased levels 
of walking with decreased levels of self-reported anxiety. It has been shown that 
walking, and exercise more generally, can be an effective adjunct to existing front-line 
psychological treatment of anxiety and depression (Merom, Phongsavan, Wagner, 
Chey, Marmane, et al., 2008; Strathopoulou et al., 2006). Information gained from the 
initial intake assessment with Susan might explain the importance of walking behaviour 
relative to self-reported anxiety in her case. Susan reported that her anxious behaviour 
had gradually developed subsequent to major knee surgery. She reported an avoidance 
of walking because according to her it was associated with an increased likelihood of 
falling. This avoidance had resulted in limited opportunities to naturally rehabilitate her 
knee, restricted activity outside of the home, and restricted her contact with naturally 
occurring reinforcement found in ‘healthy’ settings, such as socialising with friends. 195      
 
 
 
She also had reported a strengthening of her fear response to walking especially in 
challenging contexts such as the uneven grounds of parks and gardens. By significantly 
increasing her daily walking distances during the treatment phase relative to baseline 
she was able to alter the contingencies that were maintaining her anxious responding. 
This also provided her increased access to potential sources of positive reinforcement 
for other behaviours, such as planning shared activities with friends and spontaneous 
social interaction. Thus, when applied in context, walking might be potentially 
important to particular anxiety sufferers. However, generally there appeared to be no 
relationship between walking and anxiety for all the other participants in this study. This 
finding needs to be examined in future experimental studies. 
 
13.6 Limitations 
Despite the very promising outcomes there were several limitations to the 
present study that need addressing. Identification of these limitations is important 
because it places the findings in context and can function to inform future research 
efforts. In this study the author conducted all intake interviews, assessments, and 
treatment sessions. Intake involved the use of a semi-structured interview (SCID-I; First 
et al., 1997) to determine diagnoses. Ideally, two independent interviews by different 
interviewers or a dual interview should have been conducted with evidence of inter-
assessor reliability. This would have limited the possibility of single interviewer biases 
and lowered the probability of false positive diagnoses. Moreover, repeated 
measurements ideally are conducted by assessors blind to the experimental condition. 
This would avoid potential sources of biasing effects on the data, such as the possibility 
of a therapist reinforcing responses favourable to the treatment model, or a participant’s 
responses being shaped to attract social reinforcement from the therapist. It might also 
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the treatment protocol to influence outcomes (Behar & Borkovec, 2003). The use of 
multiple therapists across participants can provide for a more precise isolation of 
treatment effects. Thus, caution must be taken before generalising to wider populations 
and practitioners as treatment in this study was delivered out of necessity by one 
practitioner. The validity of future BATA research would be enhanced if multiple, 
independent assessors and therapists were used.  
The present study included self-reported measures of anxiety and activity. The 
anxiety measures (BAI, DASS-21, DARS) were used as indirect measurements of 
private events (e.g., verbal thoughts, physiological arousal) typically observable only to 
the participant. These particular instruments required the participant to tact his or her 
private events as they occurred on average during the previous week. They are 
psychometrically strong yet caution must be shown when interpreting the resultant data 
because they rely on subjective verbal responses that might not correspond with actual 
private behaviour. The inclusion of private events in behaviour analysis has been both 
objected to (Lamal, 1998) and supported (Friman et al., 1998). The use of this type of 
measurement in future research could be enhanced if there were independent 
corresponding data from other sources (e.g., observer reports, physiological 
assessment). The difficulty for the observer in determining the private events of another 
remains, yet there are some external signs of anxiety, including restlessness, worrying, 
and avoidance that are observable and could be rated. Also, some past studies have 
evaluated anxiety as measured by sympathetic and parasympathetic nervous system 
indices including heart rate, skin conductance, and vagal control of cardiovascular 
activity (Barlow, 2002a).  
It is unclear what is the best measure of overt activity to use in BA-related 
research as only one previous BA study has provided activity data that were based on 
daily frequency counts of completed ‘values-based’ activities (Gaynor & Harris, 2008). 197      
 
 
 
In general, daily diaries have been effectively used in a range of areas including the 
study of depression (Hopko, Armento, Cantu, Chambers, & Lejuez, 2003; Hopko & 
Mullane, 2008), eating disorders (Linden, 1980), and marijuana use (Twohig et al., 
2007). The activity measure used in this study (BSMD) was designed to provide real-
time ratio data of time spent engaged in broad classes of activity during waking hours. If 
the BSMD was used correctly by the participants with recording occurring in 15 minute 
chunks then it provided an objective measure of activity. However, these self-monitored 
data were sometimes not supported by independent reports (e.g., when participant’s 
partners also rated the amount of time the client spent on particular activities). Ideally, 
future research could devise a monitoring system that could provide independent 
accounts of the participant’s activity levels.  
In early reports of ‘pleasant events’ scheduling in operant approaches to the 
treatment of depression (e.g., Lewinsohn et al., 1980) participants were required to rate 
single daily activities as either ‘pleasant’, ‘unpleasant’ or ‘neutral’ in order to provide 
the quantitative data for analysis that corresponds with the central treatment aim 
(increasing pleasant activities). Future BATA research could employ a similar system in 
which participants are required to rate daily activities as ‘approach’, ‘avoidance’, or 
‘neutral’. This would match the central treatment aim of BATA which is to increase 
positive reinforcement for non-anxious approach behaviour while simultaneously 
decreasing negative reinforcement for anxious avoidance behaviour. This type of 
measure might provide an indication of changes in avoidance/approach behaviours and 
independent observer reports could be used to validate the accuracy of a participant’s 
recordings.  
Variability was evident in some of the weekly self-report baseline data for some 
participants that might be considered unacceptable. The BAI and DASS-21 baseline 
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trend. Treatment proceeded on the basis of stability of the daily measure of self-reported 
anxiety (DARS). This allowed for formal statistical analysis using a simplified time-
series procedure (Tryon, 1982) recommended in single-case research designs (Barlow et 
al., 1984). Data from the BSMD were analysed using the same method. Practical 
constraints, such as holding the participants in the baseline phase for an unacceptable 
long period of time, and post-graduate research time parameters meant that treatment 
commenced once stability in the DARS was established. Thus, baseline duration ranged 
from 16 to 38 days across cases.  
Relative to baseline, the treatment and follow-up BAI and DASS-21 data for 6 
of the 7 participants show a significant downward trend that continued subsequent to the 
cessation of treatment. In general there were peaks in the data for these participants 
once treatment began, possibly due to reductions in negative reinforcement for anxious 
behaviour (i.e., extinction bursts). However, variability was reduced during the 
treatment and follow-up phase for most participants. Thus, there can be a tentative 
conclusion that a direct relationship existed between treatment and self-reported 
anxiety. In the present study, examples of baseline instability suggested that there were 
weekly or daily changes in the variables that influenced the measured behaviour 
(anxiety). This might have been a function of repeated measurement of private 
behaviour such that the time interval between measurements, together with the relative 
heterogeneity of the participant’s everyday conditions at baseline, resulted in variable 
self-reported anxiety. BA research typically involves single pre- and post- and follow-
up assessment, yet variability is common in the few BA-related studies that have 
published repeated-measurement single-case data (Gaynor & Harris, 2008; Lundervold 
et al., 2006; Mulick & Naugle, 2004; Yon & Scogin, 2009), and these studies typically 
have a much shorter baseline of only 2 to 3 data points.  199      
 
 
 
The intra-individual variability in this study could have been a function of the 
participant’s self-monitoring behaviour. The self-monitoring requirements were 
withdrawn during the follow-up phase so that any maintenance of treatment gains could 
not be attributed to the effects of self-monitoring including ‘reactivity’ (Barlow et al., 
1984). Importantly, the data suggest that treatment corresponded with a more invariant 
and desirable pattern of responding from the participants, such that self-reported anxiety 
on the key measures (BAI, DASS-21) decreased to non-clinical levels. 
As stated earlier, a measure of treatment integrity was used in this study. All 12 
treatment sessions for all participants were audio-recorded and 4 sessions were 
randomly selected for assessment (3 sessions for case 3 due to his withdrawal). Integrity 
ratings were conducted independently by the author and the Chief Research Supervisor 
(David Leach) who were rigorously trained in the treatment protocol and in the use of 
the coding system devised for the present study. The system developed met almost all of 
the standards recommended for establishing treatment integrity in psychotherapy 
outcome research (Perepletchikova & Kazdin, 2005) but even then could be improved 
further if future research used assessors who were not directly involved in the project. 
This might decrease the potential of biased ratings due to assessors’ affiliation with the 
research project.  
It is also important to note the sample characteristics of this study. The sample 
of participants consisted of adults who replied to an advertisement in a community 
newspaper headed, ‘Anxiety sufferers needed’ (see Appendix A). The three females and 
four males who participated in the study were willing to be involved in the research 
program and had identified themselves as ‘sufferers’ of anxiety. As such, they were 
self-selected. There was no opportunity for random allocation to the treatment 
condition. In general, the participants reported having experienced variant but 
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inclusion criteria based on the results of the structured clinical interview (SCID-IV; 
First et al., 1997) were used that functioned to isolate the effects of BA among anxiety-
sufferers in the absence of any co-existing diagnosable conditions. The duration and 
severity of anxiety symptoms might have been an establishing operation (Michael, 
1993) that altered the controlling function of treatment, such as increasing the power of 
reinforcers associated with following the therapist’s instructions and completing 
between-session tasks. Further, 6 of the 7 participants were over the age of 50 years. 
The operant principles underlying BA have been demonstrated in human and non-
human organisms, males and females, disabled and non-disabled, and across all ages 
(Catania, 1998; Sulzer-Azaroff & Mayer, 1991). Nevertheless, the characteristics of this 
sample should be considered when generalising the results of this study to other 
populations.  
Finally, although there were no control participants in the present study, the 
single-case experimental design used enabled each participant to act as his or her own 
control. The baseline data function to predict the client’s (anxiety) behaviour if the 
intervention (BATA) were not implemented. As a preliminary investigation, the 
consolidating aim was to investigate whether BATA could produce successful treatment 
outcomes for anxiety sufferers and would these outcomes be maintained post treatment. 
The post treatment follow-up period (3 months) was brief but could not be extended 
within the parameters of this study, and ideally would be longer in future studies. The 
design does not provide empirical evidence of the effectiveness of BATA relative to 
other frontline treatments such as CBT and Behar and Borkovec (2003) noted that, “It is 
quite unlikely that an intervention would actually be worse than or equivalent to not 
being in treatment at all” (p. 215). The study of BATA would be enhanced if research 
could randomly assign participants to competing therapies particularly ACT (Hayes et 
al., 1999) and CBT (Follette & Ruzek, 2006). Comparative research would provide 201      
 
 
 
evidence of the effectiveness of BATA relative to other therapies and function as a type 
of component comparison similar to prior studies of BA versus CBT for depression 
(Dimidjian et al., 2006; Jacobson et al., 1996).  
 
13.7 Strengths 
There were some notable strengths in the present study. The dependent variables 
were operationally defined. Multiple assessment methods were used to evaluate anxiety 
and activity. Repeated measurement involved the weekly administration of the BAI and 
the DASS-21, two instruments with strong psychometric properties that are widely used 
in clinical and research settings to assess anxiety (Antony et al., 2001). A daily self-
monitoring measure of anxiety (DARS) was used. This was designed especially for the 
present study according to the relevant guidelines (Barlow et al., 1984). In 6 of the 7 
cases changes in the BAI and DASS-21 corresponded with changes in the DARS. A 
self-monitored real-time ratio measure of daily activity levels (BSMD) was used. This 
was designed for the present study and is unique in BA research. Also unique to the 
present study relative to typical behaviour-analytic research was the inclusion of an 
established measure of the interpersonal aspects of ‘therapeutic relationship’ variables 
(Barrett-Lennard, 1986).  
Considerable effort went towards providing an operational definition of the 
independent variable (BATA) in the form of a stepwise treatment protocol manual 
(Appendix I). The treatment consisted of a straight-forward and relatively small set of 
components with clear session parameters (i.e., 12 x weekly 60 min sessions) suitable 
for replication. The delivery of treatment was replicated in each case in the present 
study. Treatment integrity data were obtained under stringent conditions. Every 
treatment session for every participant was audio-recorded and one-third of sessions 
were randomly chosen for independent assessment by two raters using a coded 
recording system (CRS-BATS; Appendix G) designed to measure therapist verbal 202      
 
 
 
behaviour as it occurs in typical BATA sessions according to the defined categories of 
verbal behaviour that were either prescribed or proscribed. This approach is 
recommended to strengthen psychotherapy outcome research (Behar & Borkovec, 2003; 
Perepletchikova & Kazdin, 2005; Waltz et al., 1993) yet is rarely applied in 
psychotherapy research in general (Perepletchikova et al., 2007), and under-applied in 
behaviour analysis specifically (McIntyre et al., 2007).  Data for all participants showed 
a high degree of inter-rater reliability and the therapist’s behaviour and session content 
corresponded highly with the treatment protocol.  
A single-case within-subject experimental (A/B/C) design was used for each 
participant. Efforts were made to establish a high quality baseline with adequate data for 
analysis. Across participants the baseline duration ranged from 16 to 38 days (or data 
points). Barlow et al. (1984) recommended at least three data points be recorded in the 
baseline phase. The DARS provided a daily aggregate of 6 separate anxiety ratings and 
these data were used to establish stability in baseline ‘anxiety’ using an appropriate 
statistical aid (Tryon, 1982).  Daily activity data were analysed in the same way. When 
the participant’s daily anxiety was shown to be stable the second phase (treatment) was 
implemented. This procedure is an essential element of single-case experimental design 
(Hayes, 1981) and applied behaviour analysis more generally (Sulzer-Azaroff & Mayer, 
1991) and functions to isolate the effects of treatment on the main dependent variables. 
As far as can be determined this approach has rarely been applied in published BA-
related outcome research (e.g., Gaynor & Harris, 2008) and never in the context of 
extensive baseline measures. The third phase involved follow-up assessment to 3 
months. The treatment had ended, including the self-monitoring component, and the 
participants returned only to complete the BAI and the DASS-21 at 1 week, 2 week, 4 
week, 8 week, and 12 week intervals. This provided evidence of whether treatment 
gains were maintained over time in the absence of treatment and therapist variables.  203      
 
 
 
The study included multiple analytic techniques suitable for single-case 
research. All data (except treatment integrity) were graphically presented according to 
the standards of applied behaviour analysis research (Carr & Burkholder, 1998; Grehan 
& Moran, 2005) to allow for visual inspection of the data. BAI and DASS-21 and 
baseline self-monitored anxiety and activity data were analysed using a simplified time-
series analysis (Tryon, 1982) as recommended for single-case data (Barlow et al., 1984; 
Jones, 2003). For the self-monitored anxiety and activity data, visual aids were provided 
to the reader in the form of median lines superimposed over the phase data. 
Baseline/treatment differences in self-monitored data were assessed using the split-
middle technique (Kazdin, 1982; Fisher et al., 2003; Ma, 2006; White & Haring, 1980). 
Bimodial testing was used to determine the significance of any change (Sheskin, 2000). 
These analyses were suitable for use with the present data and together were aimed at 
improving the accuracy and integrity of the analysis and subsequent conclusions. In 
general, this type of analysis is not unique in applied behaviour analysis. However, it 
has been absent from previous investigations of the effectiveness of BA.  
Finally, the selection of a ‘real-life’ clinical out-patient sample ensured that 
these outcomes were obtained in real-life settings. For example, the treatment delivery 
in this investigation matched everyday clinical conditions and was an example (in 
research) of the ‘scientist-practitioner’ approach to applied clinical psychology (Barlow 
et al., 1984) taught in many modern university settings. This is important given that the 
majority of outcome research is based on analogue designs (Linden & Wen, 1990). 
Practitioners will benefit from knowing that the research on which they are basing their 
clinical decision making has been conducted in functionally equivalent conditions. 
There was a degree of homogeneity in the sample (all anxiety sufferers) which might 
limit generalisability of the findings to a degree (Blanck, Bellack, Rosnow, Rotheram-
Borus, & Schooler, 1992). However, in the present study the use of strict selection 204      
 
 
 
criteria was intended and served to isolate the effects of BA on anxiety-related 
behaviour and assist any future attempts to replicate the findings.  
 
13.8 Implications for Practice and Research 
The outcomes of the study have important implications for the practitioner 
seeking to provide cost-effective treatment for adult anxiety in typical out-patient 
settings. In Australia, the public have had access to a federal Medicare-funded health 
rebate scheme since late 2006 that provides rebates of up to 90% of the scheduled fee 
for 12 individual sessions of private out-patient allied mental health services (including 
psychotherapy) per calendar year in a sequence of 6 sessions – review – 6 sessions 
(www.health.gov.au/internet/main/publishing.nsf/Content/health-pcd-programs-
amhpm). The most recent published data show that in the year 2007-08, over 375,000 
individuals accessed psychologists through this scheme with an average number of 5 
therapy sessions per individual (Australian Institute of Health and Welfare, 2009). Thus, 
practitioners and their clients will benefit from straight-forward technologies that can 
produce clinically-relevant change across relatively brief time-frames. As Yates (1994) 
noted, the effectiveness of treatment should not only be measured in terms of clinical 
outcomes (e.g., symptom reduction) but also in terms of temporal, personal, financial, 
and spatial resources. The findings of this study suggest that BATA can produce 
clinically relevant outcomes over a short period of time for clients meeting DSM-IV 
criteria for anxiety.  
The study also has implications for practitioners seeking to apply interventions 
that are based on empirically supported principles. Rosen and Davison (2003) have 
suggested that psychotherapy ought to proceed on the basis of empirically supported 
principles (e.g., operant behavioural principles) that are established in data-driven, basic 
and applied science (see also Herbert, Lilienfeld, Lohr, Montgomery, O’Donohue, et al., 205      
 
 
 
2000). This contrasts with interventions that appear to be based mostly on clinical 
precedent and theory (e.g., Sensory Integration Therapy, Ayres, 1979; Eye Movement 
Desensitisation Reprocessing, Shapiro, 2001) and corresponds to the position paper 
published by the American Psychological Association Presidential Taskforce on 
Evidence-Based Practice (APA, 2006) that recommended practitioners maintained an 
‘openness’ to data and did not allow ‘theoretical preconceptions’ to replace empirical 
evidence. As stated by Wilson (1997, cited in Rosen & Davison, 2003, p. 304), “We 
need to stick to solid science or else risk taking on the impossibly large task: brute force 
empirical evaluation of each and every treatment that has and will be dreamed up”. The 
essential elements of BATA as applied in this study are unequivocally principle based. 
Further, the reductions in anxiety-related behaviour shown in this study were achieved 
without the use of typical therapeutic adjuncts such as relaxation, exposure or cognitive 
therapy. This is important for practitioners, especially those working in behaviour-
analysis, because it suggests that treatment gains might occur from a more streamlined 
treatment alternative without applying the full CBT package. BATA also might be 
considered easier to learn and apply compared to CBT (e.g., ACT; Hayes et al., 1999).  
For researchers, this preliminary investigation provides a strong methodology 
for future single-case designs. Barlow and Nock (2009) have strongly suggested that 
psychological science will progress ‘most efficiently’ with the inclusion of the reporting 
of ‘ideographic’ research designs, such as single-case experiments, alongside group-
based comparisons. They state that, “the flexibility and efficiency of these designs make 
them ideally suited for use by psychological scientists, clinicians, and students alike and 
yet they can provide strong evidence of causal relations between variables” (p. 20). The 
APA Presidential Taskforce (2006) has also emphasised the inclusion of single-case 
research in the ‘best research evidence’ that is used to inform evidence-based practice.  206      
 
 
 
 The study provides data on which to base future lines of research in the 
behaviour-analytic study of anxiety, the treatment of anxiety in older adults, the cost-
effectiveness of BATA relative to other treatments, the anxiolytic effects of everyday 
activities, and the occurrence and effects of behavioural cusps. The position paper 
published by the APA Presidential Taskforce in 2006 specified that more research 
should be conducted into the psychotherapy outcomes for older adults and the cost-
effectiveness of treatment. Future research could incorporate control conditions such as 
ACT (Hayes et al., 1999) or CBT (Follette & Ruzek, 2006). An interesting study would 
be to compare BATA as applied in this study with the more complex contemporary 
models of BA for depression (Martell et al., 2001). Also, BATA could be compared 
directly to the ‘values-based’ BA that is a component of the ACT protocol (Hayes et al., 
1999) and that has been previously applied without direct comparisons in the treatment 
of adolescent depression (Gaynor & Harris, 2008). Hayes et al. (1999) have defined 
values as, “verbally construed desired life consequences” (p. 206). Such a comparison 
between BA and values-based BA could provide evidence regarding the inclusion of 
values-based strategies in behaviour-analytic approaches (Ruiz & Roche, 2007) in terms 
of treatment outcomes.  
Future research could also improve on the treatment integrity instrument used in 
the study (CRS-BATS) to include measurements of participants’ in-session verbal 
behaviour. The data could be used to identify critical changes in verbal behaviour that 
might be associated with clinical improvements (Hayes et al., 1999; Kohlenberg & Tsai, 
1991). This has recently been attempted in a study that investigated the verbal behaviour 
of a single participant who received 20 sessions of FAP (Busch et al., 2009). However, 
there is a paucity of behaviour-analytic research regarding clients’ verbal behaviour in 
typical clinical therapy sessions.  207      
 
 
 
Finally, future research could focus more on identifying and measuring the 
effects of ‘behavioural cusps’ (Rosales-Ruiz & Baer, 1997) on clinically relevant 
behaviour. With the emergence of relatively ‘brief’ therapies comes a need for 
therapists to assist the client in achieving behaviour change that has consequences for 
him or her that extend well beyond the temporal limits of treatment. Treatments such as 
BATA that increase the likelihood of identifying ‘cusps’ can meet this need. Yet 
behaviour-analysis requires that cusps must be shown to have occurred in the 
corresponding data. The present study has obvious shortcomings in relation to the 
recording of cusps. However, this should not deter future efforts. Wolf (1978; see also 
Baer, Wolf, & Risely, 1968) described ‘social importance’ as an ultimate goal of 
applied behaviour analysis (ABA) even though he “wasn’t sure what ‘social 
importance’ meant or worse still, how to measure it” (p. 203). His argument was that 
behaviour analysts should focus on enabling behaviour change that is socially valid to 
the individual and to the wider society (e.g., parents, spouses, friends), including 
generalised unplanned outcomes. Cusps match Wolf’s definition of socially valid 
change. In future BA-therapy outcome research a focus on cusps could provide 
empirical support for the social validity of behaviour-analytic responses for the 
generalisation of effects over time, thus addressing key aspects of applied behaviour 
analysis in the treatment of common clinical problems.  
Very recently, there have been calls for more accounts of the application of 
behaviour analysis in the treatment of ‘everyday’ clinical problems to be reported to 
expand behaviour analysis beyond its more popular use in specialised populations such 
as individuals with developmental disabilities (Friman, 2010). Anxiety and depression 
are the ‘common-colds’ of clinical psychology. This report of BATA therapy supports 
its use in everyday, ‘typical’ clinical settings and provides an example for the teaching 
of ABA in regular, generic post-graduate Clinical Psychology training programs.  208      
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Appendix A: Advertisement in Local Community Newspaper 
Used to Recruit Participants   
 
 
Anxiety Sufferers Needed 
A team at Murdoch University is investigating a new behavioural approach to the 
treatment of anxiety in adults. Participants in the study receive 12 free weekly one-hour 
therapy sessions at the School of Psychology. 
The behavioural activation therapy aims to help people gain more control over their 
lives. Doctoral candidate Jarrod Turner said anxiety was the most common 
psychological problem in the community. “Research shows that about 30 percent of 
people will meet the criteria for at least one type of anxiety disorder during their 
lifetime and nearly 20 per cent of people will experience significant problems with 
anxiety in any given year ”, he said. “Research also suggests anxiety leads to the 
development of other psychological problems and present anxiety treatments are not 
always successful”. 
Mr Turner said that for many people, the struggle with anxiety was a daily issue. “It 
interferes with work, play, relatuionships, family life and general wellbeing”, he said. 
“The present research aims to help participants gain control of their life. It does this by 
focusing on anxiety-related behaviour rather than focusing on emotions, thoughts or 
biology”. Call Mr Turner on 0405 589 307.  
The Melville Times, 16/09/2008.235      
 
 
 
                                  Appendix B: Participant Information Letter 
Participant Information Letter 
 
Project Title: Behavioural Activation Therapy for Anxiety  
 
My name is Jarrod Turner and I would like to invite you to participate in a research study 
looking at a new psychological approach to treating anxiety. This study is part of my course for 
a Doctoral Degree in Clinical Psychology, and is being supervised by Associate Professor David 
Leach at Murdoch University. 
 
Background. 
 
Research has shown that in some cases the behavioural component of cognitive-behavioural 
therapy (CBT) (e.g., problem solving, activity scheduling, relaxation training) may be the most 
important component in treating people’s depression. In fact, some research suggests it is not 
necessary to directly focus on people’s cognitions (e.g., thoughts, beliefs) to improve their 
mental health. For example, behavioural activation therapy, which involves identifying and 
promoting engagement in positive activities in order to help improve a person's mood and 
thoughts, has been proven effective in treating depression and given CBT also is most often 
used to treat anxiety some researchers are beginning to ask whether a purely behavioural 
approach may be an effective way to treat anxiety. This approach, however, has not been widely 
investigated. 
 
Therefore, the aim of this study is to investigate whether behavioural activation therapy is an 
effective approach to treating anxiety.  
 
What does your participation involve? 
 
You have been asked to participate in this study because you experience anxiety. Your 
participation in this study essentially will involve you consenting to receive individual 
psychological treatment for anxiety. Initially, you will engage in a 60 minute assessment 
interview with a supervised trainee clinical psychologist. This will involve a standard set of 
questions which will ask you about mental health symptoms. Some of these questions may be of 
a personal nature and may even be distressing to some – but this is a fairly standard 
psychological assessment.  
This is followed by a 2 to 3-week period of pre-treatment assessment which will mostly involve 
self-monitoring (ongoing daily recording) aspects of your daily behaviour such as anxiety levels 
and your daily activities. Also, you will be required to wear a pedometer for the duration of the 
study which will record how many steps you take each day. This self-monitoring is required 
throughout your entire involvement in the study. Then, you will receive a 12-week therapy 
package (12 x 1 hour sessions) of behavioural activation therapy administered by the trainee 
clinical psychologist. The trainee is an advanced Doctoral student with experience in 
behavioural activation therapy and will be supervised by the research supervisor Associate 
Professor David Leach. All sessions will be audio-recorded to be reviewed by members of the 
psychology faculty at Murdoch University to ensure treatment is being carried out competently. 
These recordings will be destroyed following the completion of the study. Following 
completion of the 12-weeks of therapy you will be asked to complete self-report forms which 
will ask questions about your mood and anxiety at 1-month and 2-month follow-up times. A 
treatment protocol for future clinical work will be developed during the course of this study.  
As the entirety of this study is being conducted at Murdoch University, you will be required to 
travel weekly to the university throughout your involvement in the study. If you are traveling by 
car, parking costs will be reimbursed.  236      
 
 
 
Appendix B: Participant Information Letter 
 
 
Voluntary participation, confidentiality and withdrawal from the study. 
 
If you consent to take part in this study, it is important that you do so voluntarily, and with a 
good understanding of the purpose of the study and the procedures you will be asked to 
undergo. Please make sure you ask any questions you may have about this study, and that you 
are satisfied with the answers you receive, before you consent to participate. 
 
Again, your participation in this study is entirely voluntary. We hope you will participate, but if 
you do not want to, you do not need to explain why to anyone. If you do take part in this study, 
you are free to drop out at any point, with no questions asked. You will also be able to tell us if 
you do not want to do things which come up as part of your involvement in this study. We want 
to ensure that you are comfortable and satisfied with your participation in this study. 
 
Your participation in this study is entirely confidential. Data collected during your involvement 
is intended to be reported in the published literature as charts and figures, however your identity 
will be completely confidential. Aspects of your case will be reported (e.g., age, sex, anxiety 
history), but your name, date of birth, and address will definitely not be included. Made-up 
names will be used when reporting your case. If you withdraw, for any reason, all information 
will be destroyed. Following completion of the study all collected data will be securely stored, 
however any identifying personal information (including audio-recordings) will be destroyed.  
 
Potential benefits. 
 
The therapy you will receive if you consent to participate in this study is provided without 
financial cost. We hope that the therapy you receive during your involvement in this study will 
help to significantly decrease your experience of anxiety and improve your overall mental 
health and wellbeing. Also, because a treatment protocol for future clinical work will be 
developed during the course of this study and the outcomes for you will be carefully reported, 
your involvement has the potential to help many others in the future (especially given the high 
rates of anxiety in the community).  
 
Potential costs. 
 
Occasionally, when people engage in therapy, there is a chance that parts of the process may be 
upsetting (e.g., answering questions, engaging in activities which increase anxiety). Also, there 
is a (very rare) chance that someone’s condition may in fact worsen. Because the therapy you 
are receiving involves a close collaboration between you and the trainee clinical psychologist 
who will be closely supervised by an experienced psychologist, your psychological wellbeing 
will be closely monitored at all times. If you feel your symptoms are in fact worsening, we will 
be happy to refer you to other appropriate mental health services. Also, although you will not be 
provided with treatment beyond the 12-week course of therapy, we will be willing to assist you 
in finding suitable support if you feel the need to continue therapy beyond your involvement in 
this study. 
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What’s next? 
 
If you have any questions about your involvement in this study please feel free to contact either 
myself, Jarrod Turner on mbl. 0405589307 or my supervisor Associate Professor David Leach, 
on ph.9360 2703. We are happy to answer any questions you may have. When you are satisfied 
you have a good understanding of what your participation in this study involves, and are willing 
to participate, please complete the consent form attached to this information letter. 
 
This study has been approved by the Murdoch University Human Research Ethics Committee. 
If you have any concerns about how this study is to be conducted and you wish to talk to an 
independent person you can contact the Committee on 9360 6677 or email 
ethics@murdoch.edu.au. 
 
 
 
Thank you for your time, 
 
 
 
 
Jarrod Turner                                                                  Associate Professor David Leach 
Trainee Clinical Psychologist                                         Supervisor 
School of Psychology                                                      School of Psychology 
Murdoch University                                                        Murdoch University 
 
 
 
 
 
Please note: If you have any concerns or complaints about this study and wish to talk to an 
independent person, you may contact: Murdoch University Human Research Ethics Committee 
on 9360 6677 or email ethics@murdoch.edu.au  
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Appendix C: Participant Consent Form 
 
 
Consent Form 
 
Project Title: Behavioural Activation Therapy for Anxiety  
 
 
I voluntarily agree to participate in this study. 
 
I have read the information sheet provided and understand the purpose of the study, 
procedures involved, and what is expected of me. I am also aware of the possible 
benefits and risks to me from my involvement in the study. The researchers have 
allowed me to ask any questions I have regarding my participation and I am satisfied 
these questions have been answered. 
 
I understand that therapy sessions I receive due to my involvement in this study are to 
be audio-recorded. 
 
I understand that I am able to change my mind or stop my involvement in the study at 
any time with no questions asked. 
 
I understand that all information provided by me is confidential and my name and 
identity will be stored separately from any data, and these are accessible by authorised 
research personal only. 
 
I agree that the results of my participation in this study may be reported, presented, 
and/or published provided names or any other information that may identify me is not 
used. 
 
 
 
 
 
 
 
Signature of Participant:    __________________________   Date____/____/____ 
 
Name of Participant:          __________________________ 
 
 
Signature of Investigator: __________________________    Date____/____/____ 
 
Name of Investigator:       __________________________ 
 
 
Supervisor’s Signature:     __________________________    Date:____/____/____ 
 
Name of Supervisor:          __________________________ 
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Appendix D: Daily Anxiety Rating Scale (DARS) 
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Appendix E: Behaviour Self-Monitoring Diary (BSMD) 
 241      
 
 
 
Appendix F: Behaviour Self-Monitoring Diary (BSMD) Instruction Form 
Guide to completing your activity diary 
 
This Activity Diary is designed to help you to monitor and record your daily activity 
levels as well as other important information. There is 1 page for every day of the week. 
 
Walking Monitoring 
 When you get dressed in the morning record: (1) the day and date, (2) the time you got 
out of bed, and (3) the time you put on your pedometer.  
When you get undressed to go to bed at night record: (4) the time you removed your 
pedometer, and (5) your pedometer reading (i.e., distance travelled). 
 
Recording your activities 
Diary layout 
Reading from left to right, your day is broken up into 3 time periods (i.e., waking to 
12.00 midday, 12.00 midday to 6.00 pm, and 6.00 pm to bedtime) for which to record 
activities. Directly below these, you will see that you group your activities during those 
times as being (a) either at home or out of home, and (b) either alone or with others. 
 Reading from top to bottom, your activities are grouped into 4 main areas: (1) self (or 
other) care), (2) housework and errands, (3) paid or unpaid work, and (4) interests, 
hobbies, and recreation. You will find definitions of these classes of activities on the 
next page. 
 
Filling in the diary 
What we want is for you to record your daily activities in 15 minute blocks. That 
means, for each time period simply register a dash (see example) for every 15 minutes 
you spend on a particular activity. Some activities may last for only 15 minutes or even 
less. If you engage in more than one activity in any given 15 minute period only mark 
one entry in your diary and decide which activity best sums up that 15 minute period.  
Of course, we don’t expect you to stop your activities to mark your diary every 15 
minutes – but we do want as accurate a recording as possible and for your whole day to 
be accounted for. Therefore, if an activity takes longer than 15 minutes (e.g., grocery 
shopping – 2 hours), when you complete the activity simply record either 8 dashes or 
the number ‘8’ in the matching box (e.g., housework and errands/alone/out of home). 
Because of this, it may help you to carry your diary with you during the day. 242      
 
 
 
Appendix F: BSMD Instruction Form 
 
Activity Class Definitions 
-  These definitions can help to decide in which area to record your spent 
time: 
 
Self and other care: This includes time spent on attending to your personal needs 
including self-cleaning, grooming, and dressing. It can also include time spent on 
the care of others including pet care and attending to the personal needs of a family 
member or friend. 
 
Housework and errands: This includes regular house-keeping work including 
cleaning and cooking and can include house-maintenance like repairing taps or 
clearing gutters. Errands are everyday short journeys and tasks that are required 
including paying bills, grocery shopping, and car care. 
 
Paid or unpaid work: This includes typical paid work as well as volunteer or 
charity work. It also includes time spent on formal education and training (e.g., 
university). 
 
Interests, hobbies, and recreation: This includes time spent on activities that you 
enjoy and that are fun and interesting. There may be certain hobbies that you engage 
in that can be recorded in this category. Also, recreational activity such as exercise 
and reading can be placed here. 
 
Note: These are broad categories. Try your best to record your activities. Most 
importantly, be consistent. Continue to use the diary in the same way throughout the 
whole study. 
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Appendix G: Coded Recording System for Behavioural Activation 
 Therapy Sessions (CRS-BATS) 
INSTRUCTIONS: This scoring form measures ‘therapist verbal behaviour’ (TVB) in the therapy session 
which you are listening to. TVB is coded (see below) in categories of TVB prescribed and proscribed in 
behavioural activation (BA) therapy.  The occurrence of any of these TVBs is scored by marking a slash  
through the corresponding symbol during the 20 sec time interval on the coding sheet. Following each 20 
second interval make a slash through the coded-symbol which corresponds to the TVB which occurred 
during  that time. If you are unable to categorise the TVB, place a slash through all symbols and note 
‘UC’ and the interval will be scored as uncategorisable. If TVB is less than 10 secs of the interval place a 
slash through all symbols. Note: It is the therapist’s verbal behaviour that you are focusing on (not 
the client’s) and care must be taken to code independent of client behaviour. Clients may be 
difficult, elusive, or attempt to lead the therapist towards content technically incompatible with 
BATA. What is MOST important is that the therapist implements the essential elements of BATA.  
 
Possible Categories of TVB: 
SM = review of client self-monitoring and/or data review     AV = discussing avoidance   
AS = future activity scheduling                                               ED = psychoeducation                        
GS = setting or reviewing client goals                                    RA = review of past activities                              
MD = discussing medication or other drug use                      RX = relaxation training 
IP = interpersonal therapy                                                       EX = exposure                                  
CT = cognitive therapy    
 
Definitions: 
SM: Discussing and reviewing the past week’s formal self-monitoring (e.g., sleep, walking distance, 
drug/alcohol use, activities, anxiety, stress and panic) and/or client’s data.  
AV: Discussion is oriented toward identifying avoidance and escape behaviour and its function. 
AS: Discussing future activities for the participant to engage in between sessions and making strategies 
(e.g., to do lists) to prompt and support activities (more immediate and specific than longer term goals).  
ED: Providing education about anxiety and related disorders, stress, BA, functional/contextual analysis, 
Premack Principle, reward/punishment, reinforcement, response, conditioning, learning principles.  
GS: Discussing participant’s short, medium and long term goals.  
RA: Discussing past activities participants have engaged in (both scheduled and spontaneous). 
MD: Discussion may involve participant usage of medication(s), alcohol, and other drugs (e.g., coffee). 
RX: Participant led to practice controlled breathing, PMR, meditation, or the emphasis is on relaxation. 
IP: Clear and deliberate focus on client’s interpersonal interactions such as discussions of past and 
present relationships and exploration of the client/therapist relationship in the absence of BA principles. 
EX: Participants led to develop fear/avoidance hierarchy and to practice exposure to specific fearful 
stimuli in a gradual, prolonged, repetitive way either in/out of session.  
CT: Encouraging client to identify negative/dysfunctional thoughts and working to challenge, remove, 
alter, or in some way change such thoughts. 244      
 
 
 
Appendix H: CRS-BATS Coding Sheet 
 
SM  ²°            SM  ²°        SM  ²°            SM  ²°          SM  ²°         SM  ²°         SM  ²°          SM²°               
AS                  AS              AS                 AS                AS               AS              AS                AS                                                            
GS                 GS              GS                 GS                GS              GS               GS                GS              
RA                 RA              RA                RA                RA              RA              RA               RA                                       
ED                 ED               ED                ED                ED              ED               ED               ED                                           
AV                 AV              AV                AV                AV              AV               AV               AV             
MD                MD             MD                MD               MD             MD              MD              MD           
IP                   IP                IP                  IP                  IP                IP                IP                 IP              
CT                 CT               CT                CT                 CT              CT               CT               CT            
RX                 RX              RX                RX                 RX              RX               RX               RX           
EX                 EX               EX                EX                 EX               EX              EX                EX                                    
 
SM  ²°            SM  ²°        SM  ²°            SM  ²°          SM  ²°         SM  ²°         SM  ²°          SM²°                      
AS                  AS              AS                 AS                AS               AS              AS                AS                                                           
GS                 GS              GS                 GS                GS              GS               GS                GS              
RA                 RA              RA                RA                RA              RA              RA               RA                                       
ED                 ED               ED                ED                ED              ED               ED               ED                                           
AV                 AV              AV                AV                AV              AV               AV               AV              
MD                MD             MD                MD               MD             MD              MD              MD            
IP                   IP                IP                  IP                  IP                IP                IP                 IP              
CT                 CT               CT                CT                 CT              CT               CT               CT             
RX                 RX              RX                RX                 RX              RX               RX               RX            
EX                 EX               EX                EX                 EX               EX              EX                EX                  
 
SM  ²°            SM  ²°        SM  ²°            SM  ²°          SM  ²°         SM  ²°         SM  ²°          SM²°                     
AS                  AS              AS                 AS                AS               AS              AS                AS                                                           
GS                 GS              GS                 GS                GS              GS               GS                GS             
RA                 RA              RA                RA                RA              RA              RA               RA                                       
ED                 ED               ED                ED                ED              ED               ED               ED                                         
AV                 AV              AV                AV                AV              AV               AV               AV              
MD                MD             MD                MD               MD             MD              MD              MD            
IP                   IP                IP                  IP                  IP                IP                IP                 IP              
CT                 CT               CT                CT                 CT              CT               CT               CT            
RX                 RX              RX                RX                 RX              RX               RX               RX            
EX                 EX               EX                EX                 EX               EX              EX                EX                                       
                      245      
 
 
 
Appendix I: Behavioural Activation Treatment of Anxiety Treatment Protocol 
 
Behavioural Activation Treatment of Anxiety (BATA) 
Overview 
The aim of BATA is to increase the amount of approach-oriented socially 
important behaviour in the client’s daily life while producing corresponding decreases 
in the amount of habitual avoidance which is typical of the anxiety-sufferer. This is 
achieved by helping clients to bring their overt behaviour more under the control of life 
goals and scheduled activities and less under the control of in-situ emotional responses. 
BATA is delivered in an individual format with 60 min weekly sessions.  
The key components of BATA are: 
•  Self-monitoring 
•  Psycho-education 
•  Functional Analysis 
•  Goal-setting 
•  Activity Scheduling  
•  Activity Reviewing 
 
The BATA Therapist 
The BATA therapist ideally is trained in behaviour analysis and has a 
comprehensive understanding of operant principles for explaining human behaviour. 
Also, the therapist should be qualified in dealing with DSM-IV Axis I anxiety-related 
disorders. The therapist is always trying to analyse the client’s in and out of session 
behaviour according to its function within context. The therapist is working to identify 
the reinforcers that maintain clinically-relevant behaviour and its discriminative and 
eliciting stimuli. Private events such as thinking and feeling are accepted and may be 
discussed, but always as correlates or separate components of the client’s anxiety. Even 246      
 
 
 
though such variables may seem to operate as antecedents, they are understood to be 
occasioned by environmental stimuli and under the same controlling variables as overt 
behaviours. The therapist adheres to the treatment protocol. Given the client’s verbal 
behaviour has been shaped by the behaviour of others (including therapists of different 
clinical orientations), it is to be expected that he or she may deviate from the parameters 
of treatment. This may be in the form of excessive rumination, complaining, or (non-
functional) self analysis offering explanatory fictions or ‘mentalistic’ reasoning. 
Nonetheless, at those times the BATA therapist should simply listen politely and choose 
the appropriate moment to direct the client back on task.  
The BATA therapist should pay attention to his or her verbal behaviour as it 
may function as reinforcement for the client’s in-session behaviour. This is similar to 
the therapist stance recommended within functional analytic psychotherapy (FAP; 
Kohlenberg & Tsai, 1991). Thus, the BATA therapist provides immediate and genuine 
(natural) social feedback (e.g., praise, smiles) when the client acts in a way consistent 
with the aims of BATA (e.g., discussing weekly activities, goal setting, offering 
functional descriptions of behaviour), and withholds possible social reinforcement when 
the client acts inconsistently with the aims of BATA (e.g., ruminating about distal 
events). In this way the therapist is shaping the client’s in-session behaviour. In doing 
so the therapist must be careful not to create an overly punishing environment for the 
client by indiscriminately forcing the agenda at all times. Punishment is known to lead 
to unwanted behaviour such as aggression or withdrawal, as does the non-delivery of 
reinforcement (Catania, 1998). Ultimately, if the client is consistently socially punished 
for attending treatment sessions then it is likely he or she will discontinue attendance. 
Instead, the BATA therapist should patiently listen to the client, choose the appropriate 
times to reinforce the client’s behaviour, and always operate in a respectful and polite 
manner to orientate the client’s attention to the aims of the treatment protocol.  247      
 
 
 
SESSION 1.  
The goals of session 1 are to define the client’s experience of anxiety and 
provide information regarding the general nature of anxiety, the anxiety disorder that 
fits the client’s behaviour (e.g., GAD), and the origins of anxiety-related disorders. 
Firstly, as with every session, the client is asked to complete a standardised measure 
(e.g., BAI, DASS; both used in the present study). Also, self-monitoring diaries (e.g., 
daily anxiety, activities) are explained and provided and the client is instructed as to 
how they are to be collected and when fresh ones are provided. The therapist should 
refer to Barlow, Nelson, and Hayes (1984) or a similar text for guidelines on self-
monitoring including the construction of measures. The therapist should check that the 
client can follow instructions as to how the diaries are properly completed and address 
any concerns or questions the client may have. The therapist explains how any obvious 
patterns of behaviour; antecedent stimuli; functional consequences; or anomalous 
features within the data that are relevant to client clinical behaviour are to be discussed 
with client from session 2 onwards. This should take between 5 to 15 minutes.  
Therapy begins with the presentation of general information handouts regarding 
anxiety (Figure 1) and the ‘fight or flight’ response (Figure 2). The client is taken 
through the points on each hand-out and also provided with verbal information about 
the prevalence rates of specific anxiety disorders (e.g., GAD), their characteristics, and 
their course. Next, the client’s own experience of anxiety is carefully defined and 
categorised into private events (thinking and feeling) and public events (overt 
behaviour). This is known as the three-response system model for describing anxiety 
(Barlow, 2002). The therapist asks the client to describe the cognitive, physiological, 
and (overt) behavioural characteristics of his or her anxiety. This provides an 
operational definition of anxiety for the therapist and client and begins to orientate the 
client towards attending to the overt behavioural aspects of his or her anxiety.  248      
 
 
 
 
 
Figure 1. Anxiety Handout for Clients.  249      
 
 
 
 
Figure 2. ‘Fight or Flight’ Handout for Clients. 250      
 
 
 
To illustrate, the following narrative accounts of BATA were recorded during session 1 
between the therapist and participant “Jim” (T and J, respectively): 
T: When you experience anxiety, what physical changes or symptoms do you notice? 
I’ll write your answers on the white-board so we can form a picture of your anxiety 
experience. (A white-board or large sheet of paper is recommended as a tool for 
presenting the client’s answers in-session). 
J: I never sweat but I get very hot. I get very flushed in the face. I also get a feeling of 
instability on my feet, like I feel quite unsteady to stand. If I’m in a situation I can’t 
handle, like a busy shopping centre, I start to get a bit giddy. 
T: Do you mean dizziness? 
J: Yes. Like when you bend over and then come back up too quick. That’s the feeling. 
T: What other feelings go with your anxiety? 
J: Overall, I feel like I don’t have control over my body at those times. I’m shaky, dizzy, 
my heart’s pounding away, my hands tremble. I forget to breathe, even. Or other times, 
I feel a real shortness of breath. 
   
T: I wonder what thoughts you have when you experience anxiety. When you’re 
anxious, what are you thinking about? 
J: I think that people are looking at me. Like they know that something’s not quite right 
with me. Or that I look a bit odd. If I’m in a busy place and I start to feel anxious I think 
that people can see through me and they know there’s something mentally wrong with 
me.  
T: What other thoughts do you have with your anxiety? 
J: I worry about money a lot. I think, well, will I have enough money to get by on. 
Every morning I wake up and I think about that. I get anxious and I think, will 
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T: So you’re feeling anxious and thinking, will I always be like this? 
J: Yes. And I’m thinking how stupid I am to feel this way for so long.  
   
T: Can I also ask you what you do when you feel anxious or what you feel you have to 
do? 
J: I feel as though I can’t sit still. I need to move, walk away, leave the situation. I think 
people wonder why I have to just get up and go for a walk so many times but when 
people are all around me and talking and busy, I just can’t stand it. The other thing I do 
is clench and unclench my fists. I try to ease the tension out through my hands. And, if I 
remember I’ll take a few deep breaths to settle me down. I also tend to get nervous and 
get off track in conversations. I talk too much when I’m anxious and it’s usually 
irrelevant. 
T: And social situations bring these behaviours on? 
J: I’ll always use an excuse when I’m anxious. Like I’ve got to go and check on my car 
or I’ve forgotten my keys. I’ve got a million excuses I use to get away from those 
situations when I’m feeling anxious. 
T: These are my words (writing on board), but I’ll write that when you feel anxious you 
tend to escape from situations. 
J: Yes. I think that covers it well. 
This exercise should last for 25 to 35 minutes. At this point the therapist is not 
really offering interpretations of the client’s behaviour, only providing an objective 
description of his anxiety based on a client’s self-report. The therapist should be 
beginning to privately identify functional explanations for the client’s behaviour, yet the 
aim of session 1 is to clearly define the client’s own anxiety experience and provide 
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oriented the client’s attention toward the overt aspects of his anxiety as it is the public 
behaviour of the client which is to be directly targeted for change within BATA.  
The development of anxiety in the individual is briefly addressed in the last part 
of session 1. Barlow’s triple vulnerabilities model for the development of anxiety 
(2002) is applied to organise the discussion. Thus, the therapist will mention that 
anxiety may develop due to a combination of biological or familial vulnerabilities; 
generalised psychological vulnerabilities; and, specific psychological vulnerabilities. 
Above all else, this assists both the therapist and client in identifying potential learning 
experiences (distal and proximal) that have influenced the client’s present condition. 
The client’s responses are taken as facts and the information is used to illustrate the 
origins of his anxiety, but not as an explanation for how his anxiety-related behaviour is 
maintained in the present. Again, the following exchanges were recorded during session 
1 between the therapist (T) and Jim (J): 
T: Does anyone in your family experience anxiety? 
J: If anyone, it would be my father. I could never pinpoint it as anxiety, but like me he 
was quite dysfunctional.  
T: What do you mean? 
J: Well. He was like he could never sit still. Never finishing anything he started and 
quite a difficult man. I think he did suffer mental illness but it was never spoken about 
and I think he hid it quite well.  
   
T: Generally speaking, it’s our learning experiences through life that lead to the 
development of ongoing emotional problems such as anxiety. This includes those earlier 
more distant experiences, like childhood ones, that perhaps began your anxious 
responding and the more recent examples of frightening or fear-eliciting, distressing 
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J: I would agree with that. There were definitely things that happened that made me 
worry a lot and feel uncomfortable in myself. 
T: Social experiences? 
J: Yes. Going way back. I can remember someone at school saying to me I was always a 
bundle of nerves. I had told my sister once or twice about something terrible that 
happened to me when I was a child. I may have mentioned that to you before. 
At this point, it’s not necessary to prompt the client to detail his past 
experiences. The only aim is for him to understand that there is an ideographic learning 
history that has contributed to the development of his condition and lengthy discussions 
about distal events generally are to be limited to the parameters (e.g., time, content) of 
the session. Within BATA, the client’s present day context is primary. His current 
behaviour obviously has been shaped by a past history of reinforcement and 
punishment. That forms part of the context for his clinical behaviour. As a brief therapy, 
however, BATA is more concerned with addressing the present day functional relations 
underlying his clinical (anxiety) behaviour.  
The first session ends with a brief review of the content covered within and the 
therapist asking the client whether he or she has any questions or concerns regarding the 
completed session or future sessions. Clients are asked to continue their self-monitoring 
between sessions. The therapist briefly outlines the plan for the next session and the 
aims of treatment: 
T: It’s unlikely that you will ever be completely free of anxiety, however the aim of this 
treatment is to modify your behaviour to the extent that you are not controlled by your 
anxiety and when we go through the treatment model next week in some detail, you will 
see that we will be focusing on your behaviour, the things you do. The principle being 
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change accordingly. Do you have any questions? I want you to leave here today with as 
comprehensive an understanding of anxiety as is possible.  
J: I do have a better understanding now. Even with my anxiety I still can absorb 
information. Particularly with my paperwork and forms I can take them home and have 
a good read of them. I do have a question though. Did you say that my feelings and 
thoughts come from my behaviour? 
T: Essentially, yes, although feelings and thoughts are also behaviour. The important 
message to take away with you is that we can have a large amount of control over our 
overt behaviour, despite what we may be thinking or feeling. We have a lot less control 
over our thoughts and feelings in comparison.  
J: So it’s not up to the individual what thoughts come in and out of his head? 
T: Our thoughts and our feelings are products of what we do, where we go, who we are 
with. That’s the context for the private or internal events such as thinking and feeling. 
That’s why for the remaining treatment sessions we are going to be focusing on your 
overt behaviour, the things you do each day – to see whether we can get some change in 
your anxiety. 
 
SESSION 2. 
The primary goals of session 2 are to provide the client with a full treatment 
rationale and description and to explicitly introduce the concept of avoidance. Toward 
the end of the session, the client is also instructed on goal-setting. As with every 
session, the client’s self-monitoring diaries are collected and new ones provided. The 
client also completes the standardised measure(s). After this is completed, the therapist 
outlines the agenda for the session referring to the document outlining the key points of 
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anxiety rather than depression. The therapist should work through every point included 
in the outline:  
T: What I want to cover today is the actual model of treatment you are about to receive 
and the principles underlying it. First I will go through, point by point, the treatment 
model and if you have any questions, comments, or concerns don’t hesitate to raise 
them with me. 
J: That sounds ok to me.   
 
 
Ten Key Points to Address When Presenting the BA Treatment Model 
1. Behavioural activation (BA) is based on the idea that the events in your life and how you respond to such events 
influence your thoughts and feelings. 
2. BA assumes that a major reason why people continue to experience anxiety is that their lives are focused more on 
‘anxious’ behaviour rather than ‘non-anxious’ behaviour. That is to say – in response to feelings of anxiety we restrict 
and limit our day to day activities in order to avoid feeling anxious so we end up living like anxious people. 
3. Sometimes it is possible to pinpoint exactly the cause of someone’s anxiety; but at other times it is not, yet there 
maybe indicators within the person’s day to day life.  
4. When experiencing anxiety in life, people often avoid (or escape from) situations, places, or people which they 
associate with feelings of anxiety – and this means the person’s life is often restricted and limited and they are never 
really able to fully live their life as they want to. 
5. Wanting to avoid uncomfortable feelings is natural and understandable as is avoiding situations which may lead to 
these feelings. We know, however, that this ‘avoidance’ serves to maintain anxiety in the long term. 
6. Herein lies the problem. Although avoiding and/or escaping from certain situations, places and people often works 
in the short-term because we avoid feeling anxiety, or our anxiety is reduced – this has the effect of maintaining and 
often strengthening feelings of anxiety as well as impacting on one’s quality of life. In terms of how restricted 
anxious people’s lives can be, it’s not surprising anxiety often leads to depression.  
7. During BA therapy, you and I will work towards helping you become more active and engaged in your life – with 
fewer restrictions and limits. 
8. BA is not just about ‘doing more’ or ‘just doing it’. If feeling less anxious were that easy, you would already have 
done it. My role as therapist is to analyse your behaviour and evaluate which activities may help decrease your 
feelings of anxiety and also those which may be serving to maintain or strengthen your anxiety. Together we will 
work to structure your day to day life so we move you closer to living the type of life you would lead if you were free 
of anxiety. This is done collaboratively, with absolute respect and dignity shown towards your personal beliefs, 
values, and freedom. 
9. Each session will involve developing practical, achievable steps aimed at helping you to overcome the hold anxiety 
has over your life. 
10. Between sessions, you will work on various tasks that we develop together; these tasks are an essential part of BA 
therapy and will focus on reconnecting or building parts of your life that allow you to overcome anxiety and bring 
you closer to achieving life goals which are important to you.  
 
 
  
Figure 3: Therapist’s Guide for Presenting the BATA Model. 
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   
T: BA assumes that a major reason why people continue to experience anxiety is that 
their lives are focused more on anxious behaviour rather than non-anxious behaviour. 
That is to say in response to feelings of anxiety we restrict and limit our day to day 
activities in order to avoid feeling anxious so we end up living like anxious people. 
J: So true. 
T: Yes? That makes sense? 
J: Very, very true in my case. It’s become part of my life and I just adjust my life 
around my anxiety. It’s amazing to think what I would really like my life to be about. 
T: So at this point in time, the things you do in your life and how things are, they’re not 
completely how you would like them to be? 
J: They’re certainly not and they have never been. Not as long as I can remember.  
T: Because? 
J: Because I’ve (pause) always responded to the effects of anxiety 
   
T: Although avoiding and/or escaping from certain situations, places and people often 
works in the short-term…. 
J: Well I’ve done that all my life. From a young age. 
T: Because we avoid feeling anxiety or our anxiety is reduced, this has the effect of 
maintaining and often strengthening our feelings of anxiety as well as impacting on 
one’s quality of life. 
J: I don’t want to be too subjective, but I can put myself in the category of everything 
you’ve mentioned so far. My social life, dealing with people, opportunities. The part 
where you say that people miss out on this and that, well I feel I have missed out on a 
lot in life (pause) being an anxious person. 
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   
T: During BA therapy, you and I will work towards helping you become more active 
and engaged in your life with fewer restrictions and limits. 
J: That would be good. 
T: We are focusing on concrete behavioural steps to help you get in contact with what’s 
important to you. 
J: Can I just say that I’ve never really done that. It’s like I’ve just existed. It just 
becomes like a habit. I don’t really ever do what I truly want. 
   
T: So that is the description of the treatment you are to receive and the underlying 
principles. Does it sound like something you would be interested in engaging in? 
J: It sounds very good. I just hope I can bring it to fruition. 
This part of the session should be between 20 and 30 minutes. The client should 
be given the opportunity to raise any concerns or questions regarding treatment. As 
above, the client should be asked directly whether he or she is willing to engage in the 
treatment. In essence, this is contracting with the client and an informed decision is 
being made. The emphasis within the treatment rationale on avoidance and the broader 
function of the client’s behaviour is the beginning of an ongoing education regarding 
functional analysis. The aim here is for the client to be able to apply a self (functional) 
analysis that serves to prompt behaviour change in important areas, in conjunction with 
the more formal aspects of the treatment such as activity scheduling. This part of 
session 2 ends with the client being provided with a hand-out (Figure 4) that 
summarises the treatment model and rationale in plain language. The therapist reads 
through the hand-out in session and recommends the client regularly refer to the 
document throughout the course of treatment. This treatment summary focuses on 
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Anxiety is an uncomfortable feeling of fear or worry that everyone experiences from 
time to time. Bodily sensations such as trembling, shakiness, fast breathing, and 
sweating can tell us we are feeling anxious. In fact, anxiety is considered a typical 
human response which, over time, developed to help us respond to danger or threats to 
our wellbeing. Anxiety is unavoidable, natural, and for most of us not a problem. For 
some people, however, anxiety becomes a problem – especially when it interferes with 
our normal day to day activities and our lives become very restricted and unpleasant a 
lot of the time. This may be what is happening with you in your life. 
 
Because anxiety is such an unpleasant feeling, we will put effort into avoiding or 
escaping from any situations where we may either feel very anxious or predict we will 
feel anxious. We avoid these situations because deep down we believe we cannot cope 
with our feelings. Or, we will go into situations that make us feel anxious, and quickly 
look for ways to escape – without allowing ourselves time to relax and enjoy ourselves. 
This may work in the short-term, by avoiding feelings of anxiety – but in the long term 
we never allow ourselves the opportunity to reduce our anxiety. In fact, by trying to fix 
your anxiety in this way – you may have found that your anxiety has grown stronger 
over time and you may be feeling worried or fearful in all sorts of situations. This may 
be making it very hard for you to do the things you want to do, be the person you want 
to be, and live the life you want to live.  
 
You may be waiting for the day to come when you feel less anxious, more in control, 
and better able to carry out your day to day activities. As you may realise, this is easier 
said than it is done. If you don’t make clear changes in your life – it may be that your 
anxiety will persist for a long time. In fact, research tells us the more we attempt to fight 
our anxiety – the stronger it gets. The idea of the treatment you are about to undertake is 
that it is the actual activities you do, and the activities you don’t do, which affect your 
day to day feelings of anxiety. So, what is required of you is to begin to increase your 
activity levels in all meaningful areas of your life before you can begin to feel less 
anxious. Although this may be difficult at first, and feelings of anxiety may seem as 
strong as they ever have, your therapist will help you through this process, at your own 
pace, and help you to solve any problems that may arise along the way. No one expects 
you to be completely free of anxiety as you begin to increase the meaningful activity in 
your day, but the process will, in time, become easier, more rewarding, and achievable.  
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   
Finally, the client is provided with a goal setting form (Figure 5) and asked to 
complete the form between sessions. The client is also provided with a verbal rationale 
for using the form. The goal setting form is similar to those used in the BA treatment 
manual developed by Lejuez et al. (2001) which itself was based on the form used 
within the ACT manual of Hayes et al. (1999). The form requires the client to list goals 
within a range of life areas (e.g., family relations, employment, recreation). The main 
differences between the goal setting form developed for the BATA treatment protocol 
are the explicit usage of the term goals (instead of ‘life areas assessment’ or ‘valued 
directions’) and the addition of written instructions with the following point: “Focus on 
behaviours (i.e., things you would like to do) rather than how you would like to feel or 
what you would like to think”. Goal setting is introduced in the following manner: 
   
T: Along with reflecting on what we have discussed during this session, in particular the 
BA model of treatment for anxiety, this week’s homework is to complete this ‘goal-
setting’ form (hands form to client). The initial step that we get you to take is to use this 
form to list all your goals in these different areas of your life from this point onwards. It 
doesn’t matter how achievable they might seem at the moment or whether they are long, 
medium or short term goals. Whatever you come up with, the aim is to simply write 
them all down on the form and next week we can start to go through them and discuss 
what you can do to start working towards meeting your life goals. Although a 
reasonable goal at this point in your life might be ‘I want to be free of anxiety’ or ‘I 
don’t want to keep having these troubling thoughts’, we are not focusing on those type 
of goals. We are focusing on things that you can actually do, behavioural changes that 
you can make, goals that are concrete and tangible. Able to be observed by you and 
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J: So it could be anything fanciful? Anything I desire? Work wise, social wise? 
T: At this point, anything. As long as your goals are concrete and tangible. 
J: I can think of one thing right away. I need to get back to the gym, because I’ve let 
myself go the pack a bit. For a couple of years there I used to go to the gym every 
weeknight. I got myself looking and feeling pretty good.  I think….actually I don’t 
know why I gave it away. 
T: That’s a good example of a goal that you can record on your form. Either in the 
‘recreation’ or in the ‘health and physical wellbeing’ section. In fact, I’ve already heard 
a few good examples of goals from you today.  
J: I never tell people these things though. I’ve always kept my thoughts about my 
desires hidden away. 
   
T: This is an individual process Jim. It’s about the things that are important to you, the 
things you want to do, the goals that you want to strive for. We’ll work together in these 
sessions to identify what changes will help you to live a non-anxious life and also 
identify those things that you do that might be working to maintain your anxiety. We are 
looking for you to be approaching more things in your life and avoiding less. 
J: You’ve hit the nail on the head. Even coming in to be part of this program is a 
decision I made to stop avoiding my problems in life and to face up to them. I believe I 
do have the ability to do things, but I never put it into practice.  
T: Hopefully, from this point forward we can work together to help you to put things 
into practice. 
J: I have tried hard in the past, but nothing’s quite worked yet. Sometimes I feel as 
though I take one step forwards and three backwards. 
T: The aim of this treatment is for you to have built strong, concrete steps towards your 
goals in the time that we have together.  
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Goals 
Instructions: People engage in therapy to make changes in their lives. Properly identifying goals and 
working towards accomplishing those goals is of vital importance to making positive change in your life. 
In the life areas below, write down as many goals as you can think of. Don’t worry whether they seem 
achievable or not. Simply write down all your goals. Focus on behaviours (i.e., things you would like to 
do) rather than how you would like to feel or what you would like to think.  
List your goals 
Couples/intimate relationships:__________________________________________________________ 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
Family relations: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
Social relations: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
Parenting:___________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
Employment:_________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
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Education and 
training:_____________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
Recreation:___________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
Spirituality:__________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
Citizenship/ 
community:__________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
Health/ physical 
wellbeing:____________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
Any other 
goals:________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
 
Well done. 
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SESSION 3. 
The main goals of session 3 are to review the client’s between-session goal-setting 
exercise and to introduce the strategy of ‘activity scheduling’. These goals are clearly 
stated to the client at the beginning of the session. The next step is the collection of the 
client’s self-monitoring diaries and the provision of new ones. The client also completes 
the standardised measure(s). As the data are collected across sessions they can be fed-
back to the client in graphic form:  
T: You can see here from these simple graphs of your baseline period that at the times 
when you are engaged in things that really interest you, what happens to your anxiety? 
J: It goes down. 
T: Yes. It’s quite clear. And it fits with the BA model. But, what I also found on this 
other graph was that the more time you spend at home the lower your anxiety is. Which 
may not be such a good thing because we have spoken about the function of avoidance 
is to decrease feelings of anxiety. Maybe the data are telling us that when you’re at 
home you’re not having to face people, go to certain places, enter into situations that 
make you feel uncomfortable. Even if that means you’re missing out on life a bit.  
J: A bit isolated maybe. I guess it’s not helping with my anxiety in the long run. 
T: Yes. We spoke last week about how the avoidance actually maintains your anxiety. 
J: The harm that it does. I read through the hand-outs you gave me during the week. I 
know my anxiety goes up when I go to certain places, like shopping centres. If I go I 
just have to get out of there. Usually I do my best not to go at all.  
    
Following this review, the therapist begins to discuss the goal-setting exercise: 
T: Did you manage to complete the goal-setting activity during the week? 
J: Yes. I wrote everything down just as it came into my mind. 
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J: I would like to hire a country block and build transportable homes for a business. I 
would like to do something to help other people voluntarily (client continues to read out 
goals).  
T: Let’s start with the first goal. Can you explain to me what that would involve and 
why that’s important to you? 
The aim of discussing the client’s goals in detail is to identify the steps required in 
meeting the goal, the potential activities that are associated with the goal, whether the 
goal is socially ‘valid’, the likelihood of accessing positive reinforcement, and whether 
there are any potential ‘behavioural cusps’ that might occur as the client is working 
towards meeting his or her goal. 
    
T: What’s the next goal that you have written down there? 
J: I would like to do something to help people voluntarily. 
T: Any particular area that you had in mind? 
J: I did use to work at the RSPCA animal shelter for 2 years. Cleaning pens and walking 
the dogs. I love animals. I often think about going back there. It goes through my mind 
all the time that it did me good when I was helping out there. I’m not sure I have the 
time though. I’m quite busy at the moment. I’m not sure if I know anyone up there 
anymore. 
T: Do you know how much time do you would need? 
J: I used to go there for one afternoon a week for a few hours. Every Friday actually.  
T: And, you don’t have that time now?  
J: Well, I could probably find it. (Pause) Maybe I just say things like, ‘I don’t have the 
time’ as a way of justifying my behaviour. My anxiety has been pretty high for some 
time now. I just can’t get organised. I can’t seem to be able to get off my behind and do 
what I want to do. It’s just too hard and it can be easier to just put things off. 265      
 
 
 
T: Unfortunately that avoidance means you miss out on quite a bit in life. BA-therapy is 
like running a series of mini-experiments. Engage in the activity and see what happens 
for you. It won’t be done without effort and it will come down to what works for you, 
but hopefully we can collaborate through this process to enable you to be able to do the 
things you want to do regardless of how you feel.  
This example highlights another outcome of the goal-setting exercise which is to 
observe instances of potential avoidance in the client’s everyday life and apply a 
pragmatic ‘BA-type’ response in conversation. The client has stated a goal, yet initially 
offers ‘reasons’ for not attempting to accomplish the goal. The therapist signals 
‘avoidance’ and restates the objectives of BA therapy. Also, at this point the client is 
beginning to demonstrate that he is able to formulate basic functional descriptions of his 
behaviour including recognising the negative reinforcement that maintains his habitual 
avoidance.  
    
T: What’s the next goal Jim? 
J: I would like to catch up with family, relatives and friends I have ignored for years. 
T: If you were to try to get closer to this goal, what would be the first step you would 
have to take? 
J: I’d ring my brother. He rang me for Xmas and I didn’t even ring him back. I’ve 
avoided him for years. I didn’t even go to his 60
th birthday. 
T: Do you think you could give him a call this week? 
J: I could. I’d feel uncomfortable after all this time. But, I could make the time to give 
him a call. 
     
In this way, target behaviours for activation (e.g., contacting friends and family) can be 
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approximately 40 mins of session 3. It’s not necessary to hold a detailed discussion of 
every goal that the client has generated. Goals can also be discussed in subsequent 
sessions. The final 15 mins of session 3 is spent on introducing the strategy of ‘activity 
scheduling’, providing the client a Weekly Activity Log (Figure 6), showing the client 
how to use the log to schedule activities, and attempting to schedule some activities for 
the week ahead:  
T: I want to give you the ‘Weekly Activity Log’ to use from this point on. This is to 
help you to schedule in activities that you choose to engage in during the week. Can we 
use the ‘call to your brother’ as an example? I could demonstrate how to use the log. 
J: I would like to give him a call, yes. 
T: Ok. Is there a time and day you would make the call? 
J: In the evening. 
T: Good. And on what day? 
J: I think any night of the week would do. 
T: If you had to be specific. Which day would you choose? 
J: I could ring him Sunday. 
T: Good. And, what time? 
J: Between 7 and 8. 
T: So let’s schedule that in. The activity is ‘phoning brother’, the frequency is ‘1’, the 
duration – how long would you talk with him for? 
J: It depends on how it goes. Maybe half an hour. 
T: Good. So the duration is 30 mins. Then, you can simply place a yes or no in the box 
to show whether the activity was completed, then the actual frequency. You may call 
him more than once, for example. And, finally record the actual duration of the activity. 
Whether it was 30 mins, 10 mins, or 60 mins, etc. The primary aim is to conduct the 
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where the activity takes you. That’s how you use the activity log to schedule activities. 
Every session you can return your completed activity log and I’ll provide you with a 
new copy. Is that clear? The process is small steps, activities that take you closer 
towards your goals. And, you have just scheduled your first activity which is an 
important action on your part.  
J: That’s good. I think I understand ok. I’ll follow the schedule and next week I’ll tell 
you how it went. It will be hard. I’ve always felt I was the ‘black sheep’ of the family 
and compared myself unfavourably to my brother. 
T: An important aspect of BA therapy is that we accept what’s happened in the past, but 
we don’t dwell on it. Your history is important to the degree that it forms part of the 
context for your present day behaviour. You can’t directly act on the past though, so we 
look at what you can do differently today and into the future and make a difference that 
way. Is it’s important to you, then re-engaging with your family and friends might be a 
good start.  
J: I think so too. I’ve put it off for a long time.  
 
 
Weekly Activity Log 
 
 
Activity 
 
Ideal 
Frequency 
Ideal 
Duration  
 
Completed 
(yes/no) 
Actual 
Frequency 
Actual 
Duration 
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SESSION 4. 
 
As typical, the session begins with the administration of the standardised measures, a 
review of the client’s self-monitoring diaries, and the provision of fresh forms. Session 4 
is a pivotal stage in BATA because it is the first opportunity to assess the client’s 
programmed between-session activation. The therapist assists the client in describing his 
or her activation (and avoidance) that might have occurred during the previous week and 
its associated reinforcing, discriminative, and eliciting stimuli. The therapist and client 
continue to collaborate in describing the functional relations controlling the client’s 
everyday behaviours and identifying ways that the client can access positive 
reinforcement for clinically ‘healthy’ non-anxious behaviour. 
   
T: Looking at your activity log, it appears that you engaged in a number of scheduled 
activities this week? 
  J: Yes. I made sure that I phoned my brother and had a talk for about half and hour with 
him. 
T: Very good. When was the last time that you spoke with him? 
J: Three years ago.  
T: Three years ago?! 
J: I’ve been invited down there a number of times. He tries to make me very welcome. 
He and his wife are very nice people. But I always thought that he was so much better 
than me with my failures in life. I’ve avoided him for a long time. 
T: How was your anxiety leading up to making the call? 
J: I actually put it off for two days. Which is what you told me I might do. But I have to 
tell you. When I rang him I felt so relieved.  
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J: I did avoid until a couple of mornings. I didn’t phone him at night but in the morning. 
I could see it at the time. Once I feel anxious I always just back off. The anxiety goes 
away for a bit. I knew I had to call him though, eventually. Avoiding him hasn’t really 
helped overall. 
T: How was your anxiety when you were picking the phone up to call? 
J. It jumped quite a bit. It got very intense. But (pause) the minute I heard my brother 
talk I felt an enormous relief. And we had a very good conversation. We talked about 
our old footy days together. We talked about mum and dad. What his kids are up to. 
What’s going on in my life. So it was good. It was excellent that you recommended it 
for me. 
T: It came from your goals, Jim. It seemed important to you. How did you feel after the 
call? 
J: I felt good. I felt really, really good.  
T: It’s fantastic that you went through with it. 
J: I was thinking that it’s quite clever to set a task that I felt I had to go through with. 
Even though I put it off for a while. I was surprised at how well it worked actually. 
Something so simple. 
T: What about the future. Will you make regular calls? Will you try to increase contact? 
J: I will keep in touch. He even asked for my phone number, something he has never 
done before. He wants to be able to call me. We might plan to meet face to face. That 
makes me happy. 
T: That’s a very good outcome. 
   
In this example, the client and therapist were able to describe the functional relations 
acting on the client’s behaviour using informal terms. Critically, the client is beginning 
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reinforcement for his avoidance behaviour and response-contingent positive 
reinforcement for his approach behaviour. He described how he altered these 
contingencies by ‘blocking’ avoidance while simultaneously exposing himself to the 
schedules of positive reinforcement available in his contact with his brother.  
    
T: I see that you have been walking ‘Martin’ (pet dog). How did that go? 
J: Good. The first day, Sunday, was a beautiful day and I took him to a big park near my 
house where there were about 50 other dogs for him to play with. The owners were 
pretty good. They bring their dogs over to meet him and have a bit of a chat. He gets 
along ok with the other dogs. It’s good exercise for me as well. 
T: That’s good. Looking at your activity log it shows that you have been doing a few 
different things this week. Walking Martin, some clothes shopping, riding your bike 
with your girlfriend. But, your anxiety hasn’t really spiked. If anything it’s reduced. 
J: That’s right. That’s how I feel. I don’t know whether I’m not thinking about things or 
what it is. It could be that I’m starting to do the things I want to do. I’ve never really felt 
in control before, with my anxiety. The things I’ve scheduled this week have been good 
for me. 
T: And you’re spending more time out of the house? 
J: That’s right. Most of the challenges I’ve set myself this past week have meant I’ve 
had to leave the house a bit more.  
T: So, in general the more time you are out of home and doing things you have planned, 
the less anxious you feel? 
J: I think that might be true.  
    
Approximately 40 mins should be spent reviewing the client’s between-session 
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activities for the coming week with the client’s goals as a referent point to prompt 
conversation.  
   
T: Let’s look at potential targets for activation for this coming week. One of your goals 
was to restore past relationships with friends and family. Are there any old friends who 
you might like to contact this week? 
J: I do have a friend in mind who I had a bit of a falling out with a number of years ago. 
He was the best man at my wedding. Now he’s got bone-cancer and his wife has told 
me that he’s very angry and upset. I stopped seeing quite a few years ago, before he got 
cancer. I felt like, as I was working on my own mental health, I would be sabotaged 
every time I would see him. I don’t know why really. I feel like I have to see him 
though. In fact, I nearly gave him a ring before I came in today. 
T: Really? 
J: Well I’m on a bit of a roll (laughs). 
T: We should try to maintain that momentum. 
J: I hope I can keep it up. 
T: Can we schedule that phone contact in for this week? 
J: That would be a definite. I would actually like to go and see him. I can’t think of a 
good day though. 
T: Why don’t we schedule his phone call in for this Monday, and if you have to move it 
then we can be flexible. 
J: That’s ok for me. I’ll do it. 
T: I think this might be very important for you. Maybe contacting old friends is a real 
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J: It’s funny that you mention that. I do have a couple of friends who I know I don’t 
spend enough time with. They will often call and invite me places. I nearly always find 
an excuse not to go though.  
    
T: Another of your goals is to improve your fitness. We spoke a little bit about the gym 
last week. Is that a potential target? Is there anything else? 
J: I used to do quite a bit of swimming once upon a time, in the pool. I was very fit. 
T: When was the last time you went for a swim? 
J: Oh. I’m not sure. Quite a while back. That’s another thing I stopped. Silly isn’t it? 
T: This is typical of the anxiety-sufferer. The range of activities becomes smaller and 
smaller. Very restricted.  
J: My world has shrunk like you wouldn’t believe. 
T: Is swimming a target for activation? 
J: I could go. There’s a good public pool near my house. There’s a lady I do some work 
for occasionally and I think she goes there nearly every day. 
T: Can we schedule it in?  
J: I think that might work. 
T: Other than how you feel about it, is there any barrier preventing you from going 
swimming at this pool like costs or transport difficulties? 
J: There’s nothing stopping me. Swimming used to be the one time when I wouldn’t 
worry a hoot about anything. I would go to the pool with the purpose of having a good 
swim.  
T: What effect do you think that regular swimming would have on your anxiety? 
J: I think it would make it drop like nothing else. I can almost remember how swimming 
felt. I think about it now and again. Rather than being all tensed up in front of the TV. 
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J: Well it has for me in the past. 
T: I’ll be interested to hear your reports after you visit the pool.  
   
SESSION 5. 
The protocol for this session matches that of session 4. As typical, the session begins 
with the administration of the standardised measures, a review of the client’s self-
monitoring diaries, and the provision of fresh forms. The therapist reviews the client’s 
between-session activation and helps the client to schedule activities for the week 
ahead. The therapist continues to publicly formulate the client’s behaviour offering 
functional-analytic explanations according to the behaviour’s associated reinforcing, 
discriminative, and eliciting stimuli. Any potential barriers are met with a pragmatic 
response from the therapist. Increased client activation is the key aim of the therapist’s 
in-session behaviour. 
   
T:  I notice from your monitoring that you’re spending less time drinking tea and coffee 
in the mornings. 
J: Yes. I used to sometimes sit there and drink 5 or 6 cups before I got going in the day. 
T: Do you think that this was a form of procrastination. By that term I mean that at 
those times you were avoiding getting done what you had planned for the day. 
J: I think I worked that out myself. I used to look at it as a kind of relaxation. That it 
helped with my anxiety. I can see now that it actually has the opposite effect because I 
wasn’t getting done what I needed to. And that made me worry. Your talking about 
avoidance has convinced me of that. I think I probably knew anyway but just ignored 
the fact.  
T: I’m pleased to hear you talk about the possible function of your behaviours. And, I 
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That would reduce your anxiety. Paradoxically, the coffee would have had a mild 
stimulant effect as well. It’s good to see that the level of that behaviour has decreased.  
    
T: Let’s review your activities which I’m pleased to see are many and varied. What 
activities that you engaged in made a difference for you this week? 
J: I got my exercise bike out of the shed and moved some furniture and got that set up in 
the house. That was the first step. I’ve started to do about 30 mins in the morning and 
I’m trying to do a bit in the evening. 
T: Fantastic. And if you’re exercising in the early morning, then you’re not sitting at the 
table drinking cups of tea and coffee which was something we targeted for reduction.  
J: Yes. I also got my weights out and I’ve started to do some sets each day. I remember 
from my time at the gym how to put together a small routine. They are not the weight 
that I used to lift before but I feel I can build my strength up a bit before I get back to 
the gym. I can start to picture myself coming back to what I was. I’ve actually got a full 
gym set up in my shed which I haven’t used for some time. 
T: Could you set that up this week? 
J: I have been thinking about it. 
T: Let’s schedule that in. 
    
T: I see the dog walking continues? 
J: Yes, I’m walking the dog. I went out three times. Twice with the umbrella, because it 
was raining, and once with my girlfriend. The weather has been very unpredictable. I do 
take him down with me to get a paper some mornings but that’s not very far. 
T: Are you walking him enough? 
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T: It would be interesting to see the effects if you were going on planned walks with 
him everyday.  
J: Well, how about this week I’ll schedule it in as a challenge. Starting tomorrow, I’ll 
walk with him everyday rain, hail or shine. I’ll do a complete week and come and tell 
you how it goes. 
T: Let’s write this in your activity log. 
    
T: Did you contact any friends this week? 
J: I did. I took up an offer to have lunch with a friend of mine who I’ve been putting off 
for a while. We had a nice lunch. He took me to a café. I suggested we sit outside 
because the people inside, it was busy, and I thought I might get uncomfortable with too 
many people around me. 
T: So, some minor avoidance? 
J: Just a bit. It was all a bit new to me. But we sat outside, he didn’t mind and it was 
good. 
T: And am I right to believe that you calmed down the longer the lunch went on? 
J: I did. By the time I left I felt very calm and I felt good about myself. He even insisted 
on paying. 
T: He sounds like a good friend. 
J: He is. He’s a nice guy, a good guy. 
    
T: And what other activities have you engaged in this week? 
J: I’ve been doing a lot more cooking. Making some pumpkin soup. I’ve been shopping 
for fresh fruit and vegetables at different times this week. 
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J: That hasn’t eventuated as yet. I’m planning on making some enquiries about the 
swimming this coming Monday. I’m planning on doing some swimming on my way 
home from my ‘handy-man’ work that I do. 
T: That’s a good plan. 
J: I’ll see if I can go 2 or 3 days each week. 
T: Do you think you can schedule in to at least contact the swimming centre this week. 
J: I will definitely do it. I’ll certainly do it. I’ll do it on Monday. I had asked my 
girlfriend to check it out for me, but she never did. 
T: Perhaps you could take the lead. It can be more helpful not to have to rely on 
someone else to make these small steps towards your goals. It also might function as 
avoidance, by putting things off or shifting the effort towards someone who might not 
be as reliable or as motivated. It may not be at the time, it could be a practical 
consideration. But, because you have presented with anxiety I’m always trying to work 
out the function of your behaviour especially in relation to avoidance which is common 
with anxiety. 
J: I appreciate that that’s what we are doing here. And I agree, I shouldn’t let the work 
I’m doing on my mental health be dependent on someone else in my life.  
   
During the remaining part of the session the therapist continues to review the client’s 
past week’s activities, schedule activities for the coming week, and identify activities 
that match the client’s stated goals. The therapist also publicly formulates the possible 
function of the client’s behaviours. By the session’s end, the client should have 
scheduled a number of activities for the week ahead using his ‘activity log’. 
   
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SESSION 6. 
The session begins with the administration of the standardised measures, a review of the 
client’s self-monitoring diaries, and the provision of fresh forms. The main goals of this 
session are to review past activities, schedule future activities, ‘check-in’ on the client’s 
goals, and formulate functional explanations of the client’s clinically relevant 
behaviours including avoidance. 
    
T: How have you been going with your activities this week? 
J: I’ve completed a few activities that I had listed there. I’m a little bit disappointed that 
I didn’t call an old friend that I had scheduled to contact this week. I put off phoning 
him for some reason. I think mainly I’ve set my sights too high. I know he moves in 
different social circles to me now and that gives me a fear. But I also know that he’s a 
lovely guy and he would be happy to hear from me, so I’m sort of my own worst enemy 
here.  
T: I think this could be an example of avoidance. It might help to discuss the function of 
that behaviour, even if you choose not to target that particular friend for contact. Let’s 
come back to this later in the session because I want to hear more about the activities 
you completed this week. 
J: I went to Kings Park. Had a picnic with my girlfriend and a walk around the gardens. 
T: Can you tell me about that? 
J: It was good. The weather was nice. There were a couple of weddings on when we 
went there which gave us something to look at. And then we went to Subiaco and had 
some lunch and some coffee. Which is something I don’t think I’ve ever done. I used to 
think all the ‘hob-nobs’ went there, but actually I was surprised. I felt ok and it was a 
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T: That’s good. I think you’re describing to me a previously avoided situation which 
you scheduled in, entered into, and found that it had an overall positive effect on you. 
Anything else? 
J: I’ve been walking my dog on a regular basis. And, doing some handy-man work. I 
like to burn a bit of energy up physically.  
    
In this exchange the therapist is simply requiring the client to describe his activities in 
the past week. These activities are not randomly selected. They are activities that the 
client has scheduled as part of his treatment. As such, they are considered ‘clinically 
relevant’. The client is prompted to describe the functional properties of the situations 
he has entered into. The aim is for the client and therapist to be able to reliably predict 
the types of situations that are incompatible with avoidance and that provide 
reinforcement for clinically ‘healthy’ non-anxious behaviours. By discussing the client’s 
overt behaviours, the therapist gains a great deal of information about the likely 
controlling environmental stimuli for both the ‘healthy’ and ‘non-healthy’ behaviours of 
the client. Further, the therapist is emphasising the importance of external variables and 
overt behaviour on consequent ‘thoughts’ and ‘feelings’, thus matching one of the 
central principles of BATA.  
    
T: Are there any activities that you identified in the past week that could help improve 
things for you and that you might like to schedule in for this coming week? 
J: Well, I could take my girlfriend out for a meal. Somewhere apart from McDonalds or 
anywhere like that. A decent restaurant might be a nice occasion.  
T: Should we schedule in a ‘dinner date with girlfriend’? Is that ok? 
J: Yes (takes deep breath).  
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J: I’ve always been ‘panicky’ around people, especially indoors. Just the thought of it 
gets me a bit anxious. 
T: I recommend not focusing on your anxiety going into this. Start with scheduling it in, 
then choose a time and day, a restaurant, and then go through with it. You will only 
know the outcome once you go through with what I would call, ‘the experiment’. The 
actual properties of the situation could be far different from what you imagine. And, 
generally we know that when faced with an anxiety-provoking situation the only way 
to…. 
J: The only way to overcome is to challenge it head on, if I’ve put that the right way. 
T: If it’s important to you, then yes. We don’t need you to blindly crash through your 
days. But you can always choose to enter into these environments and see what effect 
that has in the long-term on your mental health. 
J: I’ll take her out this week. I don’t know when and where but I’ll work that out when I 
leave here. 
T: That’s good work Jim. Remember that at some points you will have to actively 
organise your behaviour to meet your goals. You’re responsible at that point. Although 
once you’re in the setting, we hope that your behaviours will be shaped up by the 
natural environment in  ‘healthy’ ways. 
J: I’m starting to understand that I do need to be more active here. 
    
In this example, the therapist is ‘coaching’ the client to better ‘self-manage’ his 
behaviour. Ultimately, the client’s behaviours will be shaped by him contacting the 
naturally occurring schedules of reinforcement within his new and changing 
environments. Initially, the client must attend to the task of scheduling activities and 
then conducting ‘mini’ task-analyses of the steps he needs to complete in order to 
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focus on the various tasks at hand and the actual real-time physical properties of his 
settings rather than spending time focusing on the client’s associated thoughts and 
feelings.  
     
T: We’re coming to the half way point in your treatment and it might be helpful for us 
to review your goals. We might also establish some new goals. We’ve seen some 
improvement with your activities which is great. I want to ensure that in the second half 
of treatment that you stay on track. Is that ok? 
J: Sure.  I think that already I’ve picked up a few changes in myself that are pretty 
positive. I wasn’t doing any exercise at all before we started. Now I’m doing my 
weights and swimming. I’m walking the dog a lot more and more regularly. I’m doing a 
bit more walking around with my girlfriend. 
T: That’s the type of change we’re targeting. Good work. What other things would you 
like to be doing Jim? 
J: More socialising.  
T: What socialising have you got planned for this week? 
J: Well I’m taking my girlfriend out for dinner. That’s a definite. I’ll give you the report 
next week. I’m planning on going to the football with my friend “Charles”.  I’ve 
avoided him 2 weeks in a row, but I’ve set myself to go through with it this week. 
T: I have noticed that it’s come up for a couple of weeks now. 
J: I don’t think I’ve been to a WAFL game for about 40 years. 
T: I’ll be very interested to hear the outcome. 
    
This pattern of dialogue continues throughout the session. The therapist and client 
collaborate to review the client’s activities, schedule new activities, discuss goals, and 
describe the function of the client’s behaviour. 281      
 
 
 
   
T: So is increased socialising a clear target? 
J: It is, yes. I forgot to tell you that I went last week to visit my old friend, “Ray”. He’s 
the one with cancer who I had a bit of a falling out with. He’s pretty sick. He’s had two 
blood transfusions. I went straight to his place after I left here last week. 
T: And how long since you last saw him? 
J: About three or so years. I spent about seven hours with him last Saturday and when I 
left he put his arms around me and said, “Jim, I don’t want you to go”, “I’ve only got 
another six months left”. I told him, “Not to think that way”, but from speaking to his 
wife I know that it’s true. 
T: That’s quite something. Really remarkable. 
J: He made apologies for our split, but I told him not to blame himself altogether. I had 
a part to play as well. We’ve been friends a long time. Since I was seventeen. I told him, 
“I can’t turn my back on you, “Not just because you’re unwell, you’re one of my oldest 
friends”. 
T: Looking over your monitoring now, I see that you recorded quite a spike in anxiety 
when you first went to meet him. 
J: I didn’t know what to expect. When I left here to go see him I didn’t know what I was 
feeling. I was a bit shaky. I actually pulled over a bit up the road and got some take-
away and sat in the car for quite a while wondering if I could go through with it. Then I 
rang him and told him, “I’m running a bit late”. I had already phoned him to set the day 
up. I had scheduled that call in but I thought I had better check in with him. 
T: It’s very important to recognise that these types of events can cause anxiety in the 
short term, yet despite the anxiety you can still move forward according to your plans 
and goals. I notice that for the rest of the afternoon and evening your anxiety ratings 
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J: I felt ‘at home’ a while after I had been there. Maybe after about an hour or so. And I 
didn’t want to go myself. I didn’t leave there until late. I could have stayed all night. 
T: Are you planning on seeing him again? 
J: I was going to wait for him to call. He might not want to be seen to be ‘leaning’ on 
me though given he’s quite sick. 
T: He might be avoiding also? 
J: You might be right.  I’ll make the point of giving him a call first. I’ll take him out for 
the day as well. 
T: Can we schedule that in? 
J: Yes. I will definitely give him a call this week. I might take him out to the races. 
That’s something we used to enjoy.  
T: When was the last time you went to the races? 
J: Years ago. It’s been a while. Just one of those things. 
    
 This example demonstrates the large changes that can occur for the client in a relatively 
short period of time and is core BATA protocol. By the mid-point in BATA therapy, 
‘Jim’ had re-engaged with an old friend who was dying with cancer. They had not 
spoken for over three years. He planned to widen the reinvigorated relationship with 
new shared activities in fresh environments potentially rich in reinforcement for his 
‘healthy’ behaviours. In this discussion, the therapist and the client were able to review 
an activity, schedule a new activity, link the client’s behaviour to his goals, and discuss 
the function of anxiety-related behaviours. This type of behaviour (contacting an 
estranged friend) could prove to be a ‘cusp’ behaviour, with functional consequences 
for the client that extend far beyond the single activity. This type of socially important 
and clinically-relevant target behaviour is exactly what the BATA therapist should 
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   
SESSION 7 
In session 7 the therapist and the client should be starting to consolidate the gains made 
in the first 6 sessions of treatment. The client should be showing signs of increased 
‘activation’ and decreased ‘avoidance’ behaviours. The client should also be showing an 
improved ability to publicly formulate functional explanations for his or her clinically-
relevant behaviours. As usual, the session begins with the administration of the 
standardised measures, a review of the client’s self-monitoring diaries, and the 
provision of fresh forms. Then, the therapist should begin to ‘check-in’ with the client  
about his or her completed weekly activities. 
    
T: From your monitoring diary I can see that you have been quite busy this past week. 
Can you tell me about the activities that you have completed? 
J: I’ve tried everyday to do some exercise. Like riding on the exercise bike. I’ve been 
doing quite a bit of handyman work and also I’ve been organising the materials I need 
to build my project home on the land out in the country I’ve been telling you about. 
There’s quite a lot of work involved in that if I’m going to complete the project. 
T: Are you noticing any differences in your behaviour as you’re attending to your daily 
activities? 
J: I’ve noticed something which stands out a lot. It’s my ‘decision making’. I’m not as 
rushed as I used to be. I’m planning things before I act and I’m standing back and taking 
my time now. Before I used to ‘rush in’ and often regret my decisions. 
T: And what effect does this planning and deliberating have on your anxiety 
behaviours? 
J: I’m feeling less anxious. It’s not only with shopping for materials, it’s with a lot of 
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T: What other areas do you notice improvements with your anxiety? 
J: When I used to go to an appointment or something, I’d always be in a panic because I 
was fussing around or not watching the time. I notice now that I’m organising things 
better, and I schedule things in at a certain time of the day and I stick with the schedule. 
Before I was ‘all over the place’. 
T: So you’re organising your days better? 
J: I am. I amaze myself at how much better I’ve been managing things. 
    
In this example the therapist is assessing the client’s between session activation and 
whether increased activation is affecting the client’s anxiety related behaviours. Along 
with the increased activation the client is also reporting signs of decreased anxiety and 
improved self-management. He is deliberately changing external variables such as 
planning and then scheduling activities in his diary and using clocks and watches in 
order to gain ‘control’ over his anxious behaviours (e.g., ‘rushed’ decision making, 
lateness). He talks of completing smaller steps towards accomplishing his much larger 
goal of building a ‘project home’. One of the key aims of BATA is to help the client to 
better manage his or her behaviours according to clearly stated short and long-term 
goals, rather than acting mostly to minimise feelings of anxiety and to avoid the 
conditions that elicit them.  
    
T: What else have you been doing this past week? 
J: I went to the football game with my friend. That was great. We had a really good 
time. I actually had some conversation with some people there which is something I 
would normally ‘shy’ away from. Just when I was watching the game, I thought “I may 
as well strike up a conversation here”. It all happened pretty naturally. 
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J: I felt good. Confident. I’m never sure about people, but after I finished talking about 
the game and what not I thought to myself, “Those people are really no different to me”. 
I normally feel inferior and inadequate socially but that day things felt quite normal for 
me. 
T: And to what do you attribute that to? 
J: I think just putting myself in these situations and following through with it and not 
thinking too much about it. 
T: The key to behavioural activation is increasing your learning opportunities by 
entering into new environments and then you can open yourself up to all sorts of 
experiences, even everyday ones such as holding conversations with strangers. It’s 
enjoyable for you and at the same time you’re overcoming that fear of social situations. 
J: What you’ve said fits me to a ‘tee’. I had been stopping myself from just letting go 
and seeing what happens in life. 
T: That’s what I mean when I refer to you carrying out the ‘experiment’. Pick your 
targets for activation and follow through with your plans, then evaluate your outcomes. 
You might be surprised at the results of all these ‘mini’ experiments you’ve been 
conducting. The consequences will tend to shape your behaviour one way or the other. 
J: I’m starting to appreciate the difference it makes for me when I do different things, 
even small things. 
    
T: What activities are you going to schedule for this coming week? 
J: I’m planning on calling my sister and asking her and her partner and their kids to 
come over for dinner one night this week. 
T: That sounds important. 
J: I haven’t been in contact with her as much as I would have liked over the past few 
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T: Did you avoid contacting her? 
J: I did. I would often ignore her calls and I wouldn’t take her up on her invites. That’s 
pretty silly stuff I suppose. 
T: To me it’s not silly. It’s classic avoidance behaviour with a perfectly understandable 
function of limiting your contact with situations that had made you uncomfortable in the 
past. The problem is, of course, that you miss out on all the good stuff that comes with 
that contact. 
J: Well, I’m scheduling in to call her and I’m determined that I’m not going to worry 
about how I feel this time. I’m going to make it happen. 
T: That could be very important to you. 
    
J: I have a question for you. Can I be doing too much? I feel like if I keep going I might 
run out of things to do. 
T: Your time management is important. You must continue to attend to the practical 
aspects of your activation. Essentially though, you appear to be benefiting from an 
increased range of choice and an increased and varied range of activities in your 
everyday life. I think that this is the early stages of your recovery and with practice you 
will find a formula of activities that means you meet your goals and generally be 
satisfied with how you feel. 
J: So I’m trying to improve my quality of life? 
T: Exactly. It’s not about cramming as many things as possible into your day. Although 
that might work for someone else. It’s about finding the combination of activities that 
works best for you. It’s a mix of quality and quantity.  
J: Because I’ve been thinking about joining ‘Toastmasters’ to improve my public 
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T: That would be suitable for you given your problems with social anxiety and 
performing in public and could be beneficial. Why don’t you just go to a couple of 
meetings and see how it goes. Give it time, but if it doesn’t quite work for you then you 
can always choose to move on. But, it’s very important in the first instance that you 
keep coming into contact with these new environments as part of this program. Go 
through with the experiment and then evaluate yourself the outcomes. 
    
The session continues in this form of conversation which is guided by the parameters of 
BATA. The client is prompted to review past activities, schedule new ones, reflect on 
his or her goals, and identify the consequences of his approach and avoidance 
behaviours. The therapist continues to provide an amount of prompting and psycho-
education, including offering behavioural explanations for anxiety experiences in 
response to the client’s reports, in order to help him or her to adhere to the principles of 
behavioural activation therapy.  
    
SESSIONS 8 to 10 
In these sessions the therapist should continue to practice the key elements of BATA. At 
this point the client should have shown some signs of increased activation and a 
reduction in avoidance behaviours. If the therapist and client have correctly identified 
the function of the client’s past anxious behaviours and there has been the emergence of 
new non-anxious behaviours in the client’s existing behavioural repertoire then it is 
likely that there has been a corresponding reduction in the overall amount of reported 
anxiety in the client’s everyday life. The therapist continues to help the client to 
establish the new alternative ‘healthy’ behaviours. As usual, the session begins with the 
administration of the standardised measures, a review of the client’s self-monitoring 
diaries, and the provision of fresh forms. 288      
 
 
 
    
T: What have your activities been in this past week?  
J: I set myself a number of challenges this past week. One in particular, it was my 
birthday on Thursday and my sister phoned me up because she had organised a ‘get 
together’ for me with all my family and some of my friends. I was quite proud of myself 
that I said “yes” and went along to that. 
T: Was that something you would have previously avoided? 
J: Yes. When I got there I don’t think anyone could quite work out why I had actually 
turned up. Normally I would ignore the invite or avoid going and they would all just go 
out anyway as a sort of family get together. 
T: Your family expected you to avoid the occasion? 
J: Yes. I got congratulated by a few of them for having gone to the party. I even took 
two old friends along with me who are visiting from interstate and wanted to catch up 
with me. 
T: Incredible. You’re like new man. 
J: I feel like it. In some ways I’ve changed dramatically. 
T: And was it a positive experience?  
J: It was. I had a lot of fun and it was great to catch up with everyone. It’s been a while. 
    
J: I’m starting to see how there are so many things I do which are just avoidance or what 
you call ‘avoidance behaviours’. 
T: Can you provide an example? 
J: I had this way of extracting myself from conversations quickly. Just so I wouldn’t 
have had to keep going and maybe embarrass myself or something. I always said, “I’ll 
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“Why do you have to let me go”? Then I thought, “I don’t”, I can keep talking and I’m 
ok with it. 
T: Are you getting better at noticing moments of avoidance? 
J: Yes I am. I think I’ve maybe always known but you’ve made it very clear to me that 
that’s what going on. 
    
T: What’s on your schedule for this coming week? 
J: I’ve got a few social engagements booked. The friend that I told you about with 
cancer, well I’ll be going around for dinner this week. I’m determined to continue with 
the exercise. I want to do more actual bike-riding. I need to find some alternate routes 
though. It can get a bit boring just going the same way every time. I’ve got some more 
work to do towards my building project. I’ve got a pretty busy week coming up 
actually. 
T: Can you tell me more about what you’re talking about with regards to the bike-
riding?  
J: I can see the value in the activity. It’s good for my fitness and I’m outdoors for 
example. But, I know that if I want to keep it up I have to have some variety there to 
keep things interesting. I think about what you said about having, “lots of choices and a 
variety of things to do”. I Think that maybe I’ve started stuff before and when it’s 
gotten a bit boring I’ve just stopped instead of modifying it a bit to see if I can maintain 
that enthusiasm.  
T: That’s important to recognise. The activity itself might be very beneficial to your 
mental health and you might need to continue to adjust conditions as time goes by to 
maintain its value. That way, you are less likely to stop an activity that is actually pretty 
good for you in terms of mental health outcomes. 290      
 
 
 
J: I’ve certainly been learning quite a bit as we’ve gone along. I think I knew a bit 
already but you’ve added to that. 
    
T: At this point in your treatment, if someone asks you to do something, a social 
situation for example, then you have a choice. You can either avoid the situation or you 
can accept the invitation and enter into a contract with yourself. In this contract you 
agree to enter into a situation and then evaluate the outcomes after you have given 
yourself sufficient time to really contact that particular environment. 
J: Yes. I understand that. I think that in the past I acted like I didn’t have a choice. The 
anxiety was controlling me completely. 
T: To avoid has been like an automatic response for you. To pull away. 
J: It always has been.  
T: In the past nine weeks though, you haven’t been avoiding as much and you’ve been 
getting quite a lot achieved. And you’re telling me that your anxiety has reduced. 
J: It has. It certainly hasn’t gotten any worse. I do feel like I’m getting some control 
back. 
    
T: Do you think that you’re actions are reflecting the goals that you have set? 
J: They are. I did mean to tell you that I have a new goal I came up with this week. 
T: Good. What is it? 
J: I’m thinking about maybe trying to get a bit more into the workforce. Maybe trying to 
get some part time work in a hardware store or something similar. I know a lot about 
tools and building materials and I think I can work well with customers and the like. 
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J: I’ve been on a pension for my back for some time now but I think I can do more. I do 
my handyman work when I can. I think I’ve been hiding behind my back for a while 
now. Sort of using it as an excuse not to get out there and mix with society.  
T: I agree with you and I think there is a great deal that you could contribute to society. 
Now we have to identify the steps that it would take you to reach that goal. 
    
These real-time verbatim examples taken from the treatment sessions show how therapy 
progresses through these latter sessions in treatment. BATA is a brief principle-based 
treatment. Thus, the therapist does not have to deviate from the key elements of the 
protocol. The clear communication to the client is that increased activation and 
decreased avoidance has anxiolytic effects, expands the client’s behavioural repertoire, 
and can extend the client’s overall quality of life beyond only a reduction in anxiety.  
    
 
SESSIONS 11 and 12 
These are the final sessions of treatment and should be used to review all of the material 
thus covered in treatment along with the usual review of activities and the scheduling of 
future activities. The aim of these 2 sessions is to consolidate the gains achieved in 
previous sessions. The client should be made aware of the changes that he or she has 
made and the therapist should link those changes to efforts that the client has made to 
increase activation. The therapist should encourage the client to continue to build 
patterns of ‘approach’ behaviours beyond the end of treatment and independent of 
therapy. The therapist should also discuss with the client the possibility of relapses 
occurring especially if the client begins to avoid contact with sources of reinforcement 
for ‘healthy’ approach behaviours and reverts to old patterns of avoidance responding. 292      
 
 
 
As usual, the session begins with the administration of the standardised measures, a 
review of the client’s self-monitoring diaries, and the provision of fresh forms. 
    
T: You’re monitoring diary shows me that you’ve been busy. Is that correct? 
J: Yes. I’ve been very busy in fact and I haven’t put down all of my challenges on my 
activity log because a lot of them have been done on the spur of the moment. 
T: So there have been more spontaneous examples of activation? 
J: There has. I can see straight away now when I’m doing what I’ve set out to do and 
when I’m avoiding things for no good reason.  
T: Can you give me an example? 
J: I had a very difficult talk with my girlfriend this week which I had put off for some 
time. I got very nervous when I was about to talk to her but I thought, “It’s only my 
anxiety, I can still go through with this”. 
T: And what was the outcome? 
J: It was good. There were some things we needed to clear up. I’m as much at fault as 
she is but at least now we know where each other stand. 
T: So you would previously have avoided this? 
J: Definitely. I would just sort of ‘stew’ over it and imagine what the conversation 
would look like. I would never have done it though. 
T: Did you schedule that in? 
J: Yes. I picked a time and day when we would be together and asked if she would sit 
down because I had something important to talk to her about. 
T: That sounds like a good step. 
J: It was a relief and I think it actually helped us a lot. 
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T: We can never truly know the effect of an activity until we have entered into that 
activity and made contact with the actual properties of that event or place or 
environment. 
J: I’ve learned that. If I take us back weeks ago to when I first came to you, if you had 
of suggested I just get out and ‘do things’ I would have had that many excuses why I 
couldn’t. The way you did it though, this program, showed me how my avoidance 
worked. I had never even thought of my anxiety as avoidance until I came here. 
T: And without increased activation it’s likely that your anxiety behaviours would have 
become stronger, not weaker. 
J: I agree with that. My anxiety would not have improved one little bit and I think my 
mental health was deteriorating anyway as I got older. 
T: You’ve come along way but you’ve really just started your recovery. This is a 
relatively brief therapy. There is more work to come. The challenge for you is to take 
what you’ve learned, recognise your new ‘healthy’ behaviours and what they do for 
you, and take that forward.  
    
T: It’s important to acknowledge that not everything will be smooth sailing after we 
finish here and you might experience some set-backs as you continue to go forward 
setting yourself challenges and trying to meet your goals. 
J: I can see now that if I avoid the physical side of life to help the mental side, it doesn’t 
work. I need to keep in contact with life, not avoid it. 
T: It’s important that when you leave her that you keep focusing on your concrete 
everyday behaviours. You will need to keep scheduling activities and keep setting goals.  
J: You mean just focus on the things I do and don’t worry about what I feel and think? 
T: I mean to say that everything that you feel and think is a result of your external 
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in your thoughts and feelings then you need to alter your environment and act 
differently in the environment. 
J: I’ve started to realise that I have a lot of freedom with regards to how I can choose to 
rearrange my environment. There’s not some ‘power’ or ‘force’ coming into me that 
says “You have anxiety” or “You don’t have anxiety”. I can wallow in my anxiety or I 
can make choices and move on with my life. 
    
T: We saw that when you first came here your behaviours were oriented mostly towards 
avoiding or reducing your anxiety in the short-term. Now we see that at least some of 
the time your behaviours are oriented towards achieving your goals and completing 
your scheduled activities. That’s a significant change. 
J: It is. Before that I was justifying my behaviour by focusing on my feelings of anxiety. 
T: I think that you were trapped in very well established patterns of avoidance. 
J: I could write a book on avoidance. I used to procrastinate on everything. Now when 
I’m asked to do something I try to say, “Yes” instead of “I might”, or “I could”. If I look 
at something as an important step towards my mental health recovery then I’m going to 
do it. And I don’t just say I’ll do it, I remind myself by writing it down and scheduling it 
in. 
T: It’s going to be a challenge for you for some time until your ‘healthy’ non-anxious 
behaviours become more common and fully replace your ‘old’ anxious behaviours. You 
will have to put effort into pushing yourself along until your environments are such that 
your new  behaviours are being supported more naturally. 
J: I realise that. I don’t think I’ll go backwards. I’ve got a good foundation and I’ve had 
a good ‘kick-start’ here. I wont take it for granted and become complacent.  295      
 
 
 
T: Good. Because you’re still going to have to set goals, to plan and schedule activities, 
to enter into situations that might make you uncomfortable but that are important to you 
in the longer term. 
J: I realise that this program is like teaching. This is education. I’ve learned a lot while 
I’ve been here and it’s up to me to keep putting that learning into practice. I know I 
can’t change the past. It’s pointless going there. I have to look forward. 
    
T: With time and practice your new behaviours and the people, places and things that 
you contact will likely become more natural and less anxiety provoking. What we have 
done in this treatment is to take a structured approach towards changing your behaviour. 
J: It has helped a great deal. I was terrible at getting myself organised before I came 
here. 
T: The other final point I want to make, which I can’t stress enough, is that the places 
that you go to, the people you are with, and the things you do have an enormous 
influence on how you will feel and how you will think. 
J: It has a huge bearing. I was doing too much of the one thing which was avoiding and 
cutting myself off from the world. That was the most comfortable thing but it wasn’t 
very helpful to me. 
T: We had to assume at week 1 that practically everything you were doing was in 
someway functioning to maintain your anxiety. 
J: I was looking for short term relief but not looking at the longer term. I think back to 
when I made contact with my brother and how difficult that was. Now when I talk to 
him I feel very comfortable.  
T: In that example you actively blocked anxiety and you took a strong concrete step 
towards your goals. That’s the key. Set goals, schedule activities, and plan your 
behaviour.   296      
 
 
 
CONCLUDING NOTE 
These session by session examples of therapist/client dialogue were taken from an 
actual clinical case and reflect the typical course of BATA. This protocol was designed 
to show the fundamental principles of BATA and the main techniques and materials 
used in session by the therapist and those provided to the client. The protocol is 
designed to be delivered sytematically. However, following session 4 the remaining 
sessions should include a combination of the key elements of BATA including psycho-
education, goal setting, activity scheduling, activity reviewing, and functional analysis.   
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